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Background
Bile is the primary excretory route for organic compounds with low
water solubility. Cholesterol is a nonpolar lipid dietary constituent,
absorbed from  the small intestine, transported in blood and taken up by
the liver. The hepatocyte is the major site for cholesterol synthesis and its
elimination in bile. Hepatic secretion of bile salts and cholesterol into
bile is the basis for the elimination of excess cholesterol from the body.
First, this introduction will focus on the entero-hepatic circulation, the
intrahepatic homeostasis and the detergent activity of the bile salts.
Second, the cholesterol metabolism with the “reverse cholesterol
transport” pathway and the intestinal absorption of the sterol will be
summarized. Thereafter, the process of nascent bile formation at the level
of the hepatocyte canalicular membrane will be described as well as the
bile physiology within the biliary tract and the gallbladder. Finally, the
key role of bile salts and phospholipids in cholesterol solubilization in
bile will be discussed, together with cholesterol supersaturation and
crystallization at the basis of gallstone formation.
Cholesterol
Cholesterol is a steroid nonpolar lipid that is virtually insoluble in an
aqueous solution. The molecular structure of cholesterol is reported in
Figure 1.
Figure 1. The chemical structure of cholesterol (5-cholesten-3β-ol,
C27H46O)
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The hepatocyte is the major site for the synthesis of the sterol and its
elimination from the body. Cholesterol is thought to be present in the
hepatocyte as metabolic active free cholesterol and in a pool of
cholesterol esters. Cholesterol esters can be converted to free cholesterol
by cholesterol ester hydrolase (CEH) and the reverse process is catalysed
by acyl-CoA:cholesterol acyl transferase (ACAT).  The synthesis of
cholesterol in the hepatocytes is starting from three acetate molecules
derived from oxidation of fatty acids or carbohydrate. The rate-limiting
step in cholesterol neosynthesis is the reduction of 3-hydroxy-
3methylglutaryl coenzyme A (HMG-CoA) to mevalonate. The synthesis
of cholesterol is also regulated by sterol regulatory element binding
proteins (SREBP), which can cause upregulation of the enzymes
involved in cholesterol neosynthesis (1). The secretion of cholesterol
esters into blood and subsequent delivery to the tissues is mediated by
very low density lipoprotein (VLDL) particles. Figure 2 represents a
scheme of cholesterol metabolism (A) also in relation to various risk
factors (age, diet, obesity, hypertriglyceridemia and hormonal treatment)
for cholesterol gallstone disease (B).
Phospholipids
Phosphatidylcholine, the major (>95%) phospholipid in human bile, is
synthetized de novo in the hepatocytes, starting from diacylglycerol
assembly. Then, addition of choline phosphate occurs through a direct
transfer to diacylglycerol. However, an alternative pathway, the so called
“methylation” pathway, can occur during hepatic phosphatidylcholine
neosynthesis: newly synthetized phosphatidylethanolamine is converted
to phosphatidylcholine by addition of 3 N-methyl groups. Most of the
choline employed for phosphatidylcholine synthesis is derived from
dietary sources, and choline is an essential nutrient in the human diet.
Chapter 1
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Figure 2. A schematic representation of hepatic cholesterol metabolism
(A) also in relation to various risk factors for cholesterol gallstone
disease (B). C= free cholesterol.
Neosynthetized phosphatidylcholine has to reach the hepatocyte
canalicular membrane to be secreted into bile. How phosphatidylcholine
reaches the canalicular membrane of the hepatocyte for secretion into the
bile is still under debate. Three potential mechanisms may be involved in
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this puzzling event: vesicular traffic, monomeric exchange through the
action of cytosolic protein and lateral diffusion from the basolateral
plasma membrane (2). Recently, a specific phosphatidylcholine transfer
protein (PC-TP, a cytosolic protein that catalyzes intermembrane transfer
of phosphatidylcholines in vitro) has been cloned: its hepatic expression
as well as the genomic organization have been determined (3). The
proposed functions include the supply of phosphatidylcholine required
for secretion into bile and the facilitation of enzymatic reactions
involving PC synthesis or breakdown (3). However, PC-TP knock-out
mice show no differences in bile lipid content and composition as
compared with normal mice (4). Also, the fact that PC molecules with
18:0 acyl chains at the sn-1 position are the main phospholipids bound to
bovine PC-TP in vivo but do not occur in bile, is against a role for PC-TP
in intracellular transport of bile-destined PC (5).
Bile salts
The entero-hepatic circulation
Bile salts are anionic detergents synthetized from cholesterol
representing an important pathway for cholesterol catabolism. The
circulating bile salt pool comprises primary and secondary bile salts.
Primary bile salts (cholate and chenodeoxycholate) are synthetized de
novo from cholesterol while secondary bile salts (deoxycholate and
lithocholate) are produced in the colon by bacterial 7α-dehydroxylation.
The process of hepatic bile salt secretion, expulsion in the
gastrointestinal tract, reabsorption in the intestine and hepatic reuptake
from sinusoidal blood is called the “entero-hepatic circulation” (Figure
3).
Most bile salts are amidated in the liver with glycine or taurine.
Amidated bile salts are then secreted into bile (see “lipid secretion into
Chapter 1
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bile”) and after a period of storage in the gallbladder expelled to the
duodenum.
Figure 3. The entero-hepatic circulation of bile salts. Bile salts secreted
from the liver into bile, are expelled from the gallbladder into the
digestive tract following meal ingestion. Most of the bile salts are
reabsorbed in the ileum via a sodium-dependent transport, ASBT (see
text). A small fraction of bile salts escapes ileal reabsorption, reaches
the colon where they are deconjugated by anaerobic bacteria to
secondary hydrophobic bile salts (deoxycholate and lithocholate). These
secondary bile salts are partly reabsorbed by passive diffusion and reach
the liver, where they become part of the bile salt pool. ~95% of bile salts
secreted from the liver are coming from the entero-hepatic circulation
and ~5% from the neosynthesis from cholesterol molecules.
Normally, 95 to 99% of bile salts expelled into the intestine are
reabsorbed in the ileum. The first step of this active process is mediated
synthesis (5%)
recirculation (95%)
fecal excretion
hydrophobic
deoxycholate
Enterohepatic circulation of bile salts
to the liver
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by ileal apical sodium-dependent bile salt transporter (ASBT) (6;7).
Recently, it has been shown that ASBT plays an important role in
increasing bile salt pool size (8). ASBT is upregulated in case of large
amounts of bile salts in the ileal lumen and downregulated in case of low
amounts of ileal bile salts.
A small fraction of small intestinal bile salts escapes ileal absorption and
reaches the colon, where bile salts are deconjugated by anaerobic
bacteria. The resulting secondary bile salts, deoxycholate (DC, from 7α-
dehydroxylation of cholate) and lithocholate (LC, from 7α-
dehydroxylation of chenodeoxycholate) are partly absorbed by passive
diffusion, return to the liver and are reamidated. DC is therefore part of
bile salt pool and LC is first sulfated and glucuronidated in the
hepatocyte before being secreted in bile.
Bile salt homeostasis
Two major pathways are described in the bile salt synthesis process: the
classic “neutral” pathway employing the microsomal cholesterol 7α
hydroxylase (CYP7A), which induces hydroxylation of cholesterol at the
7α position and the “alternative” pathway employing the mitochondrial
cholesterol 27 hydroxylase, which induces 27-hydroxylation (9). The
transgenic CYP7A knockout mice support the relevance of the
“alternative” bile salt synthesis pathway since at maturity, they
synthetize primary bile salts in sufficient quantities to survive and digest
normally (10). Oxysterol 7α-hydroxylase is required for bile salt
biosynthesis via the alternative pathway. Sterol-12α-hydroxylase is the
rate-controlling enzyme determining the ratio of the two primary bile
salts (cholate to chenodeoxycholate), thus regulating the hydrophobicity
of the bile salt pool (11). Recent studies have investigated the role of the
Chapter 1
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orphan nuclear receptors LXR (liver X receptor) and FXR (farnesoid X
receptor) on stimulating or inhibiting bile salt synthesis, resp.
Figure 4. Bile salt homeostasis as adapted from Moseley (19). Bile salts
are taken up from sinusoidal blood by NTCP. In order to modulate the
intracellular bile salt concentration, bile salt-activated FXR induces shp-
mediated downregulation of NTCP (which results in decreased bile salt
uptake) and upregulation of bsep (an ATP-dependent transport protein
which mediates bile salt transport across the hepatocyte canalicular
membrane (18)). Also, FXR-induced activation of shp suppresses CYP7A
activity (decreased bile salt synthesis). On the other hand, cholesterol
taken up from sinusoidal blood by LDL receptors (LDLr) and scavenger
receptors (SRB1) is oxidated to oxysterols (Ox). Oxysterol-induced LXR
activation promotes neosynthesis of bile salts from cholesterol by
upregulating CYP7A.
Oxysterols, formed by the oxidation of cholesterol in the liver, activate
LXR which has been shown to upregulate the mRNA transcription of
cholesterol 7α-hydroxylase (Figure 4), thus stimulating the classic bile
salt synthesis pathway (12). On the other hand, FXR represses the
mRNA transcription of cholesterol 7α-hydroxylase (Figure 4), thus
inducing downregulation of bile salt synthesis (13). This process is
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important in maintaining hepatic bile salt homeostasis. In fact, bile salts
are downregulating the mRNA transcription of cholesterol 7α-
hydroxylase, via FXR-mediated activation of the inhibitory nuclear liver-
enriched orphan receptor shp (small heterodimer partner) (14;15). Also,
it has been recently shown that bile salts are able to induce a
downregulation of the sinusoidal sodium/bile salt cotransporter mRNA
levels (NTCP, the main uptake system for bile salts at the hepatocyte
sinusoidal membrane (16)) by FXR-mediated activation of shp (17).
Last, the bile salt export pump (an ATP-dependent transport protein
which mediates bile salt transport across the hepatocyte canalicular
membrane (18)) appears to be upregulated by high intracellular bile salt
levels (19). Intracellular bile salt homeostasis is shown schematically in
Figure 4.
In line with these findings, FXR -/- mice have decreased mRNA levels of
bsep and increased mRNA levels of cholesterol 7α-hydroxylase (20). On
dietary challenge with cholate, FXR -/- mice develop severe
hepatotoxicity reflecting the inability of these mice to deal with bile salt
overload. These findings indicate that FXR plays a critical role in
protecting the liver against pathological levels of bile salts and is a major
regulator of bile salt homeostasis (21).
Detergent properties of bile salts
Bile salts may present as “good” or “bad” guys (22). The good aspect is
their effect in intestinal lipid absorption, bile formation and cholesterol
solubilization. The “bad” aspect is the bile salt-induced extracellular and
intracellular toxicity.
Extracellular toxicity
Bile salts are amphiphilic compounds that act as detergents above their
critical micellar concentration. The cytotoxic effect of bile salts has been
Chapter 1
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shown for hepatocytes (23), erythrocytes (24-26) and mucosa of various
organs, including stomach (27), intestine (28) and gallbladder (29;30).
The damaging effects of bile salts depend on their degree of
hydrophobicity (31) and on the cell membrane composition (32).
Figure 5. Protection of phospholipids against bile salt-induced cell
damage. In normal conditions, phospholipids incorporated in bile salt
mixed micelles within the canalicular lumen protect against bile salt
cytotoxicity. On the other hand, in absence of phospholipids in bile (like
in mice with homozygous disruption of the mdr-2 gene), bile salts are
inducing hepatocytic as well as cholangiocytic damage.
At physiological concentrations, in bile in the gallbladder and bile ducts
and within the intestinal lumen, bile salts are associated with
phospholipids and cholesterol in mixed micellar structures. However,
significant amounts of bile salts are also present under these conditions
as monomers and as "simple" micelles (i.e. without incorporated
phospholipids). There is some evidence that this so called "intermixed
bile salts phospholipids bile salts phospholipids
Normal Mdr2 (-/-) mouse
mixed micelles
Mdr2 (-/-)
knockout
cell
damage
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micellar-vesicular bile salt concentration" (IMC: bile salt monomers +
simple micelles) (33), may be responsible for the potentially damaging
effects on membrane bilayers (34;35).
At the concentrations occurring in hepatic and gallbladder biles, bile salts
could theoretically damage the apical membrane of the hepatocytes and
of the cells lining the biliary tract. The absence of such a damaging effect
in vivo suggests the existence of cytoprotective mechanisms either at the
level of the cell membrane or within biliary micelles. Increased
concentrations of cholesterol and phospholipids (in particular
sphingomyelin) in the hepatocyte canalicular membrane appear to protect
against cytotoxic effects of the bile salts within the canalicular lumen
(36-38). On the other hand, in in vitro studies, inclusion of egg yolk
phosphatidylcholine (PC) within bile salt micelles protects in a
concentration-dependent manner against bile salt-induced cytotoxicity
(39). In line with these findings, mice with homozygous disruption of the
mdr2 gene exhibit severe bile salt-induced hepatocyte damage in vivo:
since mdr2 encoded P-glycoprotein -which normally functions as a
"flippase" transporting PC molecules from the inner to the outer leaflet
of the hepatocytic canalicular membrane- is absent, there is virtually no
PC protecting against bile salt-induced hepatotoxicity in bile of these
mice (Figure 5 (40)).
Intracellular toxicity
Intracellullar toxicity caused by conjugated bile salt occurs in the intact
cell only when a transporter is present in the cell membrane that permits
conjugated bile salts to enter the cell. Bile salt intracellular toxicity has
been investigated extensively for hepatocytes (41) and cholangiocytes
(42). In the hepatocyte of healthy people, bile salt uptake is followed by
rapid elimination. When the elimination is impaired, bile salts
accumulate intracellularly, leading to mitochondrial damage and
Chapter 1
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ultimately to apoptosis and necrosis (43;44). Unconjugated bile salts,
being hydrophobic and membrane permeable, are highly cytotoxic to
isolated cells in vitro, since they can readily accumulate to intracellular
toxic levels. Cytotoxicity attributable to unconjugated bile salts in vivo
(like secondary hydrophobic DC) is of importance for the pathogenesis
of colon cancer. In this respect, it should be noted that high-fat diet
promotes bile salt accumulation in feces, where enteric bacteria
metabolize them to produce secondary bile salts, principally
deoxycholate and lithocholate (45). Epidemiological and experimental
studies have indicated a consistent correlation between increased risk of
colon cancer and elevated levels of fecal bile salts in Western
populations that consume high-fat diets (46;47). Consistent with this,
studies on animal models of colon carcinogenesis have demonstrated that
the secondary hydrophobic bile salt deoxycholate (DC) acts as tumor
promoter, inducing hyperproliferation (48;49) and increasing the number
of tumors elicited by complete carcinogens (50). Also, DC has been
proven to be involved not only in the stimulation of DNA synthesis, but
also in DNA degradation. Indeed, it has been shown that DC is also able
to induce apoptosis in some adenoma and carcinoma cell lines (51).
Cholesterol metabolism
The molecular mechanisms regulating the amount of dietary cholesterol
retained in the body as well as the elimination of cholesterol from the
body are of extreme importance, since excess cholesterol accumulation
in the body is associated with two of the major diseases of Western
countries; atherosclerosis and gallstone disease.
Hepatic cholesterol uptake and “reverse cholesterol transport”
Selective LDL related- and LDL receptors are involved in the hepatocyte
sinusoidal membrane uptake of esterified cholesterol from chylomicrons
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and low-density lipoproteins. After transfer to the lysosomes, LDL is
degraded with release of free cholesterol (52). In patients with Nieman
Pick type C disease (NPC) this process is blocked; as a result, there is an
accumulation of cholesterol in lysosomes, suggesting that the protein
encoded by the gene mutated in NPC disease is probably involved in
cholesterol intracellular trafficking (53;54).
HDL (high density lipoprotein) particles are thought to be the main
source for cholesterol secreted into bile, possibly by tranfer within the
bilayer from the sinusoidal to the canalicular side (55).
HDL cholesterol, which originates in peripheral tissues, returns to the
liver through the so called “reverse cholesterol transport pathway”
(Figure 6).
Figure 6. The “reverse cholesterol transport” pathway. ABCA1-
controlled cholesterol cellular efflux to HDL, hepatic HDL cholesterol
reuptake (SRB1) and intestinal dietary and biliary cholesterol absorption
(SRB1, ABCG5/G8). ABCA1 is the protein mutated in Tangier Disease.
C=cholesterol
catabolism
liver
intestine
efflux
peripheral/macrophages
C ABCA1 HDL-C
(serum)
C bileSRB1
Tangier
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ABCG5 / G8 SRB1
C
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This process is thought to play an essential role in the prevention of
atherosclerosis. Recently, a new scavenger receptor (SR-B1) has been
identified on the hepatocyte sinusoidal membrane, which binds HDL
particles by a process of “docking” (no internalization of the HDL
particle) (56). A protein strongly associated to this pathway is ABCA1,
the protein mutated in Tangier Disease (a rare autosomal recessive
disorder characterized by low circulating levels of HDL and the
appearance of cholesterol-engorged macrophages and reticuloendothelial
cells (57)). ABCA1 is a cellular ATP-binding cassette (ABC) transporter
which influences the cellular efflux of free cholesterol and phospholipids
to apoliprotein A-I in the HDL particles from the peripheral cells.
ABCA1 may also play a key role in intestinal cholesterol absorption (see
further).
Intestinal cholesterol absorption
The diffusion of cholesterol from lipid rich-phases of the intestinal
contents to the intestinal epithelium needs an aqueous interface and is
dependent on the solubilisation of dietary and biliary cholesterol by bile
salts. PC is necessary for micellar cholesterol solubilization together with
bile salts in bile (58). On the other hand, incorporation of PC in bile salt-
cholesterol mixed micelles suppresses cholesterol uptake by intestinal
cells in vitro (59-61). Also, it has been shown that PC hydrolysis by
phospholipase A2 inhibits the micellar PC-induced suppression of
cholesterol absorption in vitro (62). In contrast, the mdr-2 knockout
mouse, which lacks PC molecules in bile, displays decreased intestinal
cholesterol absorption (63).
Also, the intestine displays a high rate of cholesterol biosynthesis which
-under certain conditions- may even exceed synthesis in the liver (64).
Intestinal mucosa is also involved in cholesterol esterification (65) and
synthesis of various apolipoproteins (66). Furthermore, the enterocytes
General introduction
15
are a site for release of chylomicrons, nascent high density lipoprotein
and an intestinal  form of low density lipoprotein (67;68). Animal studies
have shown that jejunum and ileum combined account for 7% whole
body LDL (low density lipoprotein) clearance (69), and it has been
shown by immunohistochemistry that LDL receptors are present
throughout the rat intestine (70). Intestinal HMG-CoA reductase and
LDL receptor-mediated uptake of cholesterol are coordinately regulated
in response to diminished or increased fluxes of dietary cholesterol into
the intestinal mucosa, so that mucosal cholesterol concentrations remain
constant (71). Also, a recent study has shown that a scavenger receptor
class B type 1 (SRB1) in the intestinal brush border membrane may
facilitate the uptake of intestinal cholesterol from either bile salt micelles
or phospholipid vesicles (72). This receptor can also function as a port
for several additional classes of lipids, including cholesteryl esters,
triacylglycerols, and phospholipids. In liver and steroidogenic tissues, the
physiological ligand of this receptor is high-density lipoprotein. Indeed,
Hauser et al. (72) have shown that binding of high-density lipoprotein
and apolipoprotein A-I to SRB1 inhibits uptake of cholesterol by the
brush border membrane from lipid donor particles. This finding supports
the conclusion that SRB1 influences intestinal cholesterol uptake. Recent
studies have also shown that LXRs (liver X receptor) prevent
overaccumulation of sterols in the intestine and macrophages (73). In the
small intestine, increased dietary and/or biliary cholesterol activates
LXR-induced upregulation of at least three ABC transporters, ABCA1,
ABCG5 and ABCG8 (74). In the enterocyte, these transporters are
hypothesized to increase cholesterol efflux into the intestinal lumen and
thereby decrease net intestinal sterol absorption. Consistent with these
findings, patients with sitosterolemia (a rare autosomic recessive disease
with hyperabsorption of cholesterol and non-cholesterol sterols) have
mutations in the ABCG5 and ABCG8 genes (75;76).
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The role of ABCA1 in intestinal cholesterol absorption has recently been
studied in ABCA1 -/- mice, which have a phenotype similar to that of
human Tangier Disease (77;78). Controversial data are present in the
literature. McNeish et al (77) reported an increase of dietary cholesterol
absorption in ABCA1 knockout mice. It has therefore suggested that
ABCA1 may also facilitate resecretion of cholesterol into the intestinal
lumen (79). On the other hand, Drobnik et al. (80) with the aid of a dual
stable isotope technique, concluded that there was a significant reduction
(about 11%) in intestinal cholesterol absorption in the Abca1 -/- as
compared with the wild-type mice.
Canalicular bile formation
Hepatocyte canalicular membrane
The hepatocyte plasma membrane is functionally divided into a
canalicular (or apical) region adjacent to the lumen of the bile
canaliculus and a sinusoidal (or basolateral) region in close contact with
sinusoidal blood. Although the canalicular region comprises only 10-
15% of the total plasma membrane, it plays a crucial role in the process
of nascent bile formation and biliary secretion of bile salts, phospholipids
and cholesterol.
Both phosphatidylcholine and sphingomyelin are the major
phospholipids of the canalicular membrane outer leaflet (38;81). In
contrast, phosphatidylcholine is the exclusive (>95%) phospholipid in
bile. Also, acyl chain compositions of phosphatidylcholines in the
canalicular membrane and in bile are different: whereas
phosphatidylcholine composition in the membrane is relatively
hydrophobic (mainly 16:0-18:2 PC, 16:0-20:4 PC, 18:0-20:4 PC and
18:0-18:2 PC), relatively hydrophilic phosphatidylcholines (16:0-18:2
PC and 16:0-20:4 PC) are found in bile (82). A similar phenomenon
appears to occur for sphingomyelins, since canalicular membrane
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sphingomyelins contain mainly long (>20 C-atoms) saturated acyl chains
amidated to the sphingosine backbone, whereas the trace amounts of
sphingomyelin in bile contain mainly 16:0 acyl chains (83).
Sphingomyelin is located predominantly in the external hemileaflet of
the canalicular membrane (84). In most eukariotic cels, plasma
membrane cholesterol is located mostly on the inner hemileaflet of the
plasma membrane. However, cholesterol has a high affinity for
shingomyelin (85-87) and is thought to be preferentially located together
with this phospholipid -and with specific GPI-anchored proteins
involved in transmembrane signalling- in laterally separated domains
(“rafts”) that are detergent-resistant with low fluidity (Figure 7).
Lipid secretion into bile
A schematic model for canalicular bile secretion is shown in Figure 7.
In recent years, there has been considerable progress in understanding
lipid transport mechanisms over the canalicular membrane: mdr (multi
drug resistance) 2 P-glycoprotein functions as a "flippase" translocating
phosphatidylcholine molecules from the inner to the outer leaflet of the
canalicular membrane (40) and the bile salt export pump (bsep), an ATP-
dependent transport protein, mediates bile salt transport across the
membrane (18).
The relationship between bile salt and lipid secretion is curvilinear; the
secretion of both phospholipids and cholesterol plateaus at high bile salt
secretion rates (88). However, the phospholipid secretion rate is always
higher than that of cholesterol. The quantity of the bile salt-induced
biliary lipid secretion is positively related to the hydrophobicity of the
bile salt species secreted (89).
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Figure 7. Canalicular bile formation. The outer leaflet of the hepatocyte
canalicular membrane may contain detergent-sensitive domains with
bile-destined phosphatidylcholine species, that have unsaturated acyl
chains at the sn-2 position, together with small amounts of 16:0
sphingomyelin and cholesterol. In constrast, laterally separated domains
of sphingomyelin with long (≥ 20 C atoms) saturated acyl chains,
together with disaturated phosphatidylcholine species and cholesterol
are detergent-resistant.
Secretion of "flipped" phosphatidylcholine from the outer leaflet into the
canalicular lumen might happen in two ways: formation of vesicles from
the external  hemileaflet of the canalicular membrane or solubilization of
phosphatidylcholine molecules by bile salts micelles. With the aid of
ultrarapid cryofixation and electron microscopic imaging, Crawford et al.
could visualize significant amounts of unilamellar vesicles within the
canalicular lumen, consistent with a vesicular mode of lipid secretion
(90). Nevertheless, both experimental data and theoretical considerations
indicate that detergent bile salts, after their secretion into the canalicular
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cholesterol
saturated PC’s
Chol
+ PLand/or vesiclesmicelles
Bile salt
monomers
unsaturated
phosphatidylcholines
cholesterol
Canalicular
membrane:
outer leaflet
Canalicular
lumen
unsaturated PC’s
cholesterol             16:0-
sphingomyelin
trace amounts 16:0
sphingomyelin
detergent-sensitive detergent-resistant
General introduction
19
lumen,  should micellize directly considerable amounts of lipid from the
membrane (91;92).
Also, cholesterol secretion can occur in the absence of phospholipid
secretion, based on experiments with mdr2 deficient mice: in this model,
the presence of a hydrophobic bile salt pool (induced by infusion of the
hydrophobic bile salt deoxycholate) is sufficient for the extraction of
cholesterol from the canalicular membrane in apparent absence of
vesicles, since PC is not secreted under these circumstances (92).
From cholesterol solubilization to cholesterol crystallization
Cholesterol is poorly soluble in an aqueous environment, and is
solubilized in bile in mixed micelles by bile salts (BS) and phospholipids
(PL). Phosphatidylcholine is the major phospholipid in bile (>95% of
total: mainly 16:0 acyl chains at the sn-1 position and mainly unsaturated
(18:2>18:1>20:4) acyl chains at the sn-2 position (93)). In case of
cholesterol supersaturation, the excess sterol may be contained in
vesicles together with phospholipids (94;95) or precipitated as solid
crystals. The landmark studies of Wang & Carey (96) have revealed the
importance of the relative amounts of bile salts vs phospholipids in the
system for crystallization behavior. In case of excess bile salts
(PL/(BS+PL) ratios ~≤0.2), crystals precipitate at fast rates, and both
various intermediate anhydrous cholesterol crystals (needles, arcs,
tubules, spirals) and mature rhomboid cholesterol monohydrate crystals
can be detected by microscopy. In case of higher amounts of
phospholipids, crystal precipitation proceeds at slower rates (with
predominant formation of mature cholesterol monohydrate crystals), and
large amounts of cholesterol are solubilized in vesicles together with
phospholipids. In case of excess phospholipids (high PL/(BS+PL)
ratios), solid cholesterol crystals do not occur, and cholesterol is mainly
solubilized in vesicular phases. Based on these data, the equilibrium
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cholesterol-bile salt-phospholipid ternary phase diagram (Figure 8
(96;97)) is assumed to contain a one-phase zone (only micelles), a left
two-phase (micelles and cholesterol crystals-containing) zone, a central
three-phase (micelles, vesicles and cholesterol crystals-containing) zone
and a right two-phase (micelles and vesicles-containing) zone.
Figure 8. The ternary equilibrium cholesterol-bile salt-phospholipid
phase diagram (96). The components are expressed in mol percent.
Depicted are a one-phase (micellar) zone at the bottom, a left two-phase
zone (containing micelles and crystals), a central three-phase zone
(containing micelles, vesicles and crystals) and a right two-phase zone
(containing micelles and vesicles). On the basal axis is also depicted an
axis which takes into account the PL/(BS+PL) ratios. Interrupted line
indicates identical PL/(BS+PL) ratios for all model biles plotting on the
line (in this case PL/(BS+PL) ratio = 0.8)
In case of disaturated phospholipids and/or hydrophilic bile salts, the
right two-phase (vesicles and micelles-containing) zone is greatly
expanded to the left at the expense of the crystals-containing (central
three-phase and left two-phase) zones (Figure 9 (96;97)).
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Figure 9. (A) The ternary equilibrium cholesterol-bile salt-phospholipid
phase diagram, see legend figure 7 (96). (B) In case of di-saturated
phospholipids and/or hydrophilic bile salts, the right two-phase (vesicles
and micelles-containing) zone is greatly expanded to the left at the
expense of the crystals-containing (central three-phase and left two-
phase) zones (96;97).
●= bile 1 plotting in the three-phase (crystals-containing) zone in case
of hydrophobic bile salts or unsaturated phospholipids (A), but in the
right-two phase zone (without crystals) in case of hydrophilic bile salts
or saturated phospholipids (B), despite unchanged molar % bile salts,
phospholipids and cholesterol.
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Therefore, a cholesterol-supersaturated bile of (patho)physiogical
significance (e.g. bile 1 in Fig. 9) may plot in the three-phase (crystals-
containing) zone in case of hydrophobic bile salts or unsaturated
phospholipids, but in the right-two phase zone (without crystals) in case
of hydrophilic bile salts or saturated phospholipids, despite unchanged
molar % bile salts, phospholipids and cholesterol. As a result,
hydrophibic bile salts and saturated phospholipids might theoretically
prevent cholesterol crystallization and gallstone formation.
Cholesterol crystals and gallstone formation
Cholesterol gallstones are composed mainly of cholesterol and can be
defined by a weight fraction of cholesterol that is greater than 70%
cholesterol (98). The remainder of the cholesterol gallstone is a mixture
of biliary glycoproteins, calcium salts and bile pigments (99).
Cholesterol gallstones are organic concretions that represent
agglomerates of monohydrate cholesterol crystals (Figure 10), usually
oriented with the long axes radiating outward from the center of the
stone and held together by an organic matrix of glycoproteins (100).
Figure 10. Crystalline structures of monohydrate and anhydrous
cholesterol. Arrows indicate a plate-like monohydrate cholesterol crystal
(left panel) and arc-shaped or tubule-like anhydrous cholesterol crystals
(right panel).
monohydrate
10 um
anhydrous
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In nature, cholesterol can exist in two different crystalline forms,
anhydrous and monohydrate (Figure 10), both of which have been
visualized in human bile of cholesterol gallstone patients (101). The
structures of those crystals have been described by Craven (monohydrate
crystals (102)) and by Shieh et al (anhydrous crystals (103)).
The process of cholesterol crystal formation in human or model bile has
been the object of various studies. Rearrangements of cholesterol-
containing lipid particles (micelles and vesicles) occur before nucleation
and crystallization. Within the gallbladder, bile is concentrated due to the
water absorption (total lipid conc. from 2.4 to 7.3 g/dL, hepatic vs
gallbladder bile, resp. (104)) and micellar cholesterol carrying capacity
increases, as shown by the increase in the one-phase zone (only micelles)
of the equilibrium ternary phase diagram (96). Also, during bile
concentration in the gallbladder, there is an increase in vesicular
cholesterol/phospholipid ratios, with vesicular instability as a result.
Vesicles aggregate and fuse (thus initiating the process of cholesterol
nucleation and precipitation) in supersaturated bile when vesicular
cholesterol/phospholipid ratio reaches values above 1 (105-107).
Rhomboidal plates can be seen emerging from aggregated vesicles by
phase-contrast microscopy (107).
Support for the “vesicular” pathway of cholesterol crystallization is
coming from the observation that nucleation-promoting proteins disrupt
vesicles (108) and accelerate vesicular aggregation (105). Also, proteins
that prolong crystal nucleation time, like apolipoprotein A-I, prevent
vesicle fusion (109). A cryo transmission electron microscopy (cryo-
TEM) study supports the role of small unilamellar vesicles as key players
in cholesterol nucleation (110). Recently, with the aid of video-enhanced
light microscopy combined with time-lapse cryo-TEM, Konikoff et al.
(111) have visualized the microstructural evolution of lipid aggregates in
nucleating model and human biles. This study pointed to the role of
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vesicular (uni- and multi-lamellar) aggregates in the nucleation process.
Nevertheless, mixed micelles could also play a role in crystal formation
(“micellar” pathway). First, mixed micelles coexisting with cholesterol-
enriched vesicles may also be supersaturated (112). Second, in bile salt-
cholesterol model systems, cholesterol crystals may form in absence of
phospholipids, and cholesterol crystals have been suggested to derive
from the micellar phase in vivo (113).  Also, some native biles of
cholesterol gallstone patients plot in the left-two (micelles plus crystals-
containing) zone of the equilibrium ternary phase diagram and present
the crystallization sequence of the left-two phase zone (arc-shaped
crystals transformed via helices and tubules into plate-like monohydrate
cholesterol crystals without formation of vesicles (114)). Finally, with
the aid of an accurate technique for isolation of micellar and vesicular
cholesterol carriers, it has been shown that some gallbladder biles of
cholesterol gallstone patients did not contain vesicles (115).
Also, in a recent report, patients with intrahepatic cholesterol stones were
found to have only small amounts of biliary phospholipids, due to a
mutation in the MDR3 gene (116). One may speculate that these patients
do not have sufficient vesicular cholesterol solubilizing capacity (and
possibly biles plotting in the left-two phase zone of the ternary phase
diagram). As a result, fast crystallization from supersaturated micelles
might occur immediately after biliary lipid secretion, with hepatic
gallstones as a result. These findings point to the important (but still
often ignored) role that genetic defects may play in human cholesterol
gallstone formation (117).
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Aims of the thesis
The present work investigates the distribution of cholesterol and various
phospholipids between biliary lipid carriers and the “good” and “bad”
sides of  bile salts.
The following questions will be addresses in this thesis:
 What are the problems with the techniques for separating micelles
and vesicles? Is it possible to have an accurate isolation of biliary
lipid carriers?  (chapter 2)
 What is the influence of bile salt and phospholipid species on
cholesterol crystallization? (chapter 3)
 Are in model systems sphingomyelin and phosphatidylcholine (the
phospholipids involved in bile formation) distributing differently
between vesicular and micellar phases representing canalicular
membrane and bile lipids? (chapter 4)
 Is cholesterol influencing vesicle → micelle transitions of
sphingomyelin-phosphatidylcholine containing bilayers induced by
detergent bile salts? What are the intermediate lipid structures?
(chapter 5)
 Is there a protective effect for sphingomyelin against bile salt-induced
cytotoxicity? (chapter 6)
 Are there any lipid changes in bile of patients with obstructive
jaundice especially with regard to phospholipid classes? (addendum
to chapter 6)
 Are various hydrophobic/hydrophilic bile salts influencing the
distribution of sphingomyelin and phosphatidylcholine between
micellar and vesicular phases? (chapter 7)
  Is the diet constituent sphingomyelin protecting against bile salt-
induced intracellular cytotoxicity with potential implications for
colon cancer? (preliminary data in chapter 8).
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Abstract
Gel filtration with bile salts at intermixed micellar/vesicular
concentrations (IMC) in the eluant has been proposed to isolate vesicles
and micelles from supersaturated model biles, but the presence of
vesicular aggregates makes this method unreliable. We have now
validated a new method for isolation of various phases. First, aggregated
vesicles and -if present- cholesterol crystals are pelleted by short
ultracentrifugation. Cholesterol contained in crystals and vesicular
aggregates can be quantitated from the difference of cholesterol contents
in the pellets before and after bile salt-induced solubilization of the
vesicular aggregates. Micelles are then isolated by ultrafiltration of the
supernatant through a highly selective 300 kDa filter and unilamellar
vesicles by dialysis against buffer containing bile salts at IMC values.
Lipids contained in unilamellar vesicles are also estimated by subtraction
of lipid contents in filtered micelles from lipid contents in (unilamellar
vesicles+micelles containing) supernatant (“subtraction method”).
“Ultrafiltration-dialysis” and “subtraction” methods yielded identical
lipid solubilization in unilamellar vesicles and identical vesicular
cholesterol/phospholipid ratios. In contrast, gel filtration yielded much
more lipids in micelles and less in unilamellar vesicles, with much higher
vesicular cholesterol/phospholipid ratios. When vesicles obtained by
dialysis were analyzed by gel filtration, vesicular
cholesterol/phospholipid ratios increased strongly, despite correct IMC
values for bile salts in the eluant. Subsequent extraction of column
material showed significant amounts of lipids. In conclusion, gel
filtration may underestimate vesicular lipids and overestimate vesicular
cholesterol/phospholipid ratios, supposedly because of lipids remaining
attached to the column. Combined ultracentrifugation-ultrafiltration-
dialysis should be considered state-of-the-art methodology for
quantification of cholesterol carriers in model biles.
INTRODUCTION
Precipitation of cholesterol crystals from supersaturated bile is a
prerequisite for gallstone formation (1). The sterol molecule is poorly
soluble in an aqueous environment, and is solubilized in bile in mixed
micelles together with bile salts and phospholipids (mainly
phosphatidylcholine). In case of cholesterol supersaturation, the sterol
may also be solubilized in vesicles together with phospholipids (2-5).
Crystals may precipitate from cholesterol-enriched vesicles after their
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aggregation and fusion (6-8). Accurate quantification of vesicular and
micellar phases is important in order to increase insight in the process of
crystallization and gallstone formation.
Apart from extent of cholesterol supersaturation and total lipid
concentration, the relative amount of bile salts vs phospholipids is also an
important factor in cholesterol crystallization. In case of excess bile salts
(phospholipid/(bile salt+phospholipid) ratios ~≤0.2), crystals precipitate
at fast rates, and both various intermediate anhydrous cholesterol crystals
(needles, arcs, tubules, spirals) and mature rhomboid cholesterol
monohydrate crystals can be detected by microscopy. In case of higher
amounts of phospholipids, crystal precipitation proceeds at slower rates
(with predominant formation of mature cholesterol monohydrate
crystals), and large amounts of cholesterol are solubilized in vesicles
together with phospholipids. In case of excess phospholipids (high
phospholipid/(bile salt+phospholipid) ratios), solid cholesterol crystals
do not occur, and cholesterol is mainly solubilized in vesicular phases.
Based on these data, the equilibrium cholesterol-bile salt-phospholipid
ternary phase diagram (Fig. 1: (9)) is assumed to contain a one-phase
zone (only micelles), a left two-phase (micelles and cholesterol crystals-
containing) zone, a central three-phase (micelles, vesicles and cholesterol
crystals-containing) zone and a right two-phase (micelles and vesicles-
containing) zone.
Apart from mixed micelles, bile contains non-phospholipid associated
bile salts, either as monomers or -above their critical micellar
concentration- associated in simple micelles. The monomeric plus simple
micellar bile salt concentration is referred to as “intermixed
micellar/vesicular concentration”, usually abbreviated as “IMC” (10).
The fact that vesicles and mixed micelles are in a delicate dynamic
balance with bile salt monomers and simple micelles makes accurate
isolation and purification technically difficult. Most isolation procedures,
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like gel filtration and density gradient ultracentrifugation, inevitably
cause dilution of the sample, which may change the IMC and hence the
distribution of lipids between vesicles and micelles. Recently, a
centrifugal ultrafiltration procedure was developed to rapidly measure
IMC values in model biles (11). Subsequent gel filtration of bile using an
eluant containing bile salts in concentrations and composition identical to
the IMC of the original model bile should theoretically allow separation
and isolation of vesicles and mixed micelles without artifactual
perturbation of the lipid distribution pseudoequilibrium (11;12). This is
the method of choice when human biles are analyzed (13), which usually
contain only small amounts of mostly unilamellar vesicles. In contrast,
supersaturated model biles with often large amounts of aggregated
vesicles cannot generally be analyzed properly by this procedure, as
recently discussed by Donovan (14). Aggregated vesicles are too large to
enter the gel properly and may be lost during the procedure.
Figure 1: Equilibrium taurocholate-EYPC-cholesterol ternary phase
diagram (9). The components are expressed in mol percent. Depicted are
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a one-phase (micellar) zone at the bottom, a left two-phase zone
(containing micelles and crystals), a central three-phase zone
(containing micelles, vesicles and crystals) and a right two-phase zone
(containing micelles and vesicles). On the basal axis, phospholipid/(bile
salt + phospholipid) ratios are shown.
In the present study we tested a new approach with the aid of
ultracentrifugation and ultrafiltration/dialysis of the supernatant to isolate
mixed micelles, vesicles and -if present- cholesterol crystals from
supersaturated model biles.
MATERIALS AND METHODS
Materials
Taurocholate was obtained from Sigma Chemical Co. (St. Louis, MO,
USA) and yielded a single spot upon thin-layer chromatography
(butanol-acetic acid-water, 10:1:1 vol/vol/vol, application of 200 µg bile
salt). Cholesterol (Sigma) was ≥ 98% pure by reverse-phase HPLC
(isopropanol - acetonitrile 1:1, vol/vol, detection at 210 nm).
Phosphatidylcholine from egg yolk (EYPC; Sigma) yielded a single spot
upon thin-layer chromatography (chloroform-methanol-water 65:25:4,
vol/vol/vol, application of  200 µg lipid). As shown by reverse-phase
HPLC, EYPC contained mainly 16:0 acyl chains at the sn-1 position and
mainly unsaturated (18:1>18:2>20:4) acyl chains at the sn-2 position,
similar to phosphatidylcholine in human bile (15). All other chemicals
and solvents were of ACS or reagent grade quality.
Ultrafilters with a Mwco of 10 and 300 kDa were purchased from
Sartorius (Göttingen, Germany: Centrisart I). SpectraPor dialysis
devices containing membranes with a Mwco of 300 kDa were obtained
from Spectrum Laboratories (Laguna Hills, CA, USA: SpectraPor).
Sephacryl S400 gel filtration material was purchased from Pharmacia
LKB Biotechnology AB (Uppsala, Sweden). The enzymatic cholesterol
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assay kit was obtained from Boehringer (Mannheim, Germany) and the
enzymatic phospholipid kit from Sopar Biochem (Brussels, Belgium).
3α-Hydroxysteroid dehydrogenase for the enzymatic measurement of
bile salt concentrations (16) and a colorimetric chloride-kit were
purchased from Sigma. The reverse-phase C18 HPLC column was from
Supelco (Supelcosil LC-18-DB, Supelco, Bellefonte, PA, USA).
Preparation of model biles
Lipid mixtures containing variable proportions of cholesterol,
phospholipids (both from stock solutions in chloroform) and taurocholate
(from stock solutions in methanol) were vortex-mixed and dried at 45°C
under a mild stream of nitrogen, and subsequently  lyophilized during 24
hrs, before being dissolved in aqueous 150 mM NaCl plus 3mM NaN3.
Tubes were sealed with Teflon-lined screw caps under a blanket of
nitrogen to prevent lipid oxidation and vortex-mixed for 5 min. followed
by incubation at 37°C in the dark. All solutions were warmed up to 45°C
for 10 min. before use. The final mol percentages of cholesterol,
phospholipids and bile salts did not differ more than 1% from intended
mol percentages. Also, model systems always plotted in the intended
zones of the taurocholate-phosphatidylcholine-cholesterol ternary phase
diagram (9), as inferred from microscopic examinations.
Lipid measurement
Cholesterol and phospholipid concentrations were determined with
enzymatic assays (17;18). Bile salt concentrations were measured with
the 3α-hydroxysteroid dehydrogenase method (16). Cholesterol
saturation index (CSI) was calculated according to Carey’s critical tables
(19).
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Quasi - elastic light scattering spectroscopy (QLS)
QLS was performed with a Malvern 4700c spectrometer (Malvern Ltd.,
Malvern, UK) equipped with an argon laser (Uniphase Corp., San Jose,
CA, USA) at a wavelength of 488 nm. In optical clear solutions such as
300 kDa filtrates, the power of the laser was tuned to 50 mW. Data are
given as hydrodynamic radius (Rh) and are means of at least 3
measurements.
IMC measurement
Apart from mixed (i.e. phospholipid-bile salt) micelles, model bile
systems also contain non-phospholipid associated bile salts, either as
monomers or -above their critical micellar concentration- associated in
"simple" micelles. The monomeric plus simple micellar bile salt
concentration is referred to as “intermixed micellar/vesicular (non
phospholipid-associated) bile salt concentration”, usually abbreviated as
“IMC” (10). We determined IMC in various model systems, using the
rapid centrifugal ultrafiltration technique (10 kDa Centrisart ultrafilter)
with correction for Gibbs-Donnan effects (11;12;20;21)
Quantification of aggregated vesicles and cholesterol crystals
In case of model biles plotting in the right two-phase (vesicles and
micelles containing) zone (see Fig. 1), aggregated vesicles were pelleted
by ultracentrifugation during 30 min. at 50,000 g and 37°C in a TLS 55
rotor (Beckman, palo Alto, CA) (22). After removal of the entire
supernatant, the pellet was washed with 150 mM NaCl plus 3 mM NaN3,
containing taurocholate at intermixed micellar/vesicular concentrations,
and after repeated ultracentrifugation resuspended in 1.5 mL isopropanol.
IMC values measured in non-centrifuged model biles were identical to
IMC values in the corresponding supernatants. We did not find a bile salt
gradient in the supernatant after centrifugation, indicating that the short
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centrifugation procedure did not cause an inhomogeneous distribution of
micelles or unilamellar vesicles in the tube. Furthermore, centrifugation
did not influence the content of mixed micelles in the model bile, since
lipid contents in micelles obtained by ultrafiltration of supernatant
through the 300 kDa Mwco filter (see below) were identical to lipid
concentrations in ultrafiltrates of corresponding whole model biles.
In case of coexistent cholesterol crystals and aggregated vesicles (three-
phase (micelles, vesicles and crystals-containing) zone: see Fig. 1),
centrifugation of an additional bile sample was also performed 10 min.
after addition of deoxycholate in quantities sufficient to desaturate the
model system (final CSI <1). After such incubation, light microscopy
and stability of turbidity measurements (405 nm OD (23)) revealed that
all vesicular aggregates had been completely micellized. Experiments
with isolated cholesterol crystals showed that solubilization of the
cholesterol crystals did not occur during the short incubation with
deoxycholate. Therefore, cholesterol crystal mass equals cholesterol
content in the pellet after addition of deoxycholate, and cholesterol
content in vesicular aggregates can be calculated from the difference of
cholesterol contents between the pellets without and with added
deoxycholate (23).
Quantification of small unilamellar vesicles and micelles by various
methods
Ultrafiltration and dialysis: After centrifugation, micelles in the
supernatant were isolated by filtration through a Sartorius Centrisart
ultrafiltration device containing a membrane with a Mwco of 300 kDa
(average pore radius 23 nm). The membrane was first rinsed with 2 mL
saline containing taurocholate at IMC values by centrifugation at 500 g
during 5 min. to remove glycerol remnants. Remaining saline was
carefully removed with a syringe and thereafter, by drying under N2 at
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37°C. The membrane-containing inner tube was then placed membrane-
down on the surface of 1 mL supernatant and allowed to sink by gravity
until 100 µL of filtrate was produced, which usually took one hour.
The 300 kDa  filters were completely permeable to simple and mixed
bile salt/phospholipid micelles (tested with mixed micelles at 37°C, at
total lipid concentrations of 2.5, 5 and 10 g/dL and at phospholipid/(bile
salt+phospholipid) ratios of 0.3, 0.4, 0.5 and 0.55, either without or with
cholesterol: with taurocholate or taurodeoxycholate or
tauroursodeoxycholate as bile salt), but were completely impermeable to
small unilamellar or aggregated vesicles, as confirmed by quasielastic
light scattering spectroscopy of the filtrate. A further indication for the
complete permeability of the 300 kDa membrane for mixed micelles was
the absence of Gibbs-Donnan effects over the membrane, as can be
concluded from the identical chloride concentrations in filtrant and
filtrate (10;11).
Small unilamellar vesicles were isolated from the supernatant with the
aid of a SpectraPor dialysis device (Mwco of the membrane: 300 kDa)
by dialysis during 16 hrs. against 3 times 20 mL 0.15 M NaCl containing
bile salts at IMC values. After dialysis during 16 hrs of sonicated small
unilamellar vesicles (EYPC:cholesterol 1:1; 1.0 mM phospholipid, Rh by
quasielastic light scattering spectroscopy 44 nm), no vesicles (by QLS)
or lipids could be detected in the dialysate, indicating complete
impermeability of the filter for small unilamellar vesicles. When the
procedure was applied to unsaturated mixed micellar solutions (total
lipid conc. 2.5, 5 or 10 g/dL; EYPC/(taurocholate+EYPC) ratios 0.3, 0.4
or 0.5; 6 mol% cholesterol), no cholesterol or phospholipids could be
detected in the dialysant after the 16 hours of dialysis, indicating that all
mixed micelles had passed the membrane.
Also, when the supernatant of supersaturated dilute model bile (2.4 g/dL;
EYPC/(taurocholate+EYPC) ratio =0.3; 10.7 mol% cholesterol) was
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dialysed against 0.15 M NaCl containing taurocholate at IMC values, no
Gibbs-Donnan effects could be appreciated over the dialysis membrane,
indicating that mixed micelles were not selectively retained by the
membrane (10;11). The dialysant was also analyzed after completion of
dialysis by gel filtration using 0.15 M NaCl containing taurocholate at
IMC values as eluant. Since only vesicles could be detected by this
procedure, mixed micelles had apparently been completely removed
from the dialysant.
Lipids contained in small unilamellar vesicles were also quantified
indirectly by subtracting cholesterol and phospholipid concentrations
measured in the 300 KDa (only micelles-containing) filtrate from the
lipid concentrations measured in the (micelles + small unilamellar
vesicles containing) supernatant (“Subtraction” method).
Gel filtration: a LKB-Pharmacia column (gel bed 30 cm, internal
diameter 1.5 cm), equipped with a thermostated water jacket, was packed
with Sephacryl S400. Before each model bile fractionation, the column
was first equilibrated at 30 mL/hr with two column volumes of Tris-
buffered saline (10 mM Tris, 150 mM NaCl, 3 mM NaN3, pH 7.5)
containing taurocholate at IMC values as previously measured in that
model system. Thereafter, 1-4 mL of supernatant from previously
centrifuged model bile was fractionated on the column at a flow rate of
12 mL/hr. The eluate was collected in 40 fractions of 1 mL and
cholesterol, phospholipid and bile salt concentrations were determined in
each fraction.
Statistical analysis
Values are expressed as means ± SEM. Differences between groups were
tested for statistical significance by analysis of variance with the aid of
NCSS software (Kaysville, Utah, USA). When ANOVA detected a
significant difference, results were further compared for contrasts using
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Fisher’s least significant difference test as post-hoc test. Statistical
significance was defined as a two-tailed probability of less than 0.05.
RESULTS
Comparison between various methods for phase separation
The sum of lipids in the individual fractions (pellet, filtrate and dialyzed
supernatant) was equal (~ 98%) to amounts of lipids in corresponding
total model bile.
Lipid concentrations in fractions after gel filtration also indicated
acceptable recovery (> 80%). Lipid distribution into small unilamellar
vesicles and micelles as determined by combined dialysis and
ultrafiltration was virtually identical to data obtained in the same
supernatant with the “subtraction” method (see “methods”). In contrast,
gel filtration yielded consistently more lipids in mixed micelles and less
in small unilamellar vesicles than the “subtraction” method (Fig. 2 A-D).
Cholesterol/phospholipid ratios in vesicles obtained by dialysis of the
supernatant were much lower than cholesterol/phospholipid ratios in
vesicles obtained by gel filtration of the same supernatant. When vesicles
obtained by dialysis were subsequently analyzed with gel filtration, the
cholesterol/phospholipid ratios in these vesicles increased significantly
(from 0.99 ± 0.10 to 1.98 ± 0.56: identical to vesicular
cholesterol/phospholipid ratios by gel filtration of the supernatant, P <
0.05). This increase could not be ascribed to the presence of mixed
micelles in the dialyzed sample, because these were not detectable with
gel filtration (Figure 3).
Figure 4 shows the results of three additional gel filtration experiments
performed with vesicles obtained by dialysis, together with (between
brackets) their initial cholesterol/phospholipid ratios. There was a clear
increase of vesicular cholesterol/phospholipid ratios after gel filtration
procedure. Lipid extraction of the top 2 mL Sephacryl column material
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(24) and measurement of phospholipids and cholesterol in the extract
indicated that appreciable amounts of lipids remained attached to the
column material (phosphatidylcholine 0.07 µmol / mL column material:
cholesterol 0.04 µmol /mL column material).
Figure 2:A and B) Relationship between results obtained by
“subtraction” and dialysis” methods for cholesterol ( 
phospholipid ( ) distribution into small unilamellar vesicles in
supernatant from model biles with various compositions. C and D)
Relationship between results obtained by “gel filtration” and “dialysis”
methods for cholesterol (phospholipids ( ) distribution into small
unilamellar vesicles in supernatant. Whereas “dialysis” and
“subtraction” methods yield highly similar results, considerably lower
lipid distribution into small unilamellar vesicles is found with gel
filtration. Reciprocal results are found for micellar lipid solubilization
(not shown). (A and C expressed in mM, B and D expressed as % of
total; continuous and interrupted lines indicate correlation by linear
regression analysis for cholesterol resp. phospholipids).
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Figure 3: A) Gel filtration of the residual vesicle suspension after
dialysis during 16 hrs of model bile (2.4 g/dL;
(EYPC/(taurocholate+EYPC) =0.3; 10.7% cholesterol; CSI 1.7;
aggregated vesicles previously removed by centrifugation) against 3 x 20
volumes of 0.15 M NaCl containing taurocholate at intermixed
micellar/vesicular concentrations. All mixed micelles have been washed
out by dialysis. B) Gel filtration of the corresponding non-dialyzed
supernatant. Inset: equilibrium taurocholate-EYphosphatidylcholine-
cholesterol ternary phase diagram (9). Dot indicates model bile plotting
in right two-phase zone.
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Table 1. Cholesterol/phospholipid ratios in vesicular and micellar phases
isolated by combined ultrafiltration/dialysis method and by gel filtration
method .
Cholesterol/phospholipid ratioModel bile
SUV
(gel filtration)
SUV
(dialysis)
MIC
2.4 g / dL 1.64 ± 0.09 0.99 ± 0.10 0.27 ± 0.04
(1.02)
7.3 g / dL 1.97 ± 0.26 0.96 ± 0.21 0.30 ± 0.03
(0.97)
Model biles were prepared with the following composition:
EYPC/(taurocholate+EYPC) ratio 0.3; 10.7 % cholesterol; CSI 1.7 (2.4
g/dL) or 1.4 (7.3 g/dL) and were incubated during 14 days before
analysis. For micelles, CSI is given between brackets.
SUV, small unilamellar vesicles; MIC, mixed micelles.
Influence of total lipid concentration on lipid distribution into
various phases
Upon centrifugation, aggregated vesicles were pelleted down to the
bottom of the tube in the case of dilute model biles (2.4 g/dL), but were
found in a zone on top of the fluid phase in case of concentrated model
bile (total lipid concentration 7.3 g/dL), probably resulting from different
densities of supernatants of dilute and concentrated model biles (1.0137
±  0.0019 g/mL vs. 1.0226 ± 0.0013 g/mL; P < 0.02). After two weeks
incubation, considerable quantities of lipids (approximately 30% of
cholesterol and 5-10% of EYPC) were solubilized in vesicular
aggregates, both in dilute and concentrated model biles.
Amounts of cholesterol and EYPC contained in unilamellar vesicles
were two-fold higher in dilute than in concentrated model biles, with
reciprocal differences in mixed micellar lipid solubilization (Figure 5).
Although results obtained by gel filtration were similar in a qualitative
way, more lipids were solubilized in mixed micelles and less in vesicles,
with higher vesicular cholesterol/phospholipid ratios (Figure 5, Table 1).
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Isolation of various phases in model biles that contain cholesterol
crystals
Results reported above were all obtained from model biles that did not
contain cholesterol crystals (i.e. plotting in the right two-phase (vesicles
and micelles containing) zone). In case of model biles plotting in the
central three-phase (micelles, vesicles and cholesterol crystals
containing) zone, cholesterol in crystals and in vesicular aggregates can
be quantitated from the difference of cholesterol contents in the pellet
before and after bile salt-induced solubilization of the vesicular
aggregates (see “Methods”). Figure 6 shows lipid distribution and
cholesterol/phospholipid ratios in various phases obtained by combined
ultracentrifugation-ultrafiltration-dialysis methodology under these
circumstances after 1 and 14 days incubation.
After 14 days incubation, there was a strong decrease of cholesterol
content in vesicles and micelles, coinciding with a strong increase of
cholesterol crystal mass. There were only small changes of phospholipid
content in various phases during this time period. As a result, vesicular
cholesterol/phospholipid ratios, that were above 1 on day 1, decreased to
values ~ 1 on day 14. Micellar CSI values ~ 1 and vesicular
cholesterol/phospholipid ratios ~ 1 on day 14 indicate thermodynamic
equilibrium after this incubation period.
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Figure 4: Gel filtration of dialyzed vesicles with an eluant containing taurocholate at
intermixed micellar/vesicular concentrations after 1 (A), 10 (B) or 40 (C) days
incubation. Model bile composition is identical to Figure 3. The vesicular
cholesterol/phospholipid ratios decrease with time. Vesicular
cholesterol/phospholipid ratios in the original dialysant before gel filtration
(indicated between brackets) are much lower than in the same vesicles after gel
filtration, which can not be explained by the presence in the filtrant of residual
phospholipid-rich mixed micelles, because these are not detectable by gel filtration.
Inset: equilibrium taurocholate-EYphosphatidylcholine-cholesterol ternary phase
diagram (9). Dot indicates model bile plotting in right two-phase zone.
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Figure 5: Distribution of cholesterol (A) and EYPC (B) between small
unilamellar vesicles (SUV) and mixed micelles (MIC) in dilute (2.4 g/dL)
and concentrated (7.3 g/dL) model biles (14 days incubation at 37°C:
EYPC/(taurocholate+EYPC) = 0.3; 10.7 % cholesterol; CSI = 1.7 and
1.4 in diluted and concentrated bile). Lipid distribution in small
unilamellar vesicles was significantly higher with combined
ultracentrifugation / ultrafiltration / dialysis method compared to gel
filtration method. Reciprocal results were obtained for micellar lipid
solubilization. With both methods, the amounts of lipids contained in
small unilamellar vesicles were significantly higher in the dilute biles.
Inset: equilibrium taurocholate-EYphosphatidylcholine-cholesterol
ternary phase diagram (9). Dot indicates model bile plotting in the right
two-phase zone.
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DISCUSSION
Understanding cholesterol solubilization in model bile requires accurate
isolation of cholesterol-containing lipid particles. Although gel filtration
with bile salts at IMC values in the eluant is suitable for human bile,
which generally contains only small amounts of mostly unilamellar
vesicles (13), this method may be problematic in case of supersaturated
model biles which often contain large amounts of aggregated vesicles
that may not enter the column properly (14). In the present study, we first
pelletted aggregated vesicles by ultracentrifugation, and obtained
micelles and small unilamellar vesicles by ultrafiltration resp. dialysis of
the supernatant.
The short centrifugation procedure did not significantly affect IMC
values, nor did it cause a bile salt gradient, which may occur during
prolonged ultracentrifugation as a result of precipitation of mixed
micelles (25). The concentration of mixed micellar lipids obtained by
ultrafiltration through the 300 kDa filter was also not affected by
centrifugation. These observations suggest that no net vesicle ↔ micelle
transitions occur during centrifugal precipitation of aggregated vesicles.
The hydrodynamic radius of mixed micelles, in native bile 1 - 6.7 nm
(26), should allow them to freely pass the 23 nm pores of the 300 kDa
Mwco. Unilamellar vesicles should be retained completely since their
hydrodynamic radius in bile is ≥35 nm (2;3). A filter with a similar cut-
off has recently been used for removal of vesicles from human
gallbladder bile (27). The 300 kDa Mwco filter used in the present study
was indeed entirely permeable for a wide range of mixed micelles at a
wide range of phospholipid/(bile salt + phospholipid) ratios and lipid
concentrations, factors known to influence micellar sizes (28).
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Figure 6: Distribution of cholesterol (A) and phospholipid (B) into
various phases in supersaturated model biles composed with EYPC and
TC, plotting in the central three-phase zone (total lipid conc. = 3.6 g/dL,
PL/(BS+PL) ratio = 0.2, 20 mol% cholesterol, 37°C). Various phases
were isolated after 1 day (open bars) and 14 days (closed bars)
incubation at 37°C. There is a decrease of cholesterol content of micelles
and vesicles after 14 days, coinciding with an increased crystal mass and
decreased chol/PL ratios (C). MIC, micelles; SUV, small unilamellar
vesicles; AGG, aggregated vesicles; CRY, cholesterol crystal mass.
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Inset: equilibrium taurocholate-EYphosphatidylcholine-cholesterol
ternary phase diagram (9). Dot indicates model bile plotting in three-
phase zone.
Additional evidence for complete permeability was provided by the
absence of Gibbs-Donnan effects (an indicator for asymmetric
distribution of non-filterable ions). QLS measurements confirmed that
filtrates of supersaturated model biles never contained vesicles.
Furthermore, in supersaturated biles near or at equilibrium, the filtrate
should have a cholesterol saturation index around 1, as in the present
study (Table 1).
Unilamellar vesicles were isolated from centrifuged model bile by
dialysis through a membrane with a similar cut-off (300 kDa) as used
during ultrafiltration. This membrane was completely impermeable to
small unilamellar vesicles, whereas mixed micelles were completely
washed out (Figure 3).
With gel filtration more lipid was contained in mixed micelles, and less
in unilamellar vesicles (Figures 2 and 5), with much higher vesicular
cholesterol/phospholipid ratios compared to ultrafiltration/dialysis (Table
1). These differences could be due to interactions between biliary lipid
particles and the matrix in case of gel filtration. The matrix surface to
which the sample is exposed during analysis is several orders of
magnitude smaller in case of ultrafiltration and dialysis. A standard
protocol for gel filtration of phospholipid liposomes requires thorough
equilibration of the gel filtration column material with large volumes of
phospholipid dispersions prior to analysis of the sample to saturate the
matrix and avoid possible interactions of the sample with the matrix (29).
In the case of bile, however, this is impossible, since detergent bile salts
in the eluant would dissolve phospholipids attached to the matrix in a
previously equilibrated column. Interactions of phospholipids with the
matrix could have a profound impact on the delicate pseudoequilibrium
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in (model) bile systems. We provide some evidence for such interactions
during gel filtration. First, we observed that gel filtration of dialyzed
unilamellar vesicles strongly increased their cholesterol/phospholipid
ratios. This was not caused by micellization of part of these vesicles,
since mixed micelles could not be detected during gel filtration (Figure
3). Furthermore, vesicular cholesterol/phospholipd ratios after gel
filtration of the supernatant or gel filtration of vesicles obtained by
dialysis were identical. Secondly, we could detect considerable amounts
of phosphatidylcholine and cholesterol attached to gel filtration material.
Therefore, the vesicular cholesterol/phospholipid ratio observed after gel
filtration may be unreliable, which is of major concern as an increase of
this parameter has been strongly associated with cholesterol
crystallization (6;7). Since vesicular cholesterol/phospholipid ratios
consistently increased during gel filtration, affinity of phospholipid may
be higher than affinity of cholesterol for the column material.
Concentration of bile in the gallbladder is an important factor for
cholesterol crystallization (30). In the present study, we compared lipid
solubilization in dilute and concentrated model biles with identical mol%
lipids. We found that in dilute model biles, more lipids are contained
within unilamellar vesicles and less in mixed micelles, in agreement with
previous data (6;25) (Figure 5). Although gel filtration and combined
ultracentrifugation / ultrafiltration / dialysis yielded similar results in a
qualitative sense, again amounts of lipid contained in small unilamellar
vesicles were lower and vesicular cholesterol/phospholipid ratios higher
with gel filtration.
We employed in the present study mainly model biles plotting in the
right (micelles + vesicles containing) two-phase zone of the equilibrium
ternary phase diagram (9). Nevertheless, as shown in Figure 6, the
procedure of centrifugation with ultrafiltration/dialysis of the supernatant
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can be easily adapted to solid crystals-containing model biles by
quantitating aggregated vesicles and crystals in the pellet separately.
In summary, we have shown that ultracentrifugation can be used to
isolate aggregated vesicles and -if present- cholesterol crystals from
model biles without disturbing the delicate balance between vesicular
and micellar phases. We further demonstrate that ultrafiltration can be
used to accurately isolate mixed micelles in a rapid and simple
procedure. Unilamellar vesicles can be isolated by dialysis against a
solution containing bile salts at IMC values. This methodology should be
considered the procedure of choice for the separation of these phases
from supersaturated model biles.
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ABSTRACT
Cholesterol in human bile is solubilized in micelles by (relatively
hydrophobic) bile salts and phosphatidylcholine (unsaturated acyl chains
at sn-2 position). Hydrophilic tauroursodeoxycholate, dipalmitoyl
phosphatidylcholine and sphingomyelin all decrease cholesterol crystals-
containing zones in the equilibrium ternary phase diagram (K. J. van
Erpecum and M.C. Carey. Biochim. Biophys. Acta 1997;1345:269-282)
and thus could be valuable in gallstone prevention. We have now
compared crystallization in cholesterol-supersaturated model systems
(3.6 g/dL, 37°C) composed with various bile salts as well as egg yolk
phosphatidylcholine (unsaturated acyl chains at sn-2 position),
dipalmitoyl phosphatidylcholine or sphingomyelin throughout the phase
diagram. At low phospholipid contents (left two-phase -
micelles+crystals-containing- zone), tauroursodeoxycholate, dipalmitoyl
phosphatidylcholine and sphingomyelin all enhanced crystallization. At
pathophysiologically relevant intermediate phospholipid contents
(central three-phase -micelles+vesicles+crystals-containing- zone),
tauroursodeoxycholate inhibited, but dipalmitoyl phosphatidylcholine
and sphingomyelin enhanced crystallization. Also, during 10 days
incubation, there was a strong decrease of vesicular cholesterol contents
and vesicular cholesterol/phospholipid ratios (~1 on day 10), coinciding
with a strong increase of crystal mass. At high phospholipid contents
(right two-phase -micelles+vesicles-containing- zone), vesicles were
always unsaturated and crystallization did not occur. Strategies aiming to
increase amounts of hydrophilic bile salts may be preferable to
increasing saturated phospholipids in bile, since the latter may enhance
crystallization.
INTRODUCTION
Precipitation of cholesterol crystals from supersaturated bile is a
prerequisite for gallstone formation (1). The sterol is poorly soluble in an
aqueous enviroment, and is solubilized in bile in mixed micelles by bile
salts (BS) and phospholipids (PL). Phosphatidylcholine is the major
phospholipid in bile (>95% of total: mainly 16:0 acyl chains at the sn-1
position and mainly unsaturated (18:2>18:1>20:4) acyl chains at the sn-2
position (2)). In case of cholesterol supersaturation, the excess sterol may
be contained in vesicles together with phospholipids (3,4) or precipitated
as solid crystals.
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The studies of Wang & Carey (5) have revealed the importance of the
relative amounts of bile salts vs phospholipids in the system for
crystallization behavior. In case of excess bile salts (PL/(BS+PL) ratios
~≤0.2), crystals precipitate at fast rates, and both various intermediate
anhydrous cholesterol crystals (needles, arcs, tubules, spirals) and mature
rhomboid cholesterol monohydrate crystals can be detected by
microscopy. In case of higher amounts of phospholipids, crystal
precipitation proceeds at slower rates (with predominant formation of
mature cholesterol monohydrate crystals), and large amounts of
cholesterol are solubilized in vesicles together with phospholipids. In
case of excess phospholipids (high PL/(BS+PL) ratios), solid cholesterol
crystals do not occur, and cholesterol is mainly solubilized in vesicular
phases. Based on these data, the equilibrium cholesterol-bile salt-
phospholipid ternary phase diagram (Fig. 1: (5,6)) is assumed to contain
a one-phase zone (only micelles), a left two-phase (micelles and
cholesterol crystals-containing) zone, a central three-phase (micelles,
vesicles and cholesterol crystals-containing) zone and a right two-phase
(micelles and vesicles-containing) zone. The phase diagram describes
occurrence of cholesterol crystals, micelles and vesicles at equilibrium
conditions, but accurate quantification of these phases has been
hampered by methodological problems. Micelles and vesicles may be
separated with the aid of gel filtration with bile salts at intermixed
micellar/vesicular concentrations in the eluant buffer in order to avoid
artifactual shifts of lipids between phases (7-9). However, gel filtration is
only suitable in case of highly diluted and slightly supersaturated model
systems: in more concentrated or supersaturated model systems, large
amounts of vesicular aggregates occur that do not completely pass the
column (10). We recently developed and validated a method for accurate
separation of various phases under these circumstances (11). Aggregated
vesicles are first precipitated by short ultracentrifugation, and micelles or
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small unilamellar vesicles are subsequently isolated from the supernatant
with the aid of highly selective ultrafilters and dialysis, taking into
account the intermixed micellar/vesicular bile salt concentration.
In the present study, we have systematically determined distribution of
lipids into various phases throughout the ternary phase diagram. The
hydrophilic bile salt ursodeoxycholate is frequently used in clinical
practice to dissolve cholesterol gallstones, and dietary modulation of
biliary phospholipid composition has been suggested to prevent gallstone
formation (12-15). We therefore also evaluated effects of bile salt species
and phospholipid class composition on crystallization.
MATERIALS AND METHODS
Materials
Taurocholate (TC), taurodeoxycholate (TDC) and tauroursodeoxycholate
(TUDC) were obtained from Sigma Chemical Co. (St. Louis, MO, USA)
and yielded a single spot upon thin-layer chromatography (butanol-acetic
acid-water, 10:1:1 vol/vol/vol, application of 200 µg bile salt).
Cholesterol (Sigma) was ≥ 98% pure by reverse-phase HPLC
(isopropanol-acetonitrile 1:1, vol/vol, detection at 210 nm).
Phosphatidylcholine from egg yolk (EYPC; Sigma), dipalmitoyl
phosphatidylcholine (DPPC; Sigma) and sphingomyelin from egg yolk
(EYSM; Avanti Polar-Lipids Inc., Alabaster, AL, USA) yielded a single
spot upon thin-layer chromatography (chloroform-methanol-water
65:25:4, vol/vol/vol, application of  200 µg lipid). Acyl chain
compositions as determined by gas-liquid chromatography (16) were
virtually identical to previously published data (6) and showed a
preponderance of 16:0 acyl chains for egg yolk SM, similar to trace SM
in bile (17). As shown by reverse-phase HPLC, EYPC contained mainly
16:0 acyl chains at the sn-1 position and mainly unsaturated
(18:1>18:2>20:4) acyl chains at the sn-2 position, similar to PC in
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human bile (2). All other chemicals and solvents were of ACS or reagent
grade quality.
Ultrafilters with a Mwco of 10 and 300 kDa were purchased from
Sartorius (Göttingen, Germany: Centrisart I), and dialysis membranes
with a Mwco of 300 kDa from Spectrum Laboratories (Laguna Hills,
CA, USA: SpectraPor). The enzymatic cholesterol assay kit was obtained
from Boehringer (Mannheim, Germany) and the enzymatic phospholipid
kit from Sopar Biochem (Brussels, Belgium). 3α-Hydroxysteroid
dehydrogenase for the enzymatic measurement of bile salt concentrations
(18) and a colorimetric chloride-kit were purchased from Sigma. The
reverse-phase C18 HPLC column was from Supelco (Supelcosil LC-18-
DB, Supelco, Bellefonte, PA, USA).
Preparation of model biles
Lipid mixtures containing variable proportions of cholesterol,
phospholipids (both from stock solutions in chloroform) and bile salts
(from stock solutions in methanol) were vortex-mixed and dried at 45°C
under a mild stream of nitrogen, and subsequently  lyophilized during 24
hrs, before being dissolved in aqueous 150 mM NaCl plus 3mM NaN3.
Tubes were sealed with Teflon-lined screw caps under a blanket of
nitrogen to prevent lipid oxidation and vortex-mixed for 5 min. followed
by incubation at 37°C in the dark. All solutions were warmed up to 45°C
for 10 min. before use. The final mol percentages of cholesterol,
phospholipids and bile salts did not differ more than 1% from the
intended mol percentages. Also, model systems always plotted in the
intended zones of the appropriate phase diagrams (5,6), as inferred from
microscopic examination.
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Lipid measurement
Phospholipid concentrations in model systems were assayed by
determining inorganic phosphate (19). Cholesterol concentrations were
determined with an enzymatic assay (20), and bile salts with the 3α-
hydroxysteroid dehydrogenase method (18).
IMC measurement
Apart from mixed (i.e. phospholipid-bile salt) micelles, model bile
systems also contain non-phospholipid associated bile salts, either as
monomers or -above their critical micellar concentration- associated in
“simple” micelles. The monomeric plus simple micellar bile salt
concentration is referred to as “intermixed micellar/vesicular (non
phospholipid-associated) bile salt concentration”, usually abbreviated as
“IMC” (9). We determined IMC in various model systems, using the
rapid centrifugal ultrafiltration technique with correction for Gibbs-
Donnan effects (7-11,21).
Isolation of various lipid phases
Cholesterol crystals and aggregated vesicles: After 10 and 40 days (in
some cases also after 1 day) incubation at 37°C, various phases were
isolated from cholesterol-supersaturated model systems as described
(11). In brief, detergent-resistant aggregated vesicles were precipitated
by ultracentrifugation during 30 min. at 50000 g and at 37°C in a TLS 55
rotor (Beckman, Palo Alto, CA, USA) (22). In case of coexistent
cholesterol crystals and aggregated vesicles (three-phase (micelles,
vesicles and crystals-containing) zone: see Fig. 1), centrifugation of an
additional bile sample was also performed 10 min. after addition of
deoxycholate in quantities sufficient to desaturate the model system
(final CSI <1). After such incubation, light microscopy and stability of
turbidity measurements (405 nm OD (23)) revealed that all vesicular
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aggregates had been completely micellized. Experiments with isolated
cholesterol crystals showed that solubilization of the cholesterol crystals
did not occur during the short incubation with deoxycholate. Therefore,
cholesterol crystal mass equals cholesterol content in the pellet after
addition of deoxycholate, and cholesterol content in vesicular aggregates
can be calculated from the difference of cholesterol contents between the
pellets without and with added deoxycholate (23). IMC values measured
in non-centrifuged model biles were identical to IMC values in the
corresponding supernatants. We did not find a bile salt gradient in the
supernatant after centrifugation, indicating that the short centrifugation
procedure did not cause an inhomogeneous distribution of micelles or
unilamellar vesicles in the tube. Furthermore, centrifugation did not
influence the content of mixed micelles in the model bile, since lipid
contents in micelles obtained by ultrafiltration of supernatant through the
300 kDa Mwco filter (see below) were identical to lipid concentrations in
ultrafiltrates of corresponding whole model biles.
As model systems plotting in the left-two phase zone (see Fig. 1) contain
only micelles and cholesterol crystals at thermodynamic equilibrium,
cholesterol crystals were precipitated in this case by ultracentrifugation,
without added deoxycholate. Although studies by quasielastic light
scattering spectroscopy (5) have suggested that small unilamellar
vesicles may occur transiently in supersaturated model systems in the left
two-phase zone before equilibrium is reached, amounts of cholesterol in
these vesicles are expected to be minor compared to cholesterol crystal
mass. Recovery of cholesterol and phospholipid in various phases was
always 95-100%.
Micelles and small unilamellar vesicles: Micelles were isolated from the
supernatant by ultrafiltration with a highly selective 300 kDa ultrafilter.
Small unilamellar vesicles were obtained by dialysis (500 µL sample, 16
hours, 37°C) in a SpectraPor dialysis device with a molecular weight
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cut-off of 300 kDa, against three times 20 volumes of aqueous 0.15 M
NaCl plus 3 mM NaN3 containing the relevant bile salt at concentrations
identical to the IMC of the various original model system in order to
avoid artifactual shifts of lipids between vesicles and micelles (11,21).
The ultrafilters and dialysis membranes were completely impermeable to
small unilamellar or aggregated vesicles but completely permeable to
simple and mixed micelles (tested with a wide range of micellar
compositions (11), including TDC-, TC-, TUDC-containing mixed
micelles at 37°C, at a total lipid concentration of 3.6 g/dL and at
PL/(BS+PL) ratios of 0.2-0.55, either without or with cholesterol; with
SM or PC as phospholipid). Recovery of cholesterol and phospholipids
in various phases was always 95-100%.
Figure 1: Equilibrium taurocholate-EYPC-cholesterol ternary phase
diagram (5). The components are expressed in mol percent. Depicted are
a one-phase (micellar) zone at the bottom, a left two-phase zone
(containing micelles and crystals), a central three-phase zone
(containing micelles, vesicles and crystals) and a right two-phase zone
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(containing micelles and vesicles). The apices of the central three-phase
zone are represented by a, b and c. Positions in the three-phase zone of 4
different model biles are represented by 1-4 (see text). Interrupted line
indicates reduced one-phase micellar zone and left-ward expansion of
the right two-phase zone in case of hydrophilic bile salts (5) or saturated
phospholipids (6).
Quantitation of cholesterol crystals by microscopy
Numbers of various cholesterol crystal shapes (intermediate anhydrous
crystals such as arcs, needles, tubules and spirals: mature rhomboid
monohydrate crystals) were determined by daily examinations during 10
days with the aid of a polarizing microscope and KOVA plastic slides
(Hycor Biomedical inc., Garden Grove, California, USA) with 10
standardized examination chambers. Each chamber contains one large
grid (3 x 3 mm; volume: 0.9 µL), divided in 81 small grids (size: 0.33
mm x 0.33 mm). 7 µL from a 10x diluted sample was placed on a
KOVA slide and crystal numbers were counted in 9 consecutive small
grids at 100x magnification. In model biles plotting in the left two-phase
zone, sizes of cholesterol monohydrate crystals were highly variable and
data for small (≤10µm diameter) and larger monohydrate crystals are
given separately. Daily examinations of crystal numbers and mass druing
10 days were performed 2-3 times, and representative curves are shown.
Statistical analysis
Data for lipid distribution into various phases are expressed as means ±
SEM of 4-5 experiments. Differences between groups were tested for
statistical significance by analysis of variance (ANOVA) with the aid of
NCSS software (Kaysville, Utah, USA). When ANOVA detected a
significant difference, results were further compared for contrasts using
Fisher’s least significant difference test as post-hoc test. Statistical
significance is defined as a two-tailed probability of less than 0.05.
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RESULTS
Three-phase (micelles, vesicles and cholesterol crystals – containing)
zone
Influence of phospholipid class: Figures 2 and 3 show lipid distribution
into various phases after 1, 10 and 40 days incubation of SM- or EYPC-
containing supersaturated model systems plotting in the three-phase zone
(TC as bile salt in all cases: see insets Figs 2 and 3). In SM-containing
systems, ~90 % of all phospholipid was contained in vesicular
aggregates (Fig. 2B). By contrast, in EYPC-containing systems with the
same relative composition, large amounts of phospholipids also
distributed into micelles and small unilamellar vesicles (Fig. 3B).
Amounts of cholesterol contained in micelles or small unilamellar
vesicles were also significantly larger in EYPC- than in SM-containing
systems (Figs 2A and 3A). After 10 days incubation, there was a strong
decrease of cholesterol content in aggregated or small unilamellar
vesicles and -less pronounced- in micelles as compared with one day
incubation, coinciding with a strong increase of cholesterol crystal mass
(Figs 2A and 3A). There were only small changes of phospholipid
content in various phases during this time period (Figs 2B and 3B). As a
result, vesicular chol/PL ratios, that were above 1 on day 1 (particularly
in small unilamellar vesicles) decreased to values ~1 at day 10 (Figs 2C
and 3C). Also, chol/PL ratios in micelles (that were slightly
supersaturated on day 1), decreased (micellar CSI ~1 on day 10). There
were no significant changes after longer (40 days) incubation (Figs 2 and
3). Results in DPPC-containing systems (not shown) and SM-containing
systems of the same relative composition were identical throughout the
study period.
Although with daily examination during the first 10 days, numbers of
cholesterol monohydrate crystals were larger in EYPC- than in SM- or
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DPPC-containing systems (Fig. 4A), crystals were much larger in SM- or
DPPC-containing systems. Cholesterol crystal mass was also larger in
SM- or DPPC-containing systems both during the 10-day study period
(Fig. 4B) and after 40 days incubation (Figs 2A and 3A).
Figure 2: Distribution of cholesterol (A) and phospholipid (B) into
various phases in supersaturated model biles composed with SM and TC,
plotting in the central three-phase zone (total lipid conc. = 3.6 g/dL,
PL/(BS+PL) ratio = 0.2, 24.8 mol% cholesterol, 37°C). Various phases
were isolated after 1 day (open bars), 10 days (hatched bars) and 40
days (closed bars) incubation. There is a decrease of cholesterol and
(less pronounced) phospholipid content in micelles and vesicles after 10
days, coinciding with an increased crystal mass and decreased chol/PL
MIC SUV AGG CRY
0
25
50
75
100
MIC SUV AGG0
25
50
75
100
A
B
C
MIC SUV AGG0.00
0.50
1.00
1.50
2.00
ph
os
ph
ol
ip
id
 (%
 of
 to
tal
)
ch
ol
es
te
ro
l (%
 of
 to
tal
)
ch
ol
/P
L 
ra
tio
%
  phospholipids%
 ch
ole
ste
ro
l
% taurocholate
3 φ
1 φ
central
2 φ
2 φ
left
right
Chapter 3
74
ratios (C). MIC, micelles; SUV, small unilamellar vesicles; AGG,
aggregated vesicles; CRY, cholesterol crystal mass.
Inset: equilibrium bile salt-phospholipid-cholesterol ternary phase
diagram. Continuous line: phase diagram for EYPC (5). Interrupted
line: decreased one-phase micellar zone and extension of right two-
phase zone in case of DPPC or SM as phospholipid (6). Dot indicates
model bile plotting in three-phase zone.
Figure 3: Distribution of cholesterol (A) and phospholipid (B) into
various phases in supersaturated model biles composed with EYPC and
TC, plotting in the central three-phase zone (same relative lipid
composition as in Fig. 2). Various phases were isolated after 1 day (open
bars), 10 days (hatched bars) and 40 days (closed bars) incubation at
37°C. There is a decrease of cholesterol content of micelles and vesicles
after 10 days, coinciding with an increased crystal mass and decreased
chol/PL ratios (C). MIC, micelles; SUV, small unilamellar vesicles;
AGG, aggregated vesicles; CRY, cholesterol crystal mass.
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Inset: equilibrium bile salt-phospholipid-cholesterol ternary phase
diagram. Continuous line: phase diagram for EYPC (5). Interrupted
line: decreased one-phase micellar zone and extension of right two-
phase zone in case of DPPC or SM as phospholipid (6). Dot indicates
model bile plotting in three-phase zone.
Figure 4: Numbers of cholesterol monohydrate crystals (A) and crystal
mass (B) during 10 days incubation in supersaturated model systems
containing EYPC, SM or DPPC and plotting in the central three-phase
zone (TC as bile salt in all cases: for relative lipid composition see Figs
2 and 3). Although crystal numbers are larger in case of EYPC, crystal
mass is higher in case of SM or DPPC, related to greater crystal sizes.
(◆) EYPC; (●) SM; (■) DPPC. Please note logarithmic scale for 4A.
Influence of bile salt species: Figure 5 shows lipid distribution into
various phases after 10 days incubation of supersaturated model systems
composed with TDC, TC or TUDC and plotting in the three-phase zone
(EYPC as phospholipid in all cases: inset Fig. 5). There were increased
amounts of phospholipids and cholesterol contained in aggregated and
small unilamellar vesicles in case of more hydrophilic bile salts, whereas
solubilization in micelles was decreased. Micellar CSI as well as chol/PL
ratios in small unilamellar or aggregated vesicles (Fig. 5C) were ~1 in all
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cases. Results were essentially the same after 40 days incubation (not
shown). With daily examination during the first 10 days, numbers of
(mainly cholesterol monohydrate) crystals were much larger in case of
more hydrophobic bile salts (TDC>TC>TUDC: Fig. 6A). Cholesterol
crystal mass was also significantly higher in case of more hydrophobic
bile salts (Fig. 6B: TDC>TC>TUDC).
We also examined effects of increasing contents of one of the three lipids
by 5 mol %, keeping ratio between the other two lipids constant (model
biles 1-4 in Fig. 1). Despite changed relative lipid composition, all model
biles plotted in the central three-phase zone of the appropriate phase
diagram (5). As predicted by the “Phase Rule” (24), after 40 days
incubation, micelles are of one invariant composition, represented by the
micellar apex of the three phase-zone (for TC-containing systems:
PL/(BS+PL) ratio of 0.148, i.e. point b in Fig. 1). Location of the
micellar apex depends on hydrophobicity of the bile salts incorporated in
the system, with a leftward shift in case of TUDC-containing systems
(point b1 in Fig. 1: PL/(BS+PL) ratio of 0.127) and a rightward shift in
case of TDC-containing systems (PL/(BS+PL) ratio of 0.169). In all
model systems, micellar CSI of 1 and chol/PL ratios of ~1 in
(unilamellar and aggregated) vesicles (represented by point c in Fig.1)
indicate thermodynamic equilibrium after the prolonged (40-day)
incubation.
Right two-phase (micelles and vesicles– containing) zone
Influence of phospholipid class: We examined lipid distribution into
various phases after 10 days incubation of EYPC-, SM- or DPPC-
containing systems plotting in the right-two phase zone (TC as bile salt
in all cases: total lipid conc.=3.6 g/dL, PL/(BS+PL) ratio = 0.4, 15 mol%
cholesterol, 37°C). In SM- or DPPC-containing systems, 95% of
cholesterol was contained in vesicular aggregates. In contrast, in EYPC-
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containing model biles of the same relative composition, considerable
amounts of cholesterol were also contained in micelles (~20%) and small
unilamellar vesicles (~15%).
Figure 5: Distribution of cholesterol (A) and phospholipid (B) into
various phases in supersaturated model biles containing TDC or TC or
TUDC and plotting in the central three-phase zone (EYPC as
phospholipid in all cases: total lipid conc = 3.6 g/dL, PL/(BS+PL) ratio
= 0.3, 25 mol% cholesterol, 37°C). Various phases were isolated after
10 days incubation. Distribution of phospholipids and cholesterol into
vesicles is increased in case of hydrophilic bile salts (TDC<TC<TUDC),
with a reciprocal decrease in micelles. Crystal mass is significantly
lower in case of hydrophilic bile salts (TDC>TC>TUDC). Chol/PL
ratios in small unilamellar and aggregated vesicles are ~1 in all cases
(C). Open bars, TDC; hatched bars, TC; closed bars, TUDC. MIC,
micelles; SUV, small unilamellar vesicles; AGG, aggregated vesicles;
CRY, cholesterol crystal mass.
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Inset: equilibrium bile salt-phospholipid-cholesterol ternary phase
diagram. Continuous line: phase diagram for hydrophobic bile salts.
Interrupted line: decreased one-phase micellar zone and extension of
right two-phase zone in case of hydrophilic bile salts (5). Dot indicates
model bile plotting in three-phase zone.
Figure 6: Numbers of cholesterol monohydrate crystals (A) and crystal
mass (B) during 10 days incubation in supersaturated model systems
containing TDC, TC or TUDC and plotting in the central three-phase
zone (EYPC as phospholipid in all cases: for relative lipid composition
see Fig. 5). Crystal numbers and mass are larger in case of more
hydrophobic bile salts (TDC>TC>TUDC).
(●) TDC; (◆) TC; (■) TUDC. Please note logarithmic scale for 6A
There was also a preferential (≥ 50%) distribution of phospholipids into
aggregated vesicles in case of SM- or DPPC-containing model systems,
with lower amounts in micelles (~30%) and small unilamellar vesicles
(~20%). In case of EYPC-containing systems, distribution of
phospholipids into aggregated vesicles was lower (~40%), with larger
amounts in micelles or small unilamellar vesicles (~35% and ~25%
resp.) compared to SM- or DPPC-containing systems. Chol/PL ratios in
aggregated and small unilamellar vesicles were far below 1 in all cases.
Results were essentially the same after 40 days incubation.
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Influence of bile salt species: We also determined lipid distribution into
various phases after 10 days incubation of supersaturated model biles
containing TDC, TC or TUDC and plotting in the right-two phase zone
(EYPC as phospholipid in all cases: total lipid conc. 3.6 g/dL,
PL/BS+PL) ratio 0.5, 17 mol% cholesterol, 37°C). Distribution of
cholesterol and phospholipids into aggregated vesicles increased in the
rank order: TDC<TC<TUDC-containing systems, with reciprocal
decreases of micellar solubilization. Chol/PL ratios in small unilamellar
or aggregated vesicles were far below 1 in all cases. Results were
essentially the same after 40 days incubation.
Left two-phase (micelles + vesicles– containing) zone
In model systems plotting in the left-two phase zone, vesicles could not
be detected. With daily examination during the first 10 days, cholesterol
crystal mass as well as numbers of small cholesterol monohydrate
crystals were always higher in SM- or DPPC-containing systems than in
EYPC-containing systems (Fig. 7). Anhydrous crystal forms occurred
more frequently in EYPC-containing systems.
In contrast to results in the three-phase zone, cholesterol crystal masses
and numbers of cholesterol monohydrate crystals were higher in case of
more hydrophilic bile salts (TDC<TC<TUDC, Fig. 8). Reciprocal effects
were found for cholesterol solubilization in micelles (TDC>TC>TUDC).
Anhydrous crystal forms occurred more frequently in case of
hydrophobic bile salts.
DISCUSSION
Biliary cholesterol supersaturation has traditionally been considered as
the major factor determining precipitation of cholesterol crystals and
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gallstone formation. The studies of Wang and Carey (5) have revealed
the importance of relative amounts of bile salts vs phospholipids in the
system for the crystallization process. In case of excess bile salts,
precipitation of –intermediate anhydrous and mature monohydrate-
cholesterol crystals occurs at fast rates. At higher phospholipid contents,
cholesterol-phospholipid vesicles are formed, with the result that
precipitation of cholesterol crystals is diminished (three-phase zone), or
even completely prevented (right two-phase zone). We have evaluated in
the present study lipid distribution into various phases throughout the
phase diagram.
Figure 7: Numbers of large cholesterol monohydrate (ChM) crystals
(A), small cholesterol monohydrate crystals (B), anhydrous cholesterol
crystals (arcs, needles, tubules, spirals; C) and crystal mass (D) during
10 days incubation in supersaturated model systems containing EYPC,
SM or DPPC and plotting in the left two-phase zone (TC as bile salt in
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all cases: total lipid conc = 3.6 g/dL, PL/(BS+PL) ratio = 0.02, 10 mol%
cholesterol, 37°C). Crystal mass is larger in case of SM or DPPC than
for EYPC throughout the observation period.
(◆) EYPC; (●) SM; (■) DPPC. Please note logarithmic scale for 7A, B,
C.
Figure 8. Numbers of large cholesterol monohydrate (ChM) crystals (A),
small cholesterol monohydrate crystals (B), anhydrous cholesterol
crystals (arcs, needles, tubules, spirals; C) and crystal mass (D) during
10 days incubation in supersaturated model systems containing TDC, TC
or TUDC and plotting in the left two-phase zone (EYPC as phospholipid
in all cases: total lipid conc = 3.6 g/dL, PL/(BS+PL) ratio = 0.04, 8
mol% cholesterol, 37°C). Crystal mass is larger in case of more
hydrophilic bile salts throughout the observation period.
(●) TDC; (◆) TC; (■) TUDC. Please note logarithmic scale for 8A, B,
C.
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We also determined in supersaturated three-phase model systems that
contained cholesterol, EYPC, SM or DPPC, and TC, lipid distribution
into various phases as a function of time (after 1, 10 and 40 days
incubation: Figs 2-3). After one day, small unilamellar and aggregated
vesicles were supersaturated (chol/PL ratios >1). During prolonged
incubation, and coinciding with progressive cholesterol crystallization,
vesicular cholesterol contents and chol/PL ratios decreased, approaching
equilibrium (chol/PL ratio ~1) on day 10.
Data obtained by video enhanced contrast microscopy have suggested
that precipitation of cholesterol crystals occurs from aggregated vesicular
phases (25). In the present study, magnitude of shifts of cholesterol
between various phases (large increase of crystal mass; large decrease of
cholesterol contained in aggregated vesicles: particularly in case of SM:
Fig. 2) also provide indirect evidence for crystal precipitation from
vesicular aggregates. In the right two phase-zone, chol/PL ratios in
(unilamellar and aggregated) vesicles were always below 1, thus
explaining absence of cholesterol crystallization.
We also examined effects of varying phospholipid class. In model
systems plotting in the left two-phase or central three-phase (crystal-
containing) zones, speed and extent of crystallization was enhanced in
case of DPPC or SM as compared with EYPC. In contrast, previous
studies (12-14) have indicated that disaturated PC species inhibit
crystallization, and PC species with unsaturated acyl chains at the sn-2
position promote crystallization progressively at increasing unsaturation.
We have previously developed the equilibrium ternary phase diagram for
cholesterol, taurocholate and SM- or DPPC-containing systems (6).
Compared to EYPC-containing systems under the same conditions (5),
the right two-phase (vesicles and micelles-containing) zone is greatly
expanded to the left at the expense of the crystals-containing (central
three-phase and left two-phase) zones. In previous studies (12-14),
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position in the phase diagram was probably changed from the central
three-phase zone to the right two-phase zone in case of more saturated
PC species, thus explaining suppressed crystallization. However, with
careful attention (as in the present study) that model systems -with
identical relative lipid composition- are composed so that they all plot in
the central three-phase zone of the appropriate ternary phase diagram
(5,6), more saturated phospholipids apparently promote crystallization.
Dietary modification toward more saturated biliary phospholipids has
been proposed to prevent gallstone formation in humans (15).
Nevertheless, effects of dietary modification are expected to be relatively
small, and insufficient to induce a change from central three-phase
toward right two-phase zone position. Indeed, no changes in biliary
cholesterol crystallization or lipid solubilization could be induced by
such a dietary modification in humans (15).
More hydrophilic bile salts such as TUDC reduced crystallization in
model biles plotting in the central three phase-zone, in agreement with
previous data (26). In contrast, in model biles plotting in the left two-
phase zone, crystallization was enhanced at increasing bile salt
hydrophilicity, in the rank order: TDC<TC<TUDC. Apparently,
solubilization of cholesterol in vesicular phases (i.e. position in the
central three-phase zone) is a prerequisite for reduced crystallization by
TUDC. Enhanced crystallization in TUDC-containing model biles that
do not contain vesicles (i.e. plot in the left two-phase zone) can easily be
explained by the decreased micellar cholesterol solubility in case of more
hydrophilic bile salts (5). Although most cholesterol-supersaturated
human biles are assumed to plot in the central three phase-zone, some
may be located in the left two-phase zone, based on crystallization
sequences (27) and absence of vesicular phases (28,29). These data
would suggest potential adverse effects of ursodeoxycholate therapy
(frequently used in clinical practice to dissolve cholesterol gallstones) at
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the local level in bile. However, the major effects of ursodeoxycholate in
humans are a decrease of intestinal cholesterol absorption (30) and a
lower biliary cholesterol secretion, with the result that bile becomes
unsaturated. Indeed, we found that cholesterol crystals decreased in size
or even disappeared during prolonged ex vivo incubation of gallbladder
biles obtained from gallstone patients treated with ursodeoxycholate
(31).
Different effects of bile salt hydrophilicity vs phospholipid acyl chain
saturation on crystallization behavior in the three phase-zone (i.e.
inhibition vs promotion) may relate to different effects on micellar
cholesterol solubilization. Whereas TUDC decreases solubilization of the
sterol to a relatively minor degree (5), there is a 70% reduction of
micellar solubility limits for SM- or DPPC-containing systems as
compared to EYPC-containing system (6). Apparently, such strongly
reduced micellar solubilization cannot be compensated for by enhanced
vesicular solubilization. One should also realize, that our data on lipid
distribution with various  phospholipid classes (Figs 2-4) cannot be
compared in a quantitative way with data obtained by modulation of bile
salt species (Figs 5,6) since lipid composition could not be completely
identical due to limitations of the phase diagram (5,6).
The present study increases insight in physical-chemical interactions
between bile salts, phospholipids and cholesterol and in the process of
crystallization. Nevertheless, several limitations apply to the
(patho)physiological relevance of our findings. Obviously, residence
time of bile in the gallbladder and bile ducts in vivo is much shorter than
our prolonged in vitro model bile incubation times. Also, composition of
our model systems was far from physiological: proteins were absent,
only one bile salt was incorporated instead of a mixture of various bile
salts, and there is virtually no sphingomyelin in human bile.
Furthermore, although large amounts of aggregated vesicles form within
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a few hours of ex vivo incubation of human biles, as observed by video-
enhanced microscopy (25), vesicle aggregation may be particularly
extensive in model biles (10). These aggregated vesicles preclude
accurate separation of vesicular and micellar phases with the aid of gel
filtration (10). We therefore included an initial ultracentrifugation step in
our protocol. We obtained in our three-phase model biles at equilibrium,
vesicular cholesterol/phospholipid ratios of ~1 and micellar CSI-values
of ~1, as expected from theoretical considerations (24). Nevertheless, we
cannot definitely exclude that our multistep protocol could induce some
artifactual shifts between various lipid phases.
In summary, we found enhanced lipid distribution into vesicular phases,
and reciprocal decreases of micellar lipid solubilization in case of more
hydrophilic bile salts or more saturated phospholipids. Whereas egg yolk
phosphatidylcholine decreases crystallization compared to
sphingomyelin or dipalmitoyl phosphatidylcholine in all crystal-
containing zones, formation of vesicular phases is a prerequisite for
inhibition of crystallization by the hydrophilic bile salt
tauroursodeoxycholate.
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Abstract
Both phosphatidylcholine (PC) and sphingomyelin (SM) are the major
phospholipids in the outer leaflet of the hepatocyte canalicular
membrane. Yet, the phospholipids secreted into bile consist principally
(>95%) of PC. In order to understand the physical-chemical basis for
preferential biliary PC secretion, we compared interactions with bile salts
(taurocholate) and cholesterol of egg yolk (EY)SM (mainly 16:0 acyl
chains, similar to trace SM in bile), buttermilk (BM)SM (mainly
saturated long (>20 C-atoms) acyl chains, similar to canalicular
membrane SM) and egg yolk (EY)PC (mainly unsaturated acyl chains at
sn-2 position, similar to bile PC). Main gel to liquid-crystalline transition
temperatures were 33.6°C for BMSM and 36.6°C for EYSM. There were
no significant effects of varying phospholipid species on micellar sizes or
intermixed-micellar/vesicular bile salt concentrations in taurocholate-
phospholipid mixtures (3 g/dL, 37°C, PL/BS+PL=0.2 or 0.4). Various
phases were separated from model systems containing both EYPC and
(EY or BM)SM, taurocholate and variable amounts of cholesterol, by
ultracentrifugation with ultrafiltration and dialysis of the supernatant. At
increasing cholesterol content, there was preferential distribution of
lipids and enrichment with SM containing long saturated acyl chains in
the detergent-insoluble pelletable fraction consisting of aggregated
vesicles. In contrast, both micelles and small unilamellar vesicles in the
supernatant were progressively enriched in PC. Although SM-containing
vesicles without cholesterol were very sensitive to micellar solubilization
upon taurocholate addition, incorporation of the sterol rendered SM-
containing vesicles highly resistant against the detergent effects of the
bile salt. These findings may have important implications for canalicular
bile formation.
INTRODUCTION
The hepatocyte plasma membrane is functionally divided into a
canalicular (or apical) region adjacent to the lumen of the bile canaliculus
and a sinusoidal (or basolateral) region in close contact with sinusoidal
blood (1). Although the canalicular region comprises only 10-15% of the
total plasma membrane, it plays a crucial role in the process of nascent
bile formation and biliary secretion of bile salts, phosphatidylcholine
(PC) and cholesterol.
In recent years, there has been considerable progress in understanding
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transport mechanisms of these lipids over the canalicular membrane: mdr
(multi drug resistance) 2 P-glycoprotein functions as a "flippase"
translocating PC molecules from the inner to the outer leaflet of the
canalicular membrane (2) and the so-called "Sister P-glycoprotein"
appears to mediate bile salt transport (3). Nevertheless, only limited data
are available on the events occurring during nascent canalicular bile
formation and the physical-chemical mechanisms involved. With the aid
of ultrarapid cryofixation and electron microscopic imaging, Crawford
could visualize significant amounts of unilamellar vesicles within the
canalicular lumen, consistent with a vesicular mode of cholesterol and
PC secretion (4). Nevertheless, these findings do not exclude the
possibility that detergent bile salts, after their secretion into the
canalicular lumen, could micellize considerable amounts of cholesterol
and PC from the outer leaflet of the canalicular membrane.
Another matter of debate is why PC is the predominant phospholipid in
bile: both sphingomyelin (SM) and PC are the major structural
phospholipids in the outer leaflet of the hepatocyte canalicular membrane
(in an average ratio of 0.7) (1,5), but PC is the major (≈ 95%)
phospholipid species in bile (6). It has been well known since long, that
biliary PC contains mainly 16:0 acyl chains at the sn-1 position and
predominantly unsaturated (18:2>18:1>20:4) acyl chains at the sn-2
position (7). Recent data by Nibbering and Carey (8) indicate that the
trace amounts of SM in rat bile contain mainly 16:0 acyl chains, whereas
canalicular membrane SM contains predominantly long (>20 C-atoms)
saturated acyl chains amide-linked to the sphingosine moiety. Similar
predominance of SM with long saturated acyl chains has previously been
reported for hepatocyte plasma membrane (9). Contents of SM and
cholesterol are higher in the canalicular than in the sinusoidal membrane
(1,10), with decreased fluidity and increased resistance against detergent
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effects of bile salts as a result. Extensive physical-chemical and cell-
biological studies indicate that cholesterol has a higher affinity for
natural SM than for PC  (11-17) and may be tightly bound in laterally
segregated SM domains in the hepatocyte canalicular membrane (14,18).
The present study aims to increase insight in the process of canalicular
bile formation by means of studying interactions of bile salts with SM
and PC -with or without cholesterol- in a number of complementary in
vitro systems. We used PC from egg yolk (mainly 16:0 acyl chains at the
sn-1 position, and mainly unsaturated acyl chains at the sn-2 position,
similar to PC in bile (7)), SM from egg yolk (mainly 16:0 acyl chains,
similar to trace SM in bile (8)) and SM from buttermilk (mainly long
saturated acyl chains, similar to SM in the canalicular membrane (8,9)).
MATERIAL AND METHODS
Materials
Taurocholate was obtained from Sigma Chemical Co. (St. Louis, MO,
USA) and yielded a single spot upon thin-layer chromatography (butanol-
acetic acid-water, 10:1:1 vol/vol/vol, application of 200 µg bile salt).
Cholesterol (Sigma) was ≥ 98% pure by reverse-phase HPLC
(isopropanol - acetonitril 1:1, vol/vol, detection at 210 nm).
Phosphatidylcholine from egg-yolk (EYPC; Sigma), sphingomyelin from
egg-yolk (EYSM; Avanti Polar-Lipids Inc., Alabaster, AL, USA), and
sphingomyelin from buttermilk (BMSM; Matreya Inc., Pleasant Gap, PA,
USA) all yielded a single spot on thin-layer chromatography
(chloroform–methanol-water 65:25:4, vol/vol/vol, application of 200 µg
lipid). Methylated fatty acids (16:0, 18:0, 18:1, 18:2, 20:0, 21:0, 22:0,
23:0, 24:0, 24:1, 25:0), used as standards for gas-liquid chromatography,
were purchased from Sigma. Acyl chain compositions as determined by
gas-liquid chromatography (19) were virtually identical to previously
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published data (20) and showed mainly saturated long (≥ 20 C-atoms)
acyl chains for BMSM, similar to acyl chain composition of SM in
hepatocytic plasma membranes (8,9), and a preponderance of 16:0 acyl
chains for EYSM. As shown by reverse-phase HPLC, EYPC contained
mainly 16:0 acyl chains at the sn-1 position and mainly unsaturated
(18:1>18:2>20:4) acyl chains at the sn-2 position (21), similar to
phosphatidylcholine in human bile (7). All other chemicals and solvents
were of ACS or reagent grade quality.
Ultrafilters with a molecular weight cut-off of 10 kDa and 300 kDa were
purchased from Sartorius (Göttingen, Germany: Centrisart I), dialysis
membranes with a molecular weight cut-off of 300 kDa from Spectrum
Laboratories (Laguna Hills, CA, USA: SpectraPor). Sephacryl S400 gel
filtration material was from Pharmacia LKB Biotechnology AB
(Uppsala, Sweden). The enzymatic cholesterol assay kit was obtained
from Boehringer (Mannheim, Germany), and the enzymatic phospholipid
kit from Sopar Biochem (Brussels, Belgium). 3α-Hydroxysteroid
dehydrogenase for the enzymatic measurement of bile salt concentrations
(22) and a colorimetric chloride-kit were purchased from Sigma. The
reverse-phase C18 HPLC column was from Supelco (Supelcosil LC-18-
DB, Supelco, Bellefonte, PA, USA).
Preparation of model systems
Lipid mixtures containing variable proportions of cholesterol,
phospholipids (both from stock solutions in chloroform), or taurocholate
(from stock solutions in methanol) were vortex-mixed and dried at 45°C
under a mild stream of nitrogen and subsequently lyophilized during 24
hrs, before being dissolved in aqeous 0.15 M NaCl plus 3 mM NaN3.
Tubes were sealed with Teflon-lined screw caps under a blanket of
nitrogen to prevent lipid oxidation and vortex-mixed for 5 min followed
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by incubation at 37°C in the dark. The final mol percentages cholesterol,
phospholipid and bile salt did not differ more than 2.5% from the
intended mol percentages.
Differential Scanning Calorimetry
BMSM or EYSM (10 mg), from stock solutions in chloroform, were
dried at 45°C under a mild stream of nitrogen and dissolved in 1 mL H2O
followed by 5 cycles of freeze-thawing. Main gel to liquid-crystalline
phase transition temperatures (melting temperatures: Tm) were measured
with a Perkin-Elmer DSC-4 differential scanning calorimeter (Perkin-
Elmer, Norwalk, CT, USA), at a scan rate of 5°C / min.
Quasielastic light-scattering (QLS) spectroscopy
QLS measurements of micelles in mixtures of taurocholate and
phospholipids were performed on a home-built apparatus, the details of
which were published elsewhere (23). Measurements were performed
with the argon laser tuned to 514.5 nm at a scattering angle of 90°.
Vesicular sizes were measured with a Malvern 4700c QLS spectrometer
(Malvern Ltd., Malvern, UK), equipped with an argon laser (Uniphase
Corp., San Jose, CA, USA) at a wavelength of 488 nm. All samples were
maintained at a constant temperature of 37°C by means of a Peltier
thermostatic block or a water bath. To remove dust, tubes were first
centrifuged for 10 min. at 10000 x g. Data are given as hydrodynamic
radius (Rh: means of at least 3 measurements).
Lipid analysis
Phospholipid concentrations in model systems were assayed by
determining inorganic phosphate according to Rouser (24), but in serial
fractions from gel-filtration experiments with an enzymatic assay.
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Cholesterol concentrations were determined with an enzymatic assay or
by reverse-phase HPLC (acetonitril–isopropanol 1:1, vol/vol, detection at
210 nm), and bile salts with the 3α-hydroxysteroid dehydrogenase
method (22) or by HPLC (25). In systems containing both EYPC and
SM, the phospholipids were extracted according to Bligh and Dyer (26),
separated by thin-layer chromatography (chloroform-methanol-acetic
acid-water 50:25:8:2, vol/vol/vol/vol), and quantified by determination of
phosphorus contents of separated phospholipid spots. In order to
determine the fatty-acid profiles of sphingomyelin, 1 µmol
sphingomyelin was hydrolyzed in 1 mL nitrogen-flushed HCl-methanol-
H2O (8.3:80.6:11.1, vol/vol/vol, 16hrs, 70°C) (19). The methylated fatty
acids were extracted three times with 1 mL hexane; the pooled hexane
phase was washed with 3 mL H2O, dried over Na2SO4, and concentrated
under nitrogen. The fatty-acid methyl-esters were dissolved in 30 µl
hexane, 2 µL of which were injected in a GC14-A gas-chromatograph
(Shimadzu, Kyoto, Japan), equipped with a bonded FSOT capillary
column (length 30m, ∅ 0.32 mm).
IMC measurement
Apart from mixed (i.e. phospholipid–bile salt) micelles, model bile
systems also contain non phospholipid–associated bile salts, either as
monomers or, above their critical micellar concentration, associated in
small simple micelles. The monomeric plus simple micellar bile salt
concentration is referred to as “intermixed micellar/vesicular (non
phospholipid-associated) bile salt concentration”, usually abbreviated as
"IMC" (27). We determined the IMC in micellar model systems with
relatively low or relatively high amounts of either EYSM, BMSM or
EYPC as phospholipid and taurocholate as bile salt ((PL / (PL + bile salt)
ratio = 0.2 and 0.4; total lipid concentration 3 g / dL, 37°C). The effect of
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incorporating small (3 mol %) amounts of cholesterol on the IMC in
these systems was also explored.
A 10 kDa Centrisart ultrafilter was rinsed with H2O and centrifuged for 5
min at 500 g in order to remove glycerol remnants from the membrane.
The water was removed carefully from both sides of the membrane with
a syringe. The filter was preincubated at 37°C during 30 min. before
usage. A 2 mL aliqout of model system was put into the filter device (in
duplicate) and centrifuged at 500 g for 5 min. in a pre-warmed (37°C)
centrifuge. The filtrate was carefully collected with a syringe. Filtration
was repeatedly performed, adjusting centrifugal speed so as to obtain
constant filtrate volumes of approximately 50 µL. Bile salt and chloride
concentrations reached stable values in the third filtrate. Slightly lower
concentrations in the first and second filtrates resulted from small
amounts of water remaining in the membrane after rinsing the ultrafilter
(28). We considered the third filtrate to represent the simple micellar +
monomeric fraction, and therefore decided to use the third filtrate for
measurement of the IMC (the first two filtrates were added each time to
the filtrant) (28,29). No phospholipids were detectable in the filtrates
(detection limit of the assay:  0.048 mM), indicating that no mixed
micelles had passed through the filter. During ultrafiltration, Gibbs-
Donnan effects occur as a result of uneven distribution across the
membrane of non-filterable particles with a highly negative charge (in
particular mixed micelles), thus leading to an overestimation of the
concentrations of negatively charged monomeric and simple micellar bile
salts in the filtrate (27,28). We corrected the concentrations of bile salts
measured in the filtrate for Gibbs-Donnan effects by multiplying the bile
salt concentration in the filtrate with the ratio of chloride concentrations
in filtrant and filtrate (27-29).
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Separation of vesicular and micellar phases
Two independent procedures were used to separate vesicular and micellar
phases: ultrafiltration of the whole system or ultracentrifugation with
subsequent ultrafiltration and dialysis of the supernatant. With the first
procedure (ultrafiltration), micellar phases were isolated from model
systems containing both EYPC and SM as phospholipid, taurocholate and
various amounts of cholesterol (10 mM EYPC, 6.6 mM EYSM or
BMSM, 16.6 mM taurocholate, and 1.6, 3.2 or 6.4 mM cholesterol:
cholesterol / phospholipid ratios 0.1, 0.2 or 0.4). These model systems all
plot in the right two-phase zone of the equilibrium ternary phase diagram
(20,30) and contain micelles and vesicles of various compositions. We
used one additional model system (57mM taurocholate, 19mM EYPC,
19mM EYSM, 46mM cholesterol) plotting in the middle three-phase
(micelles, vesicles and solid cholesterol crystals containing) zone of the
equilibrium ternary phase diagram (20,30). According to the phase rule,
all three phases of this system should have one, invariant composition at
equilibrium (31). The ultrafilter had a molecular weight cut-off of 300
kDa, and had previously been rinsed with aqueous 0.15 M NaCl  plus 3
mM NaN3, containing taurocholate at concentrations identical to the IMC
of the original model systems, in order to avoid artifactual shifts of lipids
between vesicles and micelles (27-29). These filters were completely
permeable not only to simple micelles but also to mixed taurocholate /
phospholipid micelles (tested with mixed micelles at 37°C, at total lipid
concentrations of  2, 5 and 10 g/dL and at PL/(BS+PL) ratios of 0.55,
0.5, 0.4 and 0.3, either without or with small amounts (0.25 mol%)
cholesterol: either SM, EYPC or both SM and EYPC (SM/PC ratio 0.37)
as the phospholipid), but were completely impermeable to small
unilamellar or aggregated vesicles. The membrane–containing inner tube
of the filter device (placed membrane–down on top of 2 mL of model
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system) was allowed to sink slowly into the filtrant by gravity, thus
producing approximately 200 µL micelle-containing filtrate within 2 hrs.
In order to purify the vesicles, 200 µL of the remaining filtrant then was
diluted 10 times with aqeous 0.15 M NaCl / 3 mM NaN3 containing
taurocholate according to the IMC (in order to avoid artefactual shifts of
lipids between various phases), followed by ultrafiltration until
approximately 90% of the volume was contained within the filtrate. This
procedure was repeated twice in order to wash out the remaining mixed
micelles.
With the second procedure, aggregated vesicles in 2 mL of model system
were precipitated by ultracentrifugation during 30 minutes at 50.000 g
and 37°C in a TLS 55 rotor (Beckman, Palo Alto, CA, USA) (32). The
pellet was resuspended in a final volume of 2 mL isopropanol. A Tyndall
effect was generally visible in the supernatant, consistent with the
presence of small unilamellar vesicles, as confirmed with quasi-elastic
light scattering spectroscopy. Micelles were isolated from the supernatant
by ultrafiltration with the aid of the 300 kDa filter described above
(identical micellar compositions had been obtained by ultrafiltration of
the corresponding whole model system, indicating that the short
ultracentrifugation procedure did not induce artifactual shifts between
phases). Small unilamellar vesicles were isolated from the supernatant by
dialysis (500 µL sample, 16h, 37°C) in a SpectraPor® dialysis device
with a molecular weight cut-off of 300 kDa, against two times 20
volumes of aqeous 0.15 M NaCl plus 3 mM NaN3 containing
taurocholate at concentrations identical to the IMC of the original model
system. The dialysis membrane was completely permeable for the same
micelles used to validate the 300 kDa ultrafilter (see above), but not for
small unilamellar vesicles or for aggregated vesicles. Recovery of
cholesterol and phospholipids in separated micellar, unilamellar and
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aggregated vesicular phases was 95-100 % of lipids in the corresponding
whole model system.
In some experiments, small unilamellar vesicles were also separated from
micelles in model systems by gel filtration of the supernatant on a
Sephacryl S400 column (gel bed 30 cm, diameter 1.5 cm, flow-rate 0.5
ml/min, 1 mL fractions), equilibrated with aqeous 0.15 M NaCl plus 3
mM NaN3 containing taurocholate at concentrations identical to the IMC
of the original model system (27-29). Combined dialysis and
ultrafiltration yielded the same amounts of vesicles and micelles as gel
filtration, but is less time-consuming, requires smaller amounts of aqeous
bile salt solution, and does not lead to dilution of the sample. Therefore,
combined dialysis and ultrafiltration was considered to be the preferable
method to isolate micelles and small unilamellar vesicles from the model
system.
Preparation of small unilamellar vesicles
Small unilamellar vesicles were prepared by sonication. Lipids, from
stock-solutions in chloroform, were vortex-mixed, dried under a mild
stream of nitrogen and subsequently lyophilized during 24 hrs. The lipid
film was dissolved in nitrogen-flushed aqeous 0.15 M NaCl plus 3 mM
NaN3, and thereafter, the suspensions were probe-sonicated during 30
min. at 50°C (above the main transition temperatures of the
phospholipids). After sonication, the suspension was centrifuged during
30 min. at 50000 x g at 40°C, in order to remove potential remaining
vesicular aggregates and titanium particles. The resulting small
unilamellar vesicles were stored at temperatures above 40°C, and used
within 24 hrs. Small unilamellar vesicles were prepared with 100%
EYPC, 100% (EY or BM)SM, 80% EYPC / 20% (EY or BM)SM, or
60% EYPC / 40% (EY or BM)SM as the phospholipid. Final
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phospholipid concentrations were 4 mM. Vesicles were either prepared
without or with cholesterol (cholesterol / phospholipid ratio 0, 0.2 or 0.4).
Interactions of small unilamellar vesicles with bile salts
Interactions of small unilamellar vesicles with taurocholate were
examined by measuring optical density at 405 nm every min. during 80
minutes at 37°C, in a thermostated Benchmark microplate reader
(BioRad, Hercules, CA, USA). The solutions were stirred for 2 seconds
prior to each measurement. A decrease of the OD 405 after addition of
taurocholate is compatible with micellization of the vesicles, whereas an
increase can be attributed to growth, fusion or aggregation of the vesicles
(33). Absorbance measured in control vesicles without taurocholate
always remained stable during the experiment. In the case of cholesterol-
containing vesicles, after the experiment the mixtures were observed by
polarizing light microscopy, in order to examine whether liquid or solid
cholesterol crystals had formed.
In additional experiments, we added taurocholate to sonicated EYPC,
BMSM and cholesterol containing vesicles (final composition of the
system: 16 mM taurocholate, 10 mM EYPC, 6.6 mM BMSM and 6.4
mM cholesterol) and determined SM/PC ratios in micelles (obtained by
ultrafiltration) at 10 min, 1 hr, 4 hrs and 12 hrs, in order to obtain further
information on extent of asymmetric phospholipid distribution as a
function of time.
Statistical analysis
Values are expressed as mean ± SEM. Differences between groups were
tested for statistical significance by analysis of variance with the aid of
SPSS software, version 7.5. When ANOVA detected a significant
difference, results were further compared for contrasts using Fisher's
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least significant difference test as post-hoc test. Statistical significance
was defined as a two-tailed probability of less than 0.05.
RESULTS
Main gel to liquid crystalline phase transition temperatures of
BMSM and EYSM
Main gel to liquid crystalline phase transition temperatures as determined
by differential scanning calorimetry were 33.6°C for hydrated BMSM
(maximum ∆H/sec at 29°C) and 36.6°C for hydrated EYSM (maximum
∆H/sec at 33°C).
Micellar sizes and intermixed micellar/vesicular bile salt
concentrations of taurocholate–phospholipid systems.
The hydrodynamic radius (Rh) of taurocholate–phospholipid mixed
micelles (3 g/dL, 37°C) was 2.1±0.1 nm at low phospholipid content (PL
/ (PL + BS) ratio = 0.2) but increased to 2.9±0.1 nm at higher
phospholipid content (PL / (PL + BS) ratio = 0.4). There were no
significant differences in sizes between EYPC-, EYSM- or BMSM-
containing mixed micelles at these ratios. Intermixed micellar/vesicular
(i.e. monomeric + simple micellar) bile salt concentrations (IMC) of the
same systems also strongly depended on phospholipid content: the IMC
was  17.5 ± 0.3 mM at PL / (PL + BS)  ratio 0.2, but 8.4 ± 0.3 mM at PL /
(PL + BS) ratio 0.4 (37°C, 3 g/dL). Again, there were no significant
differences between systems containing EYPC, EYSM or BMSM as the
phospholipid. Inclusion of small amounts (3 mol %) of cholesterol in the
system led to turbidity due to formation of vesicles in EYSM- or BMSM-
containing systems, whereas systems containing EYPC remained clear
under these circumstances. However, the IMC did not change by
inclusion of the sterol in EYSM-, BMSM-, or EYPC-containing systems.
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Figure 1: Micellar solubilization of phospholipids (solid bars) and
cholesterol (hatched bars) as determined by ultrafiltration of model
systems after 2 weeks incubation at 37°C (16.6 mM taurocholate, 10 mM
EYPC, 6.6 mM EYSM or BMSM, 1.6, 3.2 or 6.4 mM cholesterol,
cholesterol/phospholipid ratios 0.1, 0.2 and 0.4). The amount of
phospholipid solubilized in micelles decreased significantly at higher
cholesterol content of the systems, whereas the amount of cholesterol
solubilized in micelles did not change at varying cholesterol contents.
There were no significant differences between EYSM- and BMSM-
containing systems. An asterisk (*) indicates significant difference from
chol/PL ratios 0.1 and 0.2.
Distribution of cholesterol and phospholipid between micellar and
vesicular phases
Model systems composed with taurocholate, both EYPC and
sphingomyelin as phospholipid, and variable amounts of cholesterol
(16.6 mM taurocholate / 10 mM EYPC / 6.6 mM EYSM or BMSM / 1.6,
3.2 or 6.4 mM cholesterol, see also "Materials and Methods") were
studied after 2 weeks of incubation at 37°C. These systems were highly
turbid and microscopic examination revealed the presence of large
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amounts of aggregated vesicles. Solid cholesterol crystals, however, were
not observed. In a first series of experiments, micelles were isolated from
model systems by ultrafiltration. As shown in Figure 1, with increasing
cholesterol content of the model systems, micellar phospholipid
solubilization decreased strongly, whereas micellar cholesterol
solubilization remained constant. The decrease of micellar phospholipid
occurred both in EYSM- and BMSM-containing systems.
In subsequent experiments, various cholesterol-containing phases were
separated by ultracentrifugation followed by ultrafiltration and dialysis of
the supernatant (see “Materials and Methods” section). After
precipitation of aggregated vesicles by ultracentrifugation, the
supernatant displayed a typical Tyndall effect, indicating the presence of
small unilamellar vesicles. Indeed, quasielastic light scattering
spectroscopy of the supernatant revealed the presence of particles with a
hydrodynamic radius of 43 ± 12 nm, consistent with small unilamellar
vesicles.
As shown in Figure 2A-B, at increasing cholesterol content of the
system, the excess cholesterol was mainly distributed into the detergent-
insoluble pelletable fraction consisting of aggregated vesicles.
Distribution of cholesterol into small unilamellar vesicles and in mixed
micelles decreased. Although the total amount of phospholipids was kept
constant in the system, distribution of phospholipids into aggregated
vesicles increased at higher cholesterol contents, whereas the amount of
phospholipids in small unilamellar vesicles and mixed micelles decreased
(Figure 2C-D). Whereas the cholesterol/phospholipid ratios in micelles
and small unilamellar vesicles increased only slightly at higher
cholesterol content of the system, there was a strong increase of
cholesterol/phospholipid ratio in aggregated vesicles (Figure 2E, F). The
effects of cholesterol tended to be more pronounced in systems
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containing EYSM (Figure 2A, C, E) than in systems composed with
BMSM (Figure 2B, D, F).
Distribution of sphingomyelin and egg yolk phosphatidylcholine
between vesicles and micelles
Figure 3 shows the distribution of SM and EYPC into vesicles (small
unilamellar and aggregated combined) and micelles quantified after
separation of the phases by means of ultrafiltration (see “Materials and
Methods”). Micellar enrichment with PC and vesicular enrichment with
SM is evident, particularly at high cholesterol contents of the system. A
similar pattern of phospholipid distribution was observed when various
phases were separated by ultracentrifugation with subsequent dialysis and
ultrafiltration of the supernatant. Apart from data on phospholipid
solubilization in micelles, this procedure also yielded separate
information on phospholipid distribution into small unilamellar and into
large aggregated vesicles (Figure 4). SM was highly enriched in
aggregated vesicles. In contrast, PC preferentially distributed into
micelles and into small unilamellar vesicles, particularly at high
cholesterol contents of the system. Asymmetric distribution of
phospholipids tended to be more pronounced in EYSM containing
systems (Figure 4A) than in BMSM containing systems (Figure 4B), but
significance was not reached.
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Figure 2: Solubilization of cholesterol and phospholipids in aggregated
vesicles (open circles), unilamellar vesicles (closed circles), and mixed micelles
(triangles) in model systems after 1 week incubation at 37°C. Lipid
composition of the model systems was the same as in Figure 1. The phases
were separated by ultracentrifugation and subsequent ultrafiltration and
dialysis of the supernatant (see “Materials and Methods”). Figure 2A and B
show cholesterol solubilization, 2C and D phospholipid solubilization and 2E
and F cholesterol/phospholipid ratios. Figures 2A, C, E apply to EYSM-
containing systems and Figures 2B, D, F to BMSM-containing systems. At
increasing cholesterol contents of the system, solubilization of cholesterol and
phospholipids in aggregated vesicles increased strongly, whereas
solubilization of these lipids in small unilamellar vesicles decreased strongly
(significant differences between all chol/PL ratios). The amount of mixed
micellar cholesterol and phospholipid also tended to decrease at increasing
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cholesterol content in the system. Cholesterol/phospholipid ratios increased
significantly at increasing cholesterol contents in the system, particularly in
aggregated vesicles. There was no significant influence of SM-type on lipid
solubilization in the various phases, although effects of cholesterol inclusion
tended to be more pronounced in case of EYSM.
Figure 3: Distribution of SM and PC between vesicles and micelles, as
determined by ultrafiltration of model systems after 2 weeks incubation
at 37°C. Lipid composition of the model systems was the same as in
Figure 1. Micellar SM solubilization decreased, and vesicular SM
solubilization increased at increasing cholesterol content of the system
(differences significant between all chol/PL ratios). Reciprocal results
were obtained for PC solubilization.
As shown in Figure 5, in systems composed with BMSM, there was a
preferential distribution of SM with long (> 21 C-atoms) saturated acyl
chains into aggregated vesicles, and a preferential distribution of SM
with shorter or unsaturated acyl chains in micelles or small unilamellar
vesicles, provided that the systems also contained cholesterol. No such
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asymmetric distribution occurred in systems composed with EYSM,
which can be explained by the small amounts of long acyl chains in
EYSM.
The model systems that we used above all plotted in the right two-phase
zone of the equilibrium ternary phase diagram (20,30) and contained
micelles and vesicles of various compositions. In addition, we
determined composition and SM/PC ratio of micelles from a model
system (57 mM taurocholate, 19 mM EYPC, 19 mM EYSM, 46 mM
cholesterol), plotting in the middle three-phase (micelles, vesicles and
solid cholesterol crystals containing) zone of the ternary phase diagram
(20,30), after 50 days incubation at 37°C. According to the phase rule, all
micelles in this three-phase system should have the same, invariant
composition at thermodynamic equilibrium (31). Microscopical
examination of the model system revealed aggregated vesicles and solid
cholesterol crystals. Composition of micelles (obtained by ultrafiltration
of the supernatant) was 41 mM (77 mol %) taurocholate, 11 mM (21 mol
%) phospholipids and 1.2 mM (2 mol %) cholesterol and micellar SM/PC
ratio was 0.33 (versus 1.0 in the whole system).
We also determined micellar SM/PC ratios at various time points after
addition of taurocholate to sonicated EYPC, BMSM and cholesterol
containing vesicles (final composition of the system : 16.6 mM
taurocholate, 10 mM EYPC, 6.6 mM BMSM, 6.4 mM cholesterol).
Micellar SM/PC ratio at 10 min. after addition of taurocholate was 0.67
(identical to the SM/PC ratio of 0.66 in the whole system) but decreased
to 0.61 after 1 hr, 0.55 after 4 hrs and 0.41 after 12 hrs.
Resistance of phospholipid vesicles against detergent bile salts
As  shown in Figure 6A, vesicles without cholesterol and containing
EYPC as the sole phospholipid tended to be rather resistant against the
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detergent effects of taurocholate, as indicated by the slow decrease of
absorption values during the time period studied (conditions: vesicular
phospholipid 4 mM final concentration: addition of taurocholate at 5 mM
final concentration, 37°C).
Figure 4: Distribution of SM and PC between aggregated vesicles (open
circles), small unilamellar vesicles (closed circles) and micelles
(triangles), as determined by ultracentrifugation (see “Materials and
Methods”) of model systems after 1 week incubation at 37°C. Lipid
composition of the model systems was the same as in Figure 1. SM
solubilization in micelles and small unilamellar vesicles decreased and
SM solubilization in aggregated vesicles increased significantly at
increasing cholesterol content of the system (significant differences
between all chol/PL ratios). Reciprocal results were obtained for PC
solubilization. There was no significant influence of SM-type on the
distribution of phospholipids between the various phases, although
effects of cholesterol inclusion tended to be more pronounced in the case
of EYSM.
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Figure 5: Distribution of SM species between aggregated vesicles, small
unilamellar vesicles and micelles in model systems after incubation at
37°C (16 mM taurocholate, 10 mM EYPC, 6.6 mM BMSM, 1.6, 3.2 or
6.4 mM cholesterol, cholesterol/phospholipid ratios 0.1, 0.2 or 0.4). At
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high cholesterol content, there is a preferential distribution of SM with
long (> 21 C-atoms) saturated acyl chains into aggregated vesicles and a
preferential distribution of SM with shorter or unsaturated acyl chains in
micelles and small unilamellar vesicles (significant effects for % long
and % saturated acyl chains: ANOVA).
In contrast, vesicles without cholesterol and containing (EY or BM)SM
as the sole phospholipid were extremely sensitive, with a virtual
instantaneous drop of absorbance to 0 upon addition of taurocholate.
Also, partial replacement of vesicular EYPC by EYSM or BMSM
(vesicular EYPC/SM ratios 80/20 or 60/40), without inclusion of
cholesterol, led to significant vesicular destabilization, as evidenced by
absorbtion values upon addition of taurocholate. The vesicular
destabilization depended on the amount of EYPC replaced by SM and
was strongest in case of partial replacement by EYSM (Figure 6A).
Essentially the same results were obtained upon addition of taurocholate
at 4, 6 and 7 mM final concentrations (results not shown).
As shown in Figure 6B, incorporation of cholesterol in SM-containing
EYPC vesicles prevented the destabilizing effect of SM (conditions:
vesicular phospholipid 4 mM final concentration; vesicular EYPC/SM
80/20 or 60/40; vesicular cholesterol/phospholipid ratio 0.4; addition of
taurocholate at 5 mM final concentration; 37°C): Absorbances by
spectrophotometry of these cholesterol-enriched vesicles were stable in
case of EYPC as the sole vesicular phospholipid but increased in the case
of incorporation of SM in the vesicles. The extent of increase depended
on the amount of EYPC replaced by SM and was strongest in case of
replacement by EYSM. Microscopical examination revealed formation of
aggregated vesicles under the latter circumstances, whereas solid
cholesterol crystals were absent.
As shown in Figure 6C, the increase in absorption observed in the case of
SM-containing vesicles was proportional to their cholesterol content
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(vesicular  phospholipid 4mM final concentration, vesicular EYPC/SM
ratio 60/40; vesicular  cholesterol/phospholipid ratio 0.2 and 0.4, addition
of taurocholate at a final concentration of 5 mM, 37°C). The increase of
absorption was stronger in case of EYSM- than BMSM-containing
vesicles.
Figure 6: Effects of taurocholate (final conc. 5 mM) on vesicles (final
phospholipid conc. 4 mM) with or without cholesterol (37°C). (A) Vesicles
without cholesterol and with variable phospholipid composition. Vesicles are
composed with 100% EYPC or with 20% or 40% of the EYPC replaced by
either EYSM or BMSM. In the absence of cholesterol, vesicles are
progressively destabilized at increasing SM contents (EYSM>BMSM). (B)
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Vesicles composed with fixed amounts of cholesterol and with variable
phospholipid composition. Incorporation of cholesterol (chol/PL ratio = 0.4)
prevents the destabilizing effects of SM. Absorption values now even increase
upon addition of taurocholate, depending on SM content (EYSM>BMSM)
consistent with aggregation or fusion of vesicles (33). (C) Vesicles composed
with variable amounts of cholesterol and with variable phospholipid
composition. The increase of absorption in case of cholesterol-containing
vesicles is also proportional to their cholesterol content and stronger in case of
partial replacement with EYSM than with BMSM. Vesicles are composed with
100% EYPC, or 40% of EYPC replaced with EYSM or BMSM. Variable
amounts (20% or 40%) of cholesterol are also incorporated in the vesicles.
Symbols for (A) also apply to (B).
The hydrodynamic radius (Rh) as determined by quasielastic light
scattering spectroscopy of the small unilamellar vesicles composed with
100% EYPC and without cholesterol was 50 ± 1.65 nm. Vesicles with
only SM as phospholipid were smaller, with a Rh of 38.0 ± 2.1 nm
(EYSM) and 34.2 ± 1.9 nm (BMSM). Partial replacement of EYPC with
SM also led to slightly decreased vesicle sizes (43.5 ± 1.23 nm in case of
40% EYSM, 43.9 ± 0.97 nm in case of 40% BMSM). Vesicle sizes
increased slightly with inclusion of  cholesterol (67.2 ± 0.9 nm, 49.6 ±
1.6 nm and 49.6 ± 2.6 nm for 100% EYPC, EYSM and BMSM
respectively; 62.1 ± 1.3 nm and 63.2 ± 1.9 nm in case of partial
replacement of EYPC with 40% EYSM and 40% BMSM respectively, all
at cholesterol/phospholipid ratio 0.4).
DISCUSSION
The major finding of the present study was the asymmetric distribution of
PC and SM between vesicular and micellar phases, provided that the
system also contained cholesterol. Similar results have been reported
after incubation with bile salts of isolated vesicular hepatocyte
canalicular membrane subfractions (34,35) or erythrocytes (36).
In most experiments, we have exploited the approach of Schroeder et al.
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(32) to pellet detergent insoluble material with the aid of
ultracentrifugation. These authors aptly state that “although it is likely
that any sedimentable lipids are not solubilized, the inability to sediment
does not guarantee solubilization”. Nevertheless, they considered “for
convenience the pelletable material as insoluble and material that remains
in the supernatant as soluble” (32) . We found evidence that the
supernatant was not homogeneous but contained small unilamellar
vesicles in addition to mixed micelles. We further separated these phases
with the aid of ultrafiltration and dialysis, or gel filtration techniques,
taking into account the intermixed micellar/vesicular bile salt
concentration (IMC), in order to avoid artifactual shifts between phases
(27-29). In the supernatant, both mixed micelles and small unilamellar
vesicles proved to be enriched in PC. In contrast, the pelletable fraction -
consisting of aggregated vesicles- was enriched in SM.
The 300 kDa ultrafilter that we used was completely permeable for
mixed micelles of a wide range of compositions but completely
impermeable for vesicles. We also found strong micellar depletion of SM
in a model system plotting in the middle (micelles, vesicles and solid
cholesterol crystal containing) three-phase zone of the ternary phase
diagram (20,30), after 50 days incubation (assumed thermodynamic
equilibrium). According to the phase rule (31), at thermodynamic
equilibrium, micelles in this system should be of one, invariant
composition. Therefore, these findings definitely exclude preferential
passage of phosphatidylcholine-enriched micelles through the ultrafilter
as the explanation of micellar SM depletion.
We also determined micellar SM/PC ratios as a function of time after
addition of taurocholate to sonicated SM, EYPC and cholesterol
containing vesicles. The fact that micellar SM depletion was not present
immediately after taurocholate addition but occurred at later stages,
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excludes artifacts during preparation of the model systems as the
explanation of our findings.
The present data on asymmetric distribution of (EY)PC and (EY or
BM)SM between micellar and vesicular phases are in agreement with
equilibrium ternary phase diagrams of (EY or BM)SM, taurocholate and
cholesterol (37°C, 3g/dL) (20): compared to EYPC-containing systems
under the same conditions (30), one-phase micellar zones are strongly
reduced in SM-containing systems, and there is a marked expansion of
the right two-phase (micelles + vesicles-containing) zone (20). The fact
that ternary phase diagrams for systems composed with (disaturated)
dipalmitoyl (DP)PC (Tm 41 °C) are identical to phase diagrams of SM-
containing systems (20) points to the importance of acyl chain
composition and/or physical state of the phospholipid. Also, after
separation of micellar and vesicular phases from analogous EYPC-
containing model systems with the aid of gel filtration, PC species with
unsaturated acyl chains distribute preferentially into micelles, whereas
vesicles are enriched in disaturated PC species, supposedly due to
packing constraints with more efficient packing of disaturated PC species
in vesicles (37). Similarly, differences in packing constraints in small
unilamellar vs aggregated vesicles (38) may explain their different
phospholipid composition.
Another factor of potential relevance may be the much higher gel to
liquid crystalline phase transition temperature (Tm) for SM compared to
EYPC: whereas EYPC has a Tm below 0 °C (39), we found Tm of
hydrated EYSM to be 36.6 °C, similar to previous data (39). The slightly
lower Tm (33.6 °C) for hydrated BMSM (not studied before) is not
unexpected, since in general, Tm decreases with increasing chain length
(39). Pure phospholipids exist in a solid, ordered gel phase below a
melting temperature (Tm) that is characteristic of each lipid, and in a
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liquid disordered (also called "liquid crystalline") phase above Tm. In
contrast, in the presence of cholesterol, lipids with a high Tm in the pure
state (e.g. disaturated PC species and sphingomyelins) may form a
socalled "liquid-ordered" phase around Tm (40-42). This liquid-ordered
phase has properties intermediate between the gel and liquid-crystalline
phases: Like the gel phase, the liquid-ordered phase is characterized by
tight acyl-chain packing and relatively extended acyl chains. On the other
hand, like lipids in the liquid-crystalline phase, lipids in the liquid-
ordered phase exhibit relatively rapid lateral mobility within the bilayer.
Recent data indicate that in bilayers containing more than one
phospholipid, in the presence of cholesterol, phase separation of the
phospholipids with the higher Tm (such as SM) into cholesterol-rich
liquid-ordered domains occurs, and that such a phase separation is a
prerequisite for detergent-resistance (41,42). We propose that SM in
cholesterol-rich liquid ordered domains is relatively resistant to the
micellizing effects of detergent bile salts, thus explaining asymmetric PC
and SM distribution as found in the present study.
There is some evidence that monomeric and simple micellar rather than
mixed micellar (i.e. phospholipid-associated) bile salts exert the
detergent effect on membrane bilayers (43). However, we did not find an
effect of varying phospholipid species on intermixed micellar/vesicular
(IMC: i.e. simple micellar + monomeric) bile salt concentrations or
micellar sizes. In agreement with previous data, micellar sizes were
larger (44) and IMC values were lower (27) at increasing phospholipid
contents. The absence of any change in IMC values when vesicles were
formed by inclusion of cholesterol in the system is in agreement with a
previous report of Donovan et al. (27). These findings suggest that
enhanced resistance to bile salt dissolution for cholesterol-enriched
membranes as reported in this and previous studies (45) is due to intrinsic
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properties of the membranes rather than to alterations of the IMC (43).
The pivotal role of cholesterol is also dramatically illustrated by the
incubation experiments shown in Figure 6. In agreement with previous
data (46), in the absence of cholesterol, vesicles composed with SM were
highly sensitive to detergent bile salts. Incorporation of cholesterol
restored membrane resistance against detergent bile salts and even led in
some cases to vesicle aggregation (33). Vesicles without cholesterol were
only slightly smaller than vesicles with cholesterol. Nevertheless, we
cannot definitely exclude the possibility that reduced interactions
between phospholipid molecules, due to increased curvature strain
(16,17,47,48) could explain decreased stability of the vesicles without
cholesterol.
In the present study, effects of cholesterol inclusion on vesicle
aggregation or asymmetric distribution of PC and SM tended to be more
pronounced in EYSM- than in BMSM- containing systems, possibly
related to different acyl chain composition and/or to subtle differences in
physical state due to different Tm of EYSM and BMSM. We (20) and
others (15) have found in vesicle-transfer experiments evidence for a
higher affinity of cholesterol for EYSM than for SM that contains long-
chain fatty acids such as BMSM.
Pathophysiological correlations
The findings in the present study may be relevant for epithelial cells in
general, which contain large amounts of glycosphingolipids in the apical
membrane (49). We were particularly interested to increase insight in
some puzzling events occurring at the canalicular membrane during
nascent bile formation. Since the hepatocyte –another highly polarized
cell- is enriched at the canalicular side in cholesterol and SM with long
saturated acyl chains (1,8-10), our data on BMSM with similar acyl chain
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composition appear to be most relevant. The fact that PC is the major
phospholipid secreted into bile, with only trace amounts of SM (6),
despite the presence of large quantities of both phospholipids in the outer
leaflet of the canalicular membrane (1,5) may relate to a high lateral
pressure due to translocation of PC molecules by mdr2 P-glycoprotein
(2). No such protein is known to be present for SM. The present study
indicates that the physical-chemical state of phospholipids in the
canalicular membrane could also contribute to preferential PC secretion.
The high cholesterol content of SM domains that are laterally segregated
–perhaps in conjunction with disaturated PC species- might impede bile
salt-dependent biliary secretion of SM. Furthermore, recent data by
Nibbering and Carey  (8) indicate that trace SM in bile contains mainly
16:0 acyl chains, despite the predominance of long acyl chains in
canalicular membrane SM  (8,9). Using ultracentrifugation, we found a
strong preferential distribution of SM with long acyl chains in the
“pelletable insoluble fraction” (according to the terminology of
Schroeder (32)) and a preferential distribution of 16:0 SM in the “soluble
supernatant”, which proved to contain mixed micelles and small
unilamellar vesicles. By using electron microscopic techniques, Crawford
has demonstrated the presence of significant amounts of such small
unilamellar vesicles within the canalicular lumen, consistent with a
vesicular mode of cholesterol and phospholipid secretion (4).
Nevertheless, the finding that infusion of the hydrophobic bile salt
taurodeoxycholate restores cholesterol secretion in the mdr2 “knockout”
mice to normal levels (50) would suggest a micellar mode of cholesterol
secretion since PC is still virtually absent in this situation. When one
considers our present data, there is a distinct possibility that vesicular and
micellar modes of lipid secretion could coexist during nascent bile
formation. As recently discussed by Oude Elferink (51,52), the non-linear
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relationship between phospholipid and cholesterol secretion as recently
found in mice with various expression of the mdr2 gene is consistent
with a micellar (or alternatively combined micellar + vesicular) but not
with a pure vesicular mechanism of biliary lipid secretion.
Lastly, the inhibiting effects of cholesterol within the membrane on the
amounts of phospholipids solubilized in micelles (Figure 1), would lead
to the hypothesis that cholesterol in the canalicular membrane could exert
a modulating role in regulation of biliary lipid secretion. For example,
biliary secretion of NBD-sphingomyelin infused in isolated livers of
mdr2 “knockout” mice is strongly decreased compared to mdr2 (+/+)
mice, although SM should be the predominant phospholipid on the outer
leaflet of the canalicular membrane in the absence of PC translocating
activity in mdr "knockout" mice (Frijters, C., Groen, A.K., Oude
Elferink, R.J., personal communication). This puzzling finding would be
easily understood if one assumes inhibiting effects on biliary
phospholipid secretion of an increased cholesterol content in the outer
leaflet.
In conclusion, our data reveal preferential distribution of lipids and
enrichment of SM with long saturated acyl chains in vesicular aggregates
at increasing cholesterol content. In contrast, there is preferential
distribution of PC into mixed micelles and small unilamellar vesicles
under these circumstances. These findings may be relevant for
canalicular bile formation.
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Abstract
Vesicle ↔ micelle transitions are important phenomena during bile
formation and intestinal lipid processing. The hepatocyte canalicular
membrane outer leaflet contains appreciable amounts of
phosphatidylcholine (PC) and sphingomyelin (SM), and both
phospholipids are found in the human diet. We therefore studied
detergent-induced phase transitions in SM-PC vesicles. Methods: Phase
transitions were evaluated by spectrophotometry and cryo-transmission
electron microscopy (cryo-TEM) after addition of taurocholate (3-7 mM)
to SM-PC vesicles (4 mM phospholipid, SM/PC 40%/60%, without or
with 1.6 mM cholesterol). Results: After addition of excess (5-7 mM)
taurocholate, SM-PC vesicles were more sensitive to micellization than
PC vesicles. As shown by sequential cryo-TEM, addition of equimolar (4
mM) taurocholate to SM-PC vesicles induced formation of open vesicles,
then (at the absorbance peak) multilamellar and fused vesicular structures
coinciding with thread-like micelles, and finally transformation into an
uniform picture with long thread-like micelles. Incorporation of
cholesterol in the SM/PC bilayer changed initial vesicular shape from
spherical into ellipsoid and profoundly increased detergent resistance.
Disk-like micelles and multilamellar vesicles, and then extremely large
vesicular structures were observed by sequential cryo-TEM under these
circumstances, with persistently increased absorbance values by
spectrophotometry. These findings may be relevant for bile formation
and intestinal lipid processing.
Introduction
Micelle ↔ vesicle phase transitions have been studied extensively during
the past decades for various reasons. For example, to incorporate
membrane proteins into phospholipid vesicles, in general, mixed micelles
containing surfactant, phospholipid and the protein of choice are first
constructed, and functional insertion of the protein within the bilayer of
the vesicles is subsequently obtained by inducing micelle → vesicle
transitions through removal of the surfactant. Also, several phase
transitions occur during the process of bile secretion. Nascent bile within
the canaliculus is generally believed to contain cholesterol-phospholipid
vesicles (1). Upon progressive bile concentration in the bile ducts and in
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the gallbladder, these vesicles are largely transformed into mixed bile
salt-phospholipid-cholesterol micelles. During this process, cholesterol
crystal formation (an essential step in gallstone formation) may occur in
case of cholesterol supersaturated bile, possibly after aggregation of
small unilamellar vesicles (2). Alternatively, primordial and
multilamellar vesicles have been visualized by cryo transmission electron
microscopy during the crystallization process (3-5).
After a meal, the gallbladder empties, and dilution of  bile upon entering
the intestine induces micelle → vesicle phase transitions. Enzymes within
the intestinal lumen such as phospholipase A2 may then induce the
reverse process again with formation of open vesicles, bilayer fragments
and micelles (6). The intermediate structures formed during vesicle →
micelle transition, and the vesicles and micelles themselves, are thought
to be important for optimal activities of various digestive enzymes, and
for intestinal absorption of various lipids. Vesicle ↔ micelle transitions
have therefore been studied in some detail by turbidity measurements
(7;8), nuclear magnetic resonance (8;9) and cryo-transmission electron
microscopy (10;11).
These studies were generally performed with phosphatidylcholine as the
phospholipid (often with phosphatidylcholine from egg yolk, which
contains 16:0 acyl chains at the sn-1 position and mainly unsaturated
(18:1>18:2>20:4) acyl chains at the sn-2 position). Although
phosphatidylcholine is the exclusive (>95%) phospholipid in human bile
(with an acyl chain composition similar to egg yolk phosphatidycholine
(12)), considerable amounts of saturated phosphatidylcholines and
sphingomyelins may occur in human food (13). Preliminary data in the
mouse suggest that dietary sphingomyelins may reduce markedly
intestinal cholesterol absorption (14). It should also be taken into
account, that both phosphatidylcholine and sphingomyelin are the major
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phospholipids of the hepatocyte canalicular membrane outer leaflet (15).
Cholesterol has a high affinity for sphingomyelin (16-18) and is thought
to be preferentially located together with this phospholipid in detergent-
resistant rafts (19). We therefore studied effects of including
sphingomyelin within egg yolk phosphatylcholine containing-vesicles
(with and without cholesterol) on vesicle → micelle phase transitions by
means of spectrophotometry and by sequential state-of-the-art cryo-
transmission electron microscopy. Whereas previous electron microscopy
studies were often prone to artefacts such as evaporation, advances in
technology now avoid these caveats with the aid of temperature- and
humidity-controlled conditions (37°C, 100% humidity, see “Methods”).
MATERIALS AND METHODS
Materials
Taurocholate was obtained from Sigma Chemical Co. (St. Louis, MO,
USA) and yielded a single spot upon thin-layer chromatography (butanol-
acetic acid-water, 10:1:1 vol/vol/vol, application of 200 µg bile salt).
Cholesterol (Sigma) was ≥ 98% pure by reverse-phase HPLC
(isopropanol - acetonitril 1:1, vol/vol, detection at 210 nm).
Phosphatidylcholine from egg-yolk (EYPC; Sigma), and sphingomyelin
from egg-yolk (EYSM; Avanti Polar-Lipids Inc., Alabaster, AL, USA)
yielded a single spot on thin-layer chromatography (chloroform–
methanol-water 65:25:4, vol/vol/vol, application of 200 µg lipid). Acyl
chain compositions as determined by gas-liquid chromatography (20)
showed a preponderance of 16:0 acyl chains for EYSM. As shown by
reverse-phase HPLC, EYPC contained mainly 16:0 acyl chains at the sn-
1 position and mainly unsaturated (18:1>18:2>20:4) acyl chains at the sn-
2 position, similar to phosphatidylcholine in human bile (12). All other
chemicals and solvents were of ACS or reagent grade quality.
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The enzymatic cholesterol assay kit was obtained from Boehringer
(Mannheim, Germany), 3α-hydroxysteroid dehydrogenase for the
enzymatic measurement of bile salt concentrations (21) from Sigma. The
reverse-phase C18 HPLC column was from Supelco (Supelcosil LC-18-
DB, Supelco, Bellefonte, PA, USA).
Preparation of model systems
Lipid mixtures containing variable proportions of cholesterol,
phospholipids (both from stock solutions in chloroform), or taurocholate
(from stock solutions in methanol) were vortex-mixed and dried at 45°C
under a mild stream of nitrogen and subsequently lyophilized during 24
hrs, before being dissolved in aqueous 0.15 M NaCl plus 3 mM NaN3.
Tubes were sealed with teflon-lined screw caps under a blanket of
nitrogen to prevent lipid oxidation and vortex-mixed for 5 min followed
by incubation at 37°C in the dark. The final mol percentages cholesterol,
phospholipid and bile salt did not differ more than 1% from the intended
mol percentages.
Lipid analysis
Phospholipid concentrations in model systems were assayed by
determining inorganic phosphate according to Rouser (22). Cholesterol
concentrations were determined with an enzymatic assay (23), and bile
salts with the 3α-hydroxysteroid dehydrogenase method (21).
Preparation of small unilamellar vesicles
Small unilamellar vesicles were prepared by sonication. Lipids, from
stock-solutions in chloroform, were vortex-mixed, dried under a mild
stream of nitrogen and subsequently lyophilized during 24 hrs. The lipid
film was dissolved in nitrogen-flushed aqeous 0.15 M NaCl plus 3 mM
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NaN3, and thereafter, the suspensions were probe-sonicated during 30
min. at 50°C (above the main transition temperatures of the
phospholipids). After sonication, the suspension was centrifuged during
30 min. at 50000 x g at 40°C, in order to remove potential remaining
vesicular aggregates and titanium particles. The resulting small
unilamellar vesicles were stored at temperatures above 40°C, and used
within 24 hrs. Small unilamellar vesicles were prepared with 100% PC,
or SM 40% / PC 60% as the phospholipid. Final phospholipid
concentration was 4 mM. Vesicles were either prepared without or with
cholesterol (cholesterol / phospholipid ratio 0 or 0.4).
Interactions of small unilamellar vesicles with taurocholate
Interactions of small unilamellar vesicles with various taurocholate
solutions (final concentrations varying between 3 and 7 mm) were
followed by measuring optical density (OD) at 405 nm every min. during
80 min. at 37°C, in a thermostated Benchmark microplate reader
(BioRad, Hercules, CA, USA). The solutions were stirred for 3 seconds
prior to each measurement. During this period, the time course of various
phase transitions was visualized by performing cryo-transmission
electron microscopy at several time points during the incubation. In the
case of cholesterol-containing vesicles, at the end of the incubation, the
mixtures were also examined by polarizing light microscopy, in order to
examine whether liquid or solid cholesterol crystals had formed.
Cryo-transmission electron microscopy (cryo-TEM): sample preparation
for cryo-TEM was done in a temperature and humidity controlled
chamber using a fully automated (pc-controlled) vitrification robot
(Vitrobot, patent applied). This system was recently developed in
collaboration with one of the authors (PMF) based on the work by
Bellare et al. (24) and Frederik et al. (25). Within an environmental
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chamber (temperature controlled and equipped with an ultrasonic device
generating a mist to attain a relative humidity of ∼100%), a specimen grid
is dipped into a suspension, withdrawn and excess liquid is blotted away
between two filter papers backed by foam pads. Thin films are formed
between the bars of the grid, and to vitrify these thin films, the grid is
‘shot’ into melting ethane placed just outside the chamber and accessed
through a shutter. Once a thin film is formed, it has a large surface to
volume ratio, which makes heat and mass exchange fast processes. About
dew point temperature will be attained in 0.1 sec. and further evaporation
may be substantial at this point. At normal room conditions (24 oC, 40%
relative humidity) a thin film may loose 50% of its water within 2
seconds and osmotic effects therefore have to be considered when not
working at a 100% relative humidity (see also Hubert et al. and Frederik
et al., Conference proceedings EUREM Brno 2000 and submitted). All
the experiments are conducted at 37 oC with 100% relative humidity.
When the vitrification robot is set up (vial with suspension in place, filter
papers mounted, all parameters set) a forceps with grid is loaded from
outside and melting ethane is prepared and for the rest the
preparation/vitrification process runs automatically under PC command
to end with a grid in melting ethane. The grids with vitrified thin films
were analysed in a CM-12 transmission microscope (Philips, Eindhoven,
The Netherlands) at –170°C using a Gatan-626 cryo-specimen holder and
cryo-transfer system (Gatan, Warrendale, PA/ USA). The vitrified films
were studied at 120 kV with a pressure lower than 0.2x10-3 Pa., and at
standard low-dose conditions, micrographs were taken.
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RESULTS
Resistance of phospholipid vesicles against detergent bile salts in the
absence of cholesterol
As  shown in Figure 1A-C, vesicles without cholesterol and containing
PC as the sole phospholipid tended to be rather resistant against the
detergent effects of taurocholate, as indicated by the relatively slow
decrease of absorption values during the time period studied (conditions:
vesicular phospholipid 4 mM final concentration, addition of
taurocholate at 7-5 mM final concentration, 37°C). Partial replacement of
vesicular PC by SM, without inclusion of cholesterol, led to significant
vesicular destabilization, as evidenced by low absorption values upon
addition of taurocholate. Figures 1D-E show the results obtained upon
incubation of the same vesicle population with progressively decreasing
concentrations of taurocholate. At taurocholate concentration of 4 mM
(Fig. 1D) added to PC-containing vesicles, a small increase of the
absorbance can be observed. In case of SM-PC vesicles, there is a large
but reversible increase of absorbance after addition of 4 mM
taurocholate. After addition of taurocholate at a concentration of 3 mM
(Fig. 1E), increased absorbance appears not to be reversible during the
experiment, especially in case of SM-PC vesicles.
In Figure 2, the time-course of SM-PC vesicle → micelle transitions after
addition of equimolar (4 mM) taurocholate is visualized by sequential
cryo-transmission electron microscopy (TEM). Initial vesicles before
addition of the detergent are spherical (Fig. 2A: time point a in Fig. 1D).
During the uphill part of the absorbance curve (time point b in Fig. 1D),
multiple open vesicles coexist with globular micelles. Maximal vesicular
sizes have increased from 60 nm to 100 nm diameter (Fig. 2B). At the
absorbance peak (time point c in Fig. 1D), globular micelles,
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multilamellar and fused vesicular structures are present. Vesicles have
further increased in size. Also, at this time point, some thread-like
micelles have formed (Fig 2C). During the downhill part of the
absorbance curve (time point d in Fig 1D: results not shown) and at the
end of the experiment (time point e in Fig 1D), an uniform picture of
long thread-like micelles is present (Fig 2D). In contrast, cryo-TEM after
addition of excess (7 mM) taurocholate to SM-PC vesicles revealed
globular micelles at the end of the experiment (time point a in Fig. 1A:
results not shown).
Resistance of cholesterol-containing phospholipid vesicles against
detergent bile salts
As shown in Figure 3A, incorporation of cholesterol in SM-PC vesicles
prevents the destabilizing effect of SM (conditions: vesicular
phospholipid 4 mM final concentration; vesicular SM/PC 40%/60%;
vesicular cholesterol/phospholipid ratio 0.4; addition of taurocholate at 7
mM final concentration; 37°C). Absorbances of these cholesterol-
enriched vesicles were stable in case of PC as the sole vesicular
phospholipid, but increased markedly in the case of incorporation of SM
in the vesicles. The same happened with incubation at lower taurocholate
concentrations (6 mM, 5mM, 4mM and 3 mM; figures 2B, 2C, 2D and
2E, resp.).
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Figure 1
Figure 1: Effects of taurocholate on sonicated small unilamellar vesicles
without cholesterol, composed with 100% PC or with 40% of PC
replaced by SM (final phospholipid conc. 4 mM, 37°C). As shown by the
decrease of absorbance values (OD 405nm), in case of excess
taurocholate, vesicles exhibit enhance sensitivity to detergent when SM is
also included in the bilayer. (final taurocholate conc. 7mM, 6mM and
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5mM, A, B and C, resp.). At lower taurocholate concentrations (4 mM in
D; 3 mM in E) an increase of the absorbance values can be observed.
■ = EYPC; ▲ = EYSM.
Figure 2
Figure 2: Cryo-transmission electron microscopic images after addition
of equimolar taurocholate (4 mM final conc.) to sonicated small
unilamellar vesicles composed with 40% SM and 60% PC without
cholesterol (final phospholipid conc. 4 mM, preparation at 37°C, 100%
relative humidity). A: Sphere-like vesicles  (max size ~ 60 nm) at
initiation of the experiment (time point a in Fig. 1D). B: during the uphill
part of the absorbance curve (time point b in Fig. 1D), there are some
open vesicles (max size ~ 100 nm). C: at the absorbance peak (time point
c in Fig. 1D), multilamellar and fused vesicles (max size < 290 nm),
globular and thread-like micelles are present. D: at the end of
experiment, there are large numbers of “thread”-like micelles (time
point e in Fig. 1D).
Bar represents 100 nm.
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In Figure 4, the time-course of phase transitions after addition of 4 mM
taurocholate to cholesterol-containing SM-PC vesicles is followed by
sequential cryo-TEM. As shown in Figure 4A, initial vesicles often
appear ellipsoid (time point a in Fig. 3D). During the uphill part of the
absorbance curve (time point b in Fig 3D), large numbers of
multilamellar vesicles are observed, together with disk-like micelles (Fig.
4B). At the end of the experiments (time point c in Fig. 3D), extremely
large vesicular structures are present, precluding adequate visualization
by electron microscopy. Concomitant light microscopy revealed
numerous aggregated and fused large vesicular structures.
DISCUSSION
The present study points to a key role of cholesterol in formation of
pathophysiologically relevant phosphatidylcholine plus sphingomyelin-
containing bilayers and in modulating interactions between those vesicles
and detergent bile salts. We have obtained a time-course of bile salt-
induced phase transitions with the aid of state-of-the-art cryo-TEM. By
vitrification from 37°C with 100% relative humidity, osmotic and
temperature-induced artefacts are prevented, thus allowing observation of
lipid-rich structures close to their original state: at the moment of
vitrification by ultra-rapid cooling (10-5 sec.), the vapour pressure
reduces, all supramolecular motions are arrested, thereby preserving
microstructures and avoiding any artifacts related to crystallization of
water and other compounds (24;25).
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Figure 3
Figure 3: Effects of taurocholate on sonicated small unilamellar vesicles
composed with fixed amounts of cholesterol (chol/PL ratio = 0.4) and
with 100% PC or with 40% of PC replaced by SM (final phospholipid
conc. 4 mM, 37°C). Incorporation of cholesterol  prevents the
destabilizing effects of SM (taurocholate final conc. 7 mM in A; 6 mM in
B; 5 mM in C; 4 mM in D; 3 mM in E).
■ = EYPC; ▲ = EYSM.
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Figure 4
Figure 4: Cryo-transmission electron microscopy images after addition
of taurocholate (4 mM final conc.) to sonicated small unilamellar SM-PC
vesicles (final phospholipid conc. 4 mM, SM/PC ratio 40/60,
chol/phospholipid ratio 0.4, 37°C, 100% humidity). A: Some vesicles
have an ellipsoid shpae at the initiation of the experiment (time point a in
Fig. 3D). B: During the uphill part of the absorbance curve (time point b
in Fig. 3D), large numbers of multilamellar vesicles are observed,
together with disk-like micelles (arrows). C: At the end of the experiment
(time point c in Fig. 3D), extremely large vesicular structures are
present.
Bar represents 100 nm.
Previous studies have examined in detail phase transitions induced by
addition of detergent to egg yolk phosphatidylcholine-containing vesicles
or by dilution of micellar solutions, with formation of long cylindrical
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micelles as intermediate structures (10;11;26;27). In the present study,
we have focused on phase transitions of SM-EYPC vesicles –with or
without cholesterol incorporated in the bilayer- after addition of various
amounts of taurocholate. In the absence of cholesterol, and after addition
of excess taurocholate (final taurocholate/phospholipid ratio >1), SM-
containing vesicles exhibited increased sensitivity to the detergent,
compared to vesicles composed exclusively with EYPC, as shown by
spectrophotometry (Fig. 1A-C). These data are in line with previous
reports (28-30). At equimolar taurocholate-phospholipid ratios, there was
a strong but transient increase of absorbance values. Sequential cryo-
transmission electron microscopy revealed in the early stages after
addition of the detergent open vesicles, then (coinciding with the
absorbance peak) multilamellar and fused vesicles and finally (coinciding
with low absorption values) an uniform picture of thread-like micelles.
Open vesicular structures that we visualized in the early stages after
addition of the detergent have been described before (6) and may indicate
initiation of transition toward micellar phases. Upon addition of low
amounts of taurocholate (taurocholate/phospholipid ratio <1), increased
absorbance values were not reversible during the experiment. After
addition of excess taurocholate (taurocholate/phospholipid ratio >1), the
resulting bile salt-phospholipid mixtures plot in the one-phase zone (only
micelles) of the equilibrium ternary phase diagram (31;32) and vesicle →
micelle transitions progress at extremely fast rates, thus precluding
visualization of intermediate structures. In contrast, after addition of
equimolar amounts of taurocholate (taurocholate/phospholipid ratio =1),
resulting model systems plot near or at the border of the one-phase
(micellar) zone and the right two-phase (micelles and vesicles-
containing) zone (31;32), and vesicle → micelle transitions progress at
slow rates, thus allowing visualization of intremediate structures.
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Incorporation of cholesterol in the vesicular bilayer had profound effects
on detergent-induced phase transitions. In the absence of the sterol, and
in the earliest stages, spherical vesicles were visualized, but in presence
of the sterol the vesicles often had an ellipsoid shape (Fig. 2A and 4A).
The changes in bilayer two-dimensional conformation observed in
presence of cholesterol may be due interactions between aliphatic chains
of two sterol molecules (one in each monolayer) in cholesterol-
sphingomyelin microdomains (33), thus inducing a local decrease in
bilayer curvature. Interestingly, Crawford et al. (1;34) with the aid of
electron microscopy could visualize in the bile canaliculi mostly ellipsoid
non-spherical unilamellar vesicles, which probably contained cholesterol
and phospholipid. It has been postulated that the non-spherical shapes of
vesicles with decreased curvatures at the lateral sides may have relevance
for interactions of cholesterol with detergent bile salts and subsequent
solubilization in mixed micelles (34).
Sphingomyelin-phosphatidylcholine vesicles with cholesterol
incorporated in the bilayers were highly resistant against detergent-
induced micellar solubilization. Intermediate multilamellar vesicles, disk-
like micelles and –at the end of the experiments- large vesicular
aggregates were formed upon addition of the detergent. SM exhibits a
much higher gel to liquid crystalline phase transition temperature (Tm)
than EYPC: whereas EYPC has a Tm below 0 °C (35), we previously
found Tm of hydrated EYSM to be 36.6 °C (30). Pure phospholipids exist
in a solid, ordered gel phase below a melting temperature (Tm) that is
characteristic of each lipid, and in a liquid disordered (also called "liquid
crystalline") phase above Tm. Note that the Tm of EYSM is close to the
incubation temperature in our experiments including preparation for
cryo-EM. For this lipid species it is particularly essential to attain 100%
humidity (as in the present study) during cryo-preparation to prevent a
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temperature drop (“dew-point” effect) below Tm, which is known to
change the shape of vesicles. The phase behaviour around Tm is
influenced by  presence of cholesterol: lipids with a high Tm in the pure
state (e.g. disaturated PC species and sphingomyelins) may form a so
called "liquid-ordered" phase around Tm (36-38). This liquid-ordered
phase has properties intermediate between the gel and liquid-crystalline
phases: Like in the gel phase, tight acyl-chain packing and relatively
extended acyl chains characterize the liquid-ordered phase. On the other
hand, like lipids in the liquid-crystalline phase, lipids in the liquid-
ordered phase exhibit relatively rapid lateral mobility within the bilayer.
Recent data indicate that in bilayers containing more than one
phospholipid, in the presence of cholesterol, phase separation of the
phospholipids with the higher Tm (such as SM) into cholesterol-rich
liquid-ordered domains occurs, and that such a phase separation is a
prerequisite for detergent-resistance (37;38). We propose that, when
present together with cholesterol in liquid ordered domains, SM becomes
relatively resistant to the micellizing effects of detergent bile salts.
In conclusion, we have shown that incorporation of sphingomyelin in egg
yolk phosphatidylcholine vesicles enhances vesicle → micelle phase
transitions, with formation of intermediate open, multilamellar and fused
vesicular structures. When cholesterol is also included in the bilayer,
sphingomyelin-egg yolk phosphatidylcholine vesicles appear resistant
against bile salt-induced micellar solubilization. Instead, multilamellar
and large aggregated vesicles are formed. These findings may have
implications for canalicular bile formation and intestinal lipid
solubilization.
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Abstract
Inclusion of phosphatidylcholine within bile salt micelles protects against
bile salt-induced cytotoxicity. In addition to phosphatidylcholine, bile may
contain significant amounts of sphingomyelin, particularly under cholestatic
conditions. We compared protective effects of egg yolk phosphatidylcholine
(similar to phosphatidylcholine in bile), egg yolk sphingomyelin (mainly
16:0 acyl chains) and dipalmitoyl phosphatidylcholine against taurocholate
in complementary in vitro studies. Upon addition of taurocholate-containing
micelles to sonicated egg yolk phosphatidylcholine vesicles, subsequent
micellization of the vesicular bilayer proved to be retarded when
phospholipids had also been included in these micelles in the rank order: egg
yolk phosphatidylcholine<dipalmitoyl phosphatidylcholine<sphingomyelin.
Hemolysis of erythrocytes and LDH release by CaCo-2 cells after addition
of taurocholate micelles were strongly reduced by including small amounts
of sphingomyelin or dipalmitoyl phosphatidylcholine in these micelles
(PL/(PL+BS) ≥ 0.1), whereas egg yolk phosphatidylcholine provided less
protection. Amounts of non-phospholipid-associated bile salts (thought to be
responsible for cytotoxicity) in egg yolk phosphatidylcholine-containing
micelles were significantly higher than in corresponding sphingomyelin- or
dipalmitoyl phosphatidylcholine-containing micelles (tested at PL/(PL+BS)
ratios 0.1, 0.15 and 0.2). LDH release upon incubation of CaCo-2 cells with
taurocholate simple micelles at these so-called “intermixed micellar-
vesicular” concentrations was identical to LDH release upon incubation with
corresponding taurocholate-phospholipid mixed micelles. In conclusion, we
found greatly enhanced protective effects of sphingomyelin and dipalmitoyl
phosphatidylcholine compared to egg yolk phosphatidylcholine against bile
salt-induced cytotoxicity, related to different amounts of non-phospholipid-
associated bile salts. These findings may be relevant for protection against
bile salt-induced cytotoxicity in vivo.
INTRODUCTION
Bile salts are amphiphilic compounds that act as detergents above their
critical micellar concentration. The cytotoxic effect of bile salts has been
shown for hepatocytes (1,2), erythrocytes (2-4) and mucosa of various
organs, including stomach (5), intestine (6) and gallbladder (7,8). The
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damaging effects of bile salts depend on their degree of hydrophobicity (9)
and on the cell membrane composition (10). At physiological
concentrations, in bile in the gallbladder and bile ducts and within the
intestinal lumen, bile salts are associated with phospholipids and cholesterol
in mixed micellar structures. However, significant amounts of bile salts are
also present under these conditions as monomers and as "simple" micelles
(i.e. without incorporated phospholipids). There is some evidence that this
so called "intermixed micellar-vesicular bile salt concentration" (IMC: bile
salt monomers + simple micelles) (11), may be responsible for the
potentially damaging effects on membrane bilayers (12,13). At the
concentrations occurring in hepatic and gallbladder biles, bile salts could
theoretically damage the apical membrane of the hepatocytes and of the cells
lining the biliary tract. The absence of such a damaging effect in vivo
suggests the existence of cytoprotective mechanisms either at the level of the
cell membrane or within biliary micelles. Increased concentrations of
cholesterol and phospholipids (in particular sphingomyelin) in the
hepatocyte canalicular membrane appear to protect against cytotoxic effects
of the bile salts within the canalicular lumen (14-16). On the other hand, in
in vitro studies, inclusion of egg yolk phosphatidylcholine (PC) within bile
salt micelles protects in a concentration-dependent manner against bile salt-
induced cytotoxicity (17). In line with these findings, mice with homozygous
disruption of the mdr2 gene exhibit severe bile salt-induced hepatocyte
damage in vivo: since mdr2 encoded P-glycoprotein -which normally
functions as a "flippase" transporting PC molecules from the inner to the
outer leaflet of the hepatocytic canalicular membrane- is absent, there is
virtually no PC protecting against bile salt-induced hepatotoxicity in bile of
these mice (18).
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Both PC and sphingomyelin (SM) are the major phospholipids of the
canalicular membrane outer leaflet (16,19). Although PC is the major
phospholipid species in gallbladder bile, with minor amounts of SM (20),
larger quantities of SM could be present in nascent bile within the
canalicular lumen, particularly under pathological conditions such as
cholestasis. When, in the rat model, cholestasis is induced by bile salt
infusion, there is a considerable increase of SM content, from 3% to ≤ 30%
of total phospholipids in bile (21). Also, an alkaline sphingomyelinase
recently detected in human bile (22) could contribute to the virtual absence
of SM in gallbladder bile under non-cholestatic conditions because of
reabsorption by the bile duct epithelial cells of the hydrolytic product
ceramide, which is more hydrophobic than SM (23). This hypothesis is
supported by the fact that sheep, which secrete significant amounts of SM in
their biles (20), exhibit no biliary sphingomyelinase activity (22).
In the present study we examined the protective effects of various
phospholipids against detergent taurocholate in a number of complementary
in vitro studies. We compared the effects of PC from egg yolk (EYPC,
mainly 16:0 acyl chains at the sn-1 position and mainly unsaturated
(18:1>18:2>20:4) acyl chains at the sn-2 position, similar to PC in human
bile (24)), SM from egg yolk (EYSM, mainly 16:0 acyl chains, similar to
SM in bile (25)) and dipalmitoyl PC (DPPC, similar structure and gel-to-
liquid crystalline transition temperature (26) as SM).
MATERIAL AND METHODS
Materials
Taurocholate was obtained from Sigma Chemical Co. (St. Louis, MO, USA)
and yielded a single spot upon thin-layer chromatography (butanol-acetic
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acid-water, 10:1:1 vol/vol/vol, application of 200 µg bile salt). Cholesterol
(Sigma) was ≥ 98% pure by reverse-phase HPLC (isopropanol - acetonitrile
1:1, vol/vol, detection at 210 nm).  Phosphatidylcholine from egg yolk
(EYPC; Sigma), dipalmitoyl phosphatidylcholine (DPPC; Sigma) and
sphingomyelin from egg yolk (EYSM; Avanti Polar-Lipids Inc., Alabaster,
AL, USA) all yielded a single spot upon thin-layer chromatography
(chloroform-methanol-water 65:25:4, vol/vol/vol, application of  200 µg
lipid). Acyl chain compositions as determined by gas-liquid chromatography
(27) were virtually identical to previously published data (23) and showed a
preponderance of 16:0 acyl chains for EYSM, similar to sphingomyelin in
human bile (25). As shown by reverse-phase HPLC, EYPC contained mainly
16:0 acyl chains at the sn-1 position and mainly unsaturated
(18:1>18:2>20:4) acyl chains at the sn-2 position, similar to
phosphatidylcholine in human bile (24). Dulbecco’s modified Eagle’s
minimum essential medium (DMEM) was obtained from Flow Laboratories
(Irvine, G.B.). All other chemicals and solvents were of ACS or reagent
grade quality.
Ultrafilters with a molecular weight cut-off of 5 kDa were obtained from
Sartorius (Göttingen, Germany: Centrisart I). The enzymatic cholesterol
assay kit was obtained from Boehringer (Mannheim, Germany). 3α-
Hydroxysteroid dehydrogenase for the enzymatic measurement of bile salt
concentrations (28) and a colorimetric chloride-kit were purchased from
Sigma. The reverse-phase C18 HPLC column was from Supelco (Supelcosil
LC-18-DB, Supelco, Bellefonte, PA, USA).
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Preparation of lipid solutions
Lipid mixtures containing variable proportions of cholesterol, phospholipids
(both from stock solutions in chloroform) and taurocholate (from stock
solutions in methanol) were vortex-mixed and dried at 45°C under a mild
stream of nitrogen, and subsequently  lyophilized during 24 hrs, before being
dissolved in aqueous 0.15 M NaCl plus 3mM NaN3. Tubes were sealed with
Teflon-lined screw caps under a blanket of nitrogen to prevent lipid
oxidation and vortex-mixed for 5 min. followed by incubation at 37°C in the
dark. All solutions were warmed up to 45°C for 10 min. before use. The
final mol percentages of cholesterol, phospholipids and bile salts did not
differ more than 1% from the intended mol percentages.
Lipid analysis
Phospholipid concentrations in solutions were assayed by determining
inorganic phosphate according to Rouser (29). Cholesterol concentrations
were determined with an enzymatic assay (30) and bile salts with the 3α-
hydroxysteroid dehydrogenase method (28).
Preparation of small unilamellar vesicles
Small unilamellar vesicles were prepared by sonication. Lipids, from stock-
solutions in chloroform, were vortex-mixed, dried under a mild stream of
nitrogen, freeze-dried in liquid nitrogen and subsequently lyophilized during
24 hrs. The lipid film was dissolved in nitrogen-flushed aqueous 0.15 M
NaCl plus 3 mM NaN3 and thereafter, the suspensions were probe-sonicated
during 30 min. at 45°C (above the main transition temperatures of the
phospholipids). After sonication, the suspension was centrifuged during 30
min. at 50000 g at 40°C, in order to remove potential remaining vesicular
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aggregates and titanium particles. The resulting small unilamellar vesicles
were stored above 40°C, and used within 12 hrs. Small unilamellar vesicles
were prepared with 100% EYPC or 80% EYPC / 20% EYSM or 60% EYPC
/ 40% EYSM as phospholipid (final phospholipid conc. 4mM). The
hydrodynamic radius (Rh: at 37°C), as determined by quasielastic light
scattering spectroscopy, of the small unilamellar vesicles composed with
100% EYPC was 50 ± 1.65 nm. Partial replacement of EYPC with EYSM
led to slightly decreased vesicle sizes (mean ± SEM: 43.5 ± 1.23 nm in case
of 40% EYSM).
Resistance of vesicles against taurocholate or taurocholate-phospholipid
mixed micelles
Interactions of sonicated small unilamellar vesicles with taurocholate were
examined by measuring optical density at 405 nm every min during 30 min.
at 37°C in a termostated Benchmark microplate reader (BioRad, Hercules,
CA, USA). Solutions were stirred for 2 sec. prior to each measurement. A
decrease of the OD at 405 nM after addition of taurocholate is compatible
with micellization of the vesicles. Absorbance measured in control vesicles
without addition of taurocholate always remained stable during the
experiments. We added taurocholate (final conc. 6 mM) or mixed micellar
solutions containing both taurocholate (final conc. 6 mM) and either EYPC
or EYSM or DPPC (PL / (PL+BS) ratio = 0.2, 37°C) to EYPC-containing
vesicles (final vesicular phospholipid conc. 4 mM). Furthermore, we added
taurocholate (final conc. 5 mM) to sonicated vesicles containing 100%
EYPC or 80% EYPC / 20% EYSM or 60% EYPC / 40% EYSM as
phospholipids (final phospholipid conc. 4 mM, 37°C).
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Last, 40 µL of taurocholate simple micelles or mixed micellar solutions
containing both taurocholate and either EYPC or EYSM or DPPC
(PL/(PL+BS) ratio = 0.2, 180 mM taurocholate, 37°C) were added to 200
µL of supersaturated model bile (10.5 mM EYPC, 42.3 mM taurocholate,
17.5 mM cholesterol), in order to decrease cholesterol saturation of the
resulting model system to unsaturated levels (see inset Fig. 3: final
cholesterol saturation index 0.25 and 0.21, resp. (according to Carey’s
Critical Tables (31,32), which are based on EYPC-containing systems)).
Because micellar cholesterol solubility in SM- or DPPC-containing systems
is approximately one-third of micellar solubility in EYPC-containing system
(23), all final systems were unsaturated regardless phospholipid type. Since
the original model bile was composed so, that it plotted in the middle three-
phase zone of the equilibrium ternary phase diagram (33) and thus contained
large quantities of vesicles in addition to micelles and cholesterol
monohydrate crystals, a decrease of OD at 405 nm was considered to be
consistent with micellization of these vesicles.
Resistance of erythrocytes against taurocholate simple micelles and
taurocholate-phospholipid mixed micelles
Fresh human erythrocytes (aliquots of 10 mL human blood from a single
volunteer) were sedimented 3 times by centrifugation at 3000 rpm for 15
min.; the plasma and buffy coat were discarded and the pellet was
resuspended to the original blood volume in TRIS buffer (10 mM TRIS, 130
mM NaCl and 10 mM glucose, pH 7.4). A constant temperature of 37°C was
maintained during the experiment. When these erythrocytes are incubated
during 15 min. with 50 mM taurocholate, hemolysis amounts to 95-100%
(i.e. identical to values after 15 min. incubation in distilled water (17)). In
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order to determine potential protective effects of various phospholipids
against detergent bile salts, erythrocytes (0.2 mL) were added to 0.8 mL
taurocholate (50 mM) or mixed micellar solutions containing both
taurocholate (50 mM) and increasing amounts (5, 10, 15, 20 or 25 mM) of
either EYPC or EYSM or DPPC. After incubation for 15 min., 7 mL buffer
was added, in order to decrease the progress of hemolysis to negligible
levels (2). The samples were then centrifuged for 1 min. at 10000 g and the
extent of lysis was assayed in the supernatant (absorbance at 540 nm).
In order to examine potential changes of erythrocyte membrane composition
due to incubation with mixed phospholipid-taurocholate micelles, after such
incubation (PL / (PL+BS) ratio of added mixed micelles = 0.35: complete
protection against hemolysis at this ratio), erythrocytes were washed
extensively and membrane phospholipids extracted according to Reed (34),
separated by thin-layer chromatography (chloroform-methanol-acetic acid-
water 50:25:8:4 vol/vol/vol/vol) and separated spots quantified with the
Rouser assay (29).  
Finally we incubated erythrocytes with mixed micellar solutions containing
taurocholate (50 mM) and small amounts (total phospholipid conc. 5 mM) of
both EYPC and EYSM at various ratios (PC/SM ratios: 100/0, 90/10, 80/20,
70/30, 60/40, 50/50, 40/60, 30/70, 20/80, 10/90 and 0/100).
Resistance of CaCo-2 cells against taurocholate simple micelles and
taurocholate-phospholipid mixed micelles
CaCo-2 cells were cultured as previously described (35) with minor
modification. Briefly, CaCo-2 cells were grown in T-75 plastic flasks in
DMEM supplemented with 20% fetal calf serum (Gibco, New England,
N.Y., USA), 50 U/mL penicillin and 50 U/mL streptomycin (Irvine, GB).
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Before confluency, the cells were split (split ratio 1:8) as follows: CaCo-2
cells were rinsed twice with Hank’s balanced salt solution (Gibco, New
England, N.Y., USA) and incubated during 5 min. at 37°C with 1 mL of
dissociation solution (Sigma, St. Louis MO, USA), after DMEM medium
supplemented with 20% fetal calf serum was added to the cell suspension.
Monolayers were grown in microwell plates in DMEM, which was replaced
daily with fresh medium. After 10 days, the postconfluent cultures were
washed with phosphate-buffered saline (pH 7.4) and the cells were
incubated with taurocholate (bile salt conc. 30 mM) or mixed micelles
containing taurocholate plus EYPC or EYSM or DPPC (bile salt conc.
30mM, PL / (PL+BS) ratio = 0.05, 0.1, 0.15, 0.2, 0.25 and 0.3, 37°C, pH
7.4). After 30 min. incubation, the medium was collected and the cells were
treated with 0.4% Triton X-100. Lactate dehydrogenase (LDH) activity -as a
sensitive parameter of cell damage- was measured according to Mitchell et
al. (36) in both medium and in Triton X-100 treated cells. Fat-free bovine
serum albumine (final concentration 0.6%) was added to prevent
interference of bile salts with the spectrophotometric assay of LDH activity.
Enzyme activity in each single experiment was normalized as percentage of
the total LDH activity (medium + Triton X-100 treated cells).
IMC measurement
Under the conditions of the experiments in this study, in systems containing
taurocholate and phospholipids, taurocholate is contained not only in mixed
(i.e. bile salt-phospholipid) micelles, but occurs also as non-phopholipid-
associated bile salt, either as monomers or -above the critical micellar
concentration- in small "simple" micelles. The monomeric plus simple
micellar bile salt concentration is referred to as “intermixed micellar-
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vesicular (non phospholipid-associated) bile salt concentration”, usually
abbreviated as “IMC” (11). We determined IMC in micellar model systems
containing either EYPC, DPPC or EYSM as phospholipids and taurocholate
as bile salt (PL / (PL+BS) ratio = 0.1, 0.15 and 0.2, bile salt concentration 30
mM, 37°C), using a minor modification of the rapid centrifugal
ultrafiltration technique (37).
A 5 kDa Centrisart ultrafilter was rinsed with H2O and centrifuged for 5
min. at 500 g in order to remove glycerol remnants from the membrane. The
water was removed carefully from both sides of the membrane with a
syringe. The filter was preincubated at 37°C during 1 hr before usage. A 2
mL aliquot of model system was put into the filter device (in duplicate) and
centrifuged at 500 g for 5 min. in a pre-warmed (37°C) centrifuge. The
filtrate was carefully collected with a syringe. Filtration was repeatedly
performed, adjusting centrifugal speed so as to obtain constant filtrate
volumes of approximately 50 µL. Bile salt and chloride concentrations
reached stable values in the third filtrate. Slightly lower concentrations in the
first and second filtrates resulted from small amounts of water remaining in
the membrane after rinsing the ultrafilter (37). We considered the third
filtrate to represent the simple micellar + monomeric fraction, and therefore
decided to use the third filtrate for measurement of the IMC (the first two
filtrates were added each time to the filtrant) (37). This technique has been
validated before (12,37,38). During ultrafiltration, Gibbs-Donnan effects
occur as result of uneven distribution across the membrane of non-filterable
particles with a highly negative charge (in particular mixed micelles), thus
leading to an overestimation of the concentrations of negatively charged
monomeric and simple micellar bile salts in the filtrate (11,37). We
corrected the concentrations of bile salts measured in the filtrate for Gibbs-
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Donnan effects by multiplying the bile salt concentration in the filtrate with
the ratio of chloride concentrations in filtrant and filtrate (11,37,38).
Statistical analysis
Values are expressed as means ± SEM. Differences between groups were
tested for statistical significance by analysis of variance with the aid of
NCSS software (Kaysville, Utah, USA). When ANOVA detected a
significant difference, results were further compared for contrasts using
Fisher’s least significant difference test as post-hoc test. Statistical
significance was defined as two-tailed probability of less than 0.05.
RESULTS
Interaction between phospholipid vesicles and taurocholate or
taurocholate-phospholipid mixed micelles
Incubation with detergent taurocholate led to fast micellization of sonicated
EYPC vesicles as indicated by decrease of absorbance values (Fig. 1).
Incorporation of phospholipid in taurocholate micelles delayed micellization
of the vesicular bilayer in the rank order: EYPC < DPPC < EYSM. In order
to examine whether this protective effect was caused by phospholipid
transfer from mixed micelles into the vesicular bilayer, we performed the
following experiment: EYPC in vesicles was partially replaced by EYSM
(vesicular SM/PC ratios 20/80 or 40/60).
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Figure 1: Effects of taurocholate (final conc. 6 mM) or taurocholate plus
phospholipid-containing mixed micelles (final taurocholate conc. 6 mM, PL
/ (PL+BS) ratio = 0.2, 37 °C) on sonicated EYPC vesicles (final vesicular
EYPC conc. 4 mM). Compared to taurocholate alone, decrease of
absorption was delayed by incorporation of phospholipid in the micelles in
the rank order: EYPC < DPPC < EYSM, consistent with delayed
micellization of the vesicle bilayers. SEMs are contained within the symbols
(n=4).
 (•) taurocholate; (■) EYPC-taurocholate; (♦) DPPC-taurocholate; (▲)
EYSM-taurocholate.
Figure 2: Effect of taurocholate (final conc. 5 mM) on vesicles (final
vesicular phospholipid conc. 4 mM, 37 °C). Vesicles were composed with
100% EYPC or with 20% or 40% of the EYPC replaced by EYSM. Decrease
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of absorption values was enhanced by inclusion of SM in the vesicular
bilayer, depending on the amount of vesicular SM. These findings indicate
faster micellization in case of SM-containing vesicles. SEMs are contained
within the symbols (n=4).
(•) 100% EYPC; (■) 80% EYPC / 20% EYSM; (♦) 60% EYPC / 40% EYSM.
As shown in Fig. 2, these SM-containing vesicles exhibited increased rather
than decreased sensitivity for the detergent action of taurocholate, the
magnitude of this effect depending on the amount of vesicular EYPC
replaced by EYSM. These results suggest that protective effects of
phospholipids such as SM occur because of decreased detergent effects of
mixed EYSM-taurocholate micelles compared to simple micelles or EYPC-
taurocholate micelles rather than transfer of EYSM from mixed micelles into
the vesicular bilayer.
Micellization of vesicles in supersaturated EYPC-containing model bile
after addition of taurocholate simple micelles in quantities sufficient to
decrease CSI to unsaturated levels was delayed by incorporation of
phospholipid in these micelles in the rank order: EYPC < DPPC < EYSM
(Fig. 3).
Effect of various phospholipids on taurocholate-induced hemolysis
When erythrocytes were incubated with 50 mM taurocholate, cytolysis
amounted to 95-100% (virtually identical to values after incubation with
distilled water). Whereas incorporation of EYPC in quantities ≥ 20 mM (PL
/ (PL+BS) ratio ≥ 0.29) in taurocholate micelles reduced cytolysis
appreciably, the same protective effect occurred for taurocholate-DPPC and
taurocholate-EYSM micelles already at phospholipid concentrations ≥ 5 mM
(PL / (PL+BS) ratio ≥ 0.1, Fig. 4). When the erythrocytes were incubated
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with mixed micelles containing both EYPC and EYSM (bile salt conc. 50
mM, total phospholipid conc. 5 mM), hemolysis was progressively inhibited
at increasing SM contents (Fig. 5).
Figure 3: Effect of taurocholate simple micelles or mixed micelles
containing taurocholate and either EYPC or EYSM or DPPC (PL / (PL+BS)
ratio = 0.2, 37°C) on supersaturated model bile (42.3 mM taurocholate,
10.5 mM EYPC, 17.5 mM cholesterol, total lipid concentration 3.6 g/dL),
plotting in the middle three-phase zone of the ternary equilibrium phase
diagram (33), and containing large amounts of vesicles besides mixed
micelles and cholesterol monohydrate crystals. Inclusion of phospholipids in
the taurocholate micelles reduced decrease of absorption values in the rank
order EYPC < DPPC < EYSM, indicating decreased micellization of
vesicular bilayers. Note non-linear scale for X-axis.
(•) taurocholate; (■) EYPC-taurocholate; (♦) DPPC-taurocholate; (▲)
EYSM-taurocholate.
Inset: equilibrium taurocholate-phospholipid-cholesterol ternary phase
diagram for EYPC- (continuous lines (33)) as well as DPPC- or EYSM-
(interrupted lines (23)) containing systems. Arrows indicate changes in
relative lipid composition after addition of simple or mixed micelles. 1φ = 1-
phase zone; 2φ = 2-phase zone; 3φ = 3-phase zone.
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Light microscopical examination of red blood cells after incubation with
each micellar solution revealed no differences in sizes or shapes compared
with control erythrocytes. Moreover, no changes in phospholipid
composition or SM/PC ratio in erythrocyte membranes were found after
incubation with EYPC-taurocholate or EYSM-taurocholate mixed micelles:
25% of total phospholipids consisted of PE, 14% of PI-PS, 25% of SM and
36% of PC, and SM/PC ratios were 0.68, 0.65 and 0.69 for control
erythrocytes, after incubation with EYPC-taurocholate micelles and EYSM-
taurocholate micelles respectively. It should be noted that these data were
obtained after incubation with micelles at a micellar PL / (PL+BS) ratio of
0.35, in order to ensure complete protection against hemolysis.
Figure 4: Effect of phospholipids on taurocholate-induced lysis of human
erythrocytes. Red blood cells were incubated for 15 min. at 37°C with 50
mM taurocholate (100% lysis) or with mixed micelles containing
taurocholate (50 mM) and progressive amounts of phospholipids. EYSM and
DPPC had enhanced protective effects compared with EYPC.
(■) EYPC-taurocholate; (♦) DPPC-taurocholate; (▲) EYSM-taurocholate.
* P<0.05 compared to EYPC-taurocholate
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Figure 5: Effects of phospholipids on taurocholate-induced lysis of human
erythrocytes. Red blood cells were incubated for 15 min. at 37°C with mixed
micelles (taurocholate conc. 50 mM, total phospholipid conc. 5mM) that
contained variable amounts of both EYPC and EYSM. Hemolysis was
progressively inhibited at increasing SM contents.
Effect of various phospholipids on taurocholate-induced damage of
CaCo-2 cells and on intermixed micellar-vesicular bile salt
concentrations
As shown in Figure 6A, incorporation of increasing amounts of
phospholipids (up to PL/(BS+PL) ratio 0.3) in taurocholate micelles (bile
salt conc. 30 mM) progressively reduced LDH release upon incubation with
CaCo-2 cells. Protective effects were significantly higher for EYSM or
DPPC than EYPC. Intermixed micellar-vesicular (i.e. monomeric plus
simple micellar) bile salt concentrations (IMC) in EYPC-containing micellar
solutions were significantly higher than in corresponding EYSM- or DPPC-
containing solutions at all ratios examined (PL/(BS+PL) ratios 0.1, 0.15 and
0.2). For all taurocholate-phospholipid systems, there was a decrease of IMC
at increasing phospholipid contents (Table 1).
Since the intermixed micellar-vesicular (IMC) bile salts have been suggested
to be responsible for the membrane-damaging effects (12,13), we also
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incubated CaCo-2 cells with taurocholate simple micelles (i.e. without
phospholipids) at concentrations identical to IMC values of Table 1.
Whereas there was only minor LDH release below 15 mM bile salt
concentrations, there was a steep increase of LDH release at higher
concentrations (Fig. 6B). LDH release after incubation with mixed
(phospholipid-containing) taurocholate micelles was virtually the same as
LDH release after incubation with taurocholate simple micelles (without
phospholipids) at concentrations identical to corresponding IMC values (Fig.
6C).
TABLE 1: Intermixed micellar-vesicular bile salt concentration (IMC) in
systems containing taurocholate and various phospholipids.
IMC (mM)
PL / (PL+BS) ratio 0.1 0.15 0.2
TC + EYPC 19±0.6 17.7±0.8 14±1.1
TC + SM 14.6±0.6 12.9±0.8 10.9±0.4
TC + DPPC 13.8±0.7 12.4±0.4 11.2±0.6
Monomeric plus simple micellar bile salt concentration (IMC) measured in
model systems containing constant taurocholate concentration (30 mM) plus
increasing amounts of EYPC or SM or DPPC. Values are expressed as
means ± SEM of three different experiments in duplicate. There was a
significant difference at all PL / (PL+BS) ratios between EYPC-containing
systems and SM- or DPPC-containing systems. Moreover, for all
phospholipids there was a significant decrease of IMC values at increasing
phospholipid contents.
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Figure 6 A): Effect of phospholipids on taurocholate-induced LDH release
by CaCo-2 cells. CaCo-2 cells were incubated for 30 min. at 37°C with
taurocholate simple micelles (30 mM) or mixed micelles containing
taurocholate (30 mM) and progressive amounts of phospholipids. Protective
effects of SM and DPPC were greater than protective effects of EYPC. (■)
EYPC-taurocholate; (♦) DPPC-taurocholate; (▲) EYSM-taurocholate.
*P<0.05 compared to EYSM- and DPPC-taurocholate. B): LDH release by
CaCo-2 cells upon incubation with taurocholate simple micelles at
concentrations identical to IMC-values of mixed micelles used in 6A (given
in Table 1). C): Identical LDH release upon incubation of CaCo-2 cells with
taurocholate-phospholipid mixed micelles or taurocholate simple micelles at
corresponding IMC concentrations.
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DISCUSSION
Bile salts play a pivotal role in cholesterol and phospholipid secretion in bile
and in intestinal lipid absorption. Nevertheless, in particular hydrophobic
bile salts may also have adverse effects: they may damage the canalicular
membrane of the hepatocyte in cholestasis, and promote formation of
adenomas and cancer in the colon (39).
The main finding in the present study was that incorporation of
phospholipids in taurocholate micelles protected against detergent effects of
the bile salts, with a greater protection offered by EYSM or DPPC than
EYPC. Similar results were obtained in a large variety of in vitro systems
such as sonicated vesicles, supersaturated model systems, human
erythrocytes and the CaCo-2 cell line. In the experiments with sonicated
EYPC vesicles (Fig. 1), including phospholipids within taurocholate
micelles retarded micellization. Nevertheless, at the end of the experiment,
absorbance values were very low regardless whether simple or mixed
(phospholipid-containing) micelles had been added. These findings are
consistent with complete micellization of all vesicles and thermodynamic
equilibrium reached during the experiment. These results can easily be
explained since, in the absence of cholesterol, final compositions of all
model systems plot in the (one-phase) micellar zone of the appropriate
equilibrium phase diagrams (23,33). In contrast, in the experiments with
cholesterol-supersaturated EYPC-containing model systems (Fig. 3),
absorbance values at the end of the experiment were much higher after
addition of phospholipid-containing mixed micelles (rank order EYPC <
DPPC < EYSM) than after addition of simple taurocholate micelles,
indicating persistence of significant amounts of vesicles. For all these
systems, cholesterol saturation after addition of micelles was far below 1.
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Therefore, all final systems were unsaturated and should have contained
only micelles at equilibrium, even if one takes into account the considerably
reduced micellar cholesterol solubility in SM- or DPPC-containing systems
compared to EYPC-containing systems (23). The progressive decreases of
absorbance after addition of phospholipid-containing micelles, as well as the
high absorbance values at the end of the experiment, indicate that
thermodynamic equilibrium was not reached during the experiment. The
slower decrease of absorbance after addition of EYSM- (or DPPC-)
containing mixed micelles than after addition of EYPC-containing mixed
micelles can easily be explained by the well-known prolonged metastability
of SM-containing systems (40). One should realize in interpreting results in
cholesterol-supersaturated model systems displayed in Fig. 3, that decreases
of turbidity are supposed to reflect a (partial) shift of lipids from vesicles to
mixed micelles, but that we cannot exclude the possibility that
disaggregation of large into smaller vesicular clusters or precipitation of
cholesterol crystals could have contributed to decreased absorbance values
under these circumstances.
In principle, protective effects could result from transfer of phospholipids
from mixed micelles into the membrane bilayer or from a local effect of the
phospholipids within the mixed micelles. There were no changes in
phospholipid composition or SM/PC ratio of the erythrocyte membrane after
incubation with EYPC- or EYSM-containing taurocholate micelles. Also,
we found no changes of erythrocyte morphology after incubation with these
micelles. Even small changes in phospholipid composition of the erythrocyte
membrane should have had a profound impact on erythrocyte shape (41).
Furthermore, incubation of sonicated EYPC vesicles with EYSM-containing
taurocholate micelles resulted in delayed micellization of the vesicular
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bilayer compared to incubation with taurocholate micelles. In contrast,
partial replacement of vesicular EYPC by EYSM increased rather than
decreased sensitivity to taurocholate, in line with previous studies (42).
Taken together, these findings suggest that protective effects of including
phospholipids such as EYSM within the micelles are not caused by transfer
of these phospholipids from the micelles into the vesicular bilayer, but rather
by a local effect at the level of the micelles.
The so called "intermixed micellar/vesicular bile salt concentration" (IMC:
bile salt monomers + simple micelles (11)) has been proposed to exert the
damaging effects on the membrane  bilayer (12,13). Indeed, LDH release
upon incubation of CaCo-2 cells with the various mixed (phospholipid-
containing) taurocholate micelles was identical to LDH release upon
incubation with taurocholate simple micelles at corresponding IMC values
(Fig. 6C). The enhanced protective effect of incorporating EYSM or DPPC
compared to EYPC within taurocholate micelles can thus be explained by
the much lower intermixed micellar-vesicular bile salt concentrations found
in the present study for EYSM- and DPPC-containing micelles. Similar
magnitude of protective effects of including EYSM or DPPC within
taurocholate micelles may relate to similarity in molecular structure and acyl
chain composition of both phospholipids: whereas DPPC contains 16:0 acyl
chains at both sn-1 and sn-2 positions, in case of EYSM, 16:0 is also the
major acyl chain amidated to the sphingosine backbone. Also, main gel to
liquid-crystalline transition temperatures are similar for DPPC and EYSM
(42°C vs 37°C; (26)). EYPC offered less protection against detergent effects
of taurocholate than EYSM or DPPC. EYPC has a molecular structure quite
different from both other phospholipids, due the presence of cis-unsaturated
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acyl chains at the sn-2 position. Also main gel to liquid-crystalline transition
temperature is much lower (< 0°C; (26)).
The differences in IMC values found in the present study suggest different
micellar structure and a smaller “coexistence (mixed + simple micelles
containing) region” (43) for EYSM- or DPPC-taurocholate micelles
compared to EYPC-taurocholate micelles: more taurocholate molecules may
be required to dissolve a molecule of EYSM or DPPC than a molecule of
EYPC. As a result, in a mixed micellar solution, the proportion of
taurocholate associated with phospholipid would be greater in case of
EYSM or DPPC than EYPC, with reciprocal decrease of taurocholate
concentration in the IMC.
Our findings may be relevant for canalicular bile formation. Upon addition
of bile salts to isolated canalicular membranes (44,45) or erythrocytes (46),
there is a considerable release of PC but not of SM from the membranes. In
line with these in vitro findings, PC is the major phospholipid species in
gallbladder bile, with minor amounts of SM (20). Nevertheless, these data
do not exclude the possibility that larger amounts of SM could be present in
nascent bile within the canalicular lumen, due to a putative cholehepatic
shunt (23) after hydrolysis of SM to more hydrophobic ceramide by an
alkaline sphingomyelinase recently detected in bile (22). Also, under
pathological condition such as cholestasis, large amounts of SM may appear
in bile (21). Under such cholestatic conditions, SM within micelles in the
canalicular lumen could protect against further bile salt-induced liver injury.
The protective effects of SM may also be relevant at the level of the
intestinal tract. In the small intestine, intraluminal bile salts exert a negative
feedback control on cholecystokinin release and gallbladder contraction
(47). We have found in duodenal infusion experiments in humans that the
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extent of the negative feedback control is decreased by including
phospholipids in bile salt micelles that are infused, with stronger effects for
DPPC or EYSM than EYPC, supposedly due to different IMC values
(unpublished data).
Phospholipids may also be relevant at the level of the colon, in particular by
decreasing IMC for hydrophobic bile salts such as deoxycholate, a well
known promotor of colon cancer (39). It has indeed been shown recently,
that rats fed a high sphingomyelin diet exhibit a significantly reduced
susceptibility for colon cancer on experimental carcinogenic diet (48,49).
In conclusion, our data reveal greatly enhanced protective effects of
sphingomyelin and dipalmitoyl phosphatidylcholine compared to egg yolk
phosphatidylcholine against bile salt-induced cytotoxicity, which may relate
to different intermixed micellar-vesicular (i.e. non-phospholipid associated)
bile salt concentrations. These findings may be relevant at the level of the
hepatocyte canalicular membrane and intestinal lumen.
References
1. Barnwell, S. G., P. J. Lowe, and R. Coleman. 1983. Effect of
taurochenodeoxycholate or tauroursodeoxycholate upon biliary output of
phospholipids and plasma-membrane enzymes, and the extent of cell damage, in
isolated perfused rat livers. Biochem. J. 216: 107-111.
2. Heuman, D. M., W. M. Pandak, P. B. Hylemon, and Z. R. Vlahcevic. 1991.
Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic
bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology
14: 920-926.
3. Coleman, R., S. Iqbal, P. P. Godfrey, and D. Billington. 1979. Membranes and bile
formation. Composition of several mammalian biles and their membrane-damaging
properties. Biochem. J. 178: 201-208.
4. Lowe, P. J., and R. Coleman. 1981. Membrane fluidity and bile salt damage.
Biochim. Biophys. Acta 640: 55-65.
“Protection by phospholipids against bile salts”   
173
5. Davenport, H.W. 1968. Destruction of the gastric mucosal barrier by detergent and
urea. Gastroenterology 54: 175-181.
6. Chadwick, V.S., T. S. Gaginella, G. L. Carlson, J. C. Debognie, S. F. Phillips, and
A. Hoffmann. 1979. Effect of molecular structure on bile acid-induced alterations
in absorptive function, permeability, and morphology in the perfused rabbit colon.
J. Lab. Clin.. Med. 94: 661-674.
7. Ostrow, J. D. 1969. Absorption by the gallbladder of bile salts,
sulfobromophthalein and iodipamide. J. Lab. Clin. Med.. 74: 482-494.
8. Ostrow, J. D. 1967. Absorption of bile pigments by the gallbladder. J. Clin. Invest.
46: 2035-2052.
9. Coleman R. 1987. Bile salts and biliary lipids. Biochem. Soc. Trans. 15: 68S-80S.
10. Coleman, R., P. J. Lowe, and D. Billington. 1980. Membrane lipid composition and
susceptibility to bile salt damage. Biochim. Biophys. Acta 599: 294-300.
11. Donovan, J. M., N. Timofeyeva, and M. C. Carey. 1991. Influence of total lipid
concentration, bile salt:lecithin ratio, and cholesterol content on inter-mixed
micellar/vesicular (non-lecithin-associated) bile salt concentrations in model bile. J.
Lipid Res. 32: 1501-1512.
12. Donovan, J. M., A. A. Jackson, and M. C. Carey. 1993. Molecular species
composition of inter-mixed micellar/vesicular bile salt concentrations in model bile:
dependence upon hydrophilic-hydrophobic balance. J. Lipid Res. 34: 1131-1140.
13. Narain, P. K., E. J. DeMaria, and D. M. Heuman. 1998. Lecithin protects against
plasma membrane disruption by bile salts. J. Surg. Res. 78: 131-136.
14. Amigo, L., H. Mendoza, S. Zanlungo, J. F. Miquel, A. Rigotti, S. Gonzalez, and F.
Nervi. 1999. Enrichment of canalicular membrane with cholesterol and
sphingomyelin prevents bile salt-induced hepatic damage. J. Lipid Res. 40: 533-
542.
15. Schachter, D. 1988: The hepatocyte plasma membrane: organization and
differentiation. In  The Liver: Biology and Pathobiology. Arias I. M., W. B. Jakoby,
H. Popper, D. Schachter, and D. A. Shafritz, editors. Raven Press, Ltd., New York,
NY. 131-140.
16. Kremmer, T., M. H. Wisher, and W. H. Evans. 1976. The lipid composition of
plasma membrane subfractions originating from the three major functional domains
of the rat hepatocyte cell surface. Biochim. Biophys. Acta 455: 655-664.
17. Velardi, A.L.M., A. K. Groen, R. P. Oude Elferink, R. van der Meer, G. Palasciano,
and G. N. Tytgat. 1991. Cell type-dependent effect of phospholipid and cholesterol
on bile salt cytotoxicity. Gastroenterology 101: 457-464.
Chapter 6
174
18. Smit, J. J., A. H. Schinkel, R. P. J. Oude Elferink, A. K. Groen, E. Wagenaar, L.
van Deemter, C. A. Mol, R. Ottenhoff, N. M. van der Lugt, and M. A. van Roon.
1993. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a
complete absence of phospholipid from bile and to liver disease. Cell 75: 451-462.
19. Higgins, J. A., and W. H. Evans. 1978. Transverse organization of phospholipids
across the bilayer of plasma membrane subfractions of rat hepatocytes. Biochem. J.
174: 563-567.
20. Alvaro, D., A. Cantafora, A. F. Attili, C. S. Ginanni, C. De Luca, G. Minervini, A.
Di Biase, and M. Angelico. 1986. Relationships between bile salts hydrophilicity
and phospholipid composition in bile of various animal species. Comp. Biochem.
Physiol. [B.] 83: 551-554.
21. Barnwell, S. G., B. Tuchweber, and I. M. Yousef. 1987. Biliary lipid secretion in
the rat during infusion of increasing doses of unconjugated bile acids. Biochim.
Biophys. Acta  922: 221-233.
22. Duan, R. D., E. Hertervig, L. Nyberg, T. Hauge, B. Sternby, J. Lillienau, A.
Farooqi, and A. Nilsson. 1996. Distribution of alkaline sphingomyelinase activity in
human beings and animals. Time and species differences. Dig. Dis. Sci. 41: 1801-
1806.
23. van Erpecum K. J., and M. C. Carey. 1997. Influence of bile salts on molecular
interactions between sphingomyelin and cholesterol: relevance to bile formation
and stability. Biochim. Biophys. Acta 1345: 269-282.
24. Hay, D. W., M. J. Cahalane, N. Timofeyeva, and M. C. Carey. 1993. Molecular
species of lecithins in human gallbladder bile. J. Lipid Res. 34: 759-768.
25. Nibbering, C. P., and M. C. Carey. 1999. Sphingomyelins of rat liver: biliary
enrichment with molecular species containing 16:0 fatty acids as compared to
canalicular-enriched plasma membranes. J. Membr. Biol. 167: 165-171.
26. Koynova, R., and M. Caffrey. 1995. Phases and phase transitions of the
sphingolipids. Biochim. Biophys. Acta 1255: 213-236.
27. Hakomori, S. 1983. Chemistry of Glycosphingolipids. In  Handbook of Lipid
Research. Hanahan D. J., editor.  Plenum Press, New York, NY. 37-39.
28. Turley, S. D., and J. M. Dietschy. 1978. Reevaluation of the 3	

dehydrogenase assay for total bile acids in bile. J. Lipid Res. 19: 924-928.
29. Rouser, G., S. Fleischer, and A. Yamamoto. 1970. Two dimensional thin layer
chromatographic separation of polar lipids and determination of phospholipids by
phosphorus analysis of spots. Lipids 5: 494-496.
“Protection by phospholipids against bile salts”   
175
30. Fromm, H., P. Hamin, H. Klein, and I. Kupke. 1980. Use of a simple enzymatic
assay for cholesterol analysis in human bile. J. Lipid Res. 21: 259-261.
31. Carey, M. C. 1978. Critical tables for calculating the cholesterol saturation of
native bile. J. Lipid Res. 19: 945-965.
32. Carey, M. C., and D. M. Small. 1978. The physical chemistry of cholesterol
solubility in bile. Relationship to gallstone formation and dissolution in man. J.
Clin. Invest. 61: 998-1026.
33. Wang, D. Q. H., and M. C. Carey. 1996. Complete mapping of crystallization
pathways during cholesterol precipitation from model bile: influence of physical-
chemical variables of pathophysiologic relevance and identification of a stable
liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems.
J. Lipid Res. 37: 606-630.
34. Reed, C.F., S. N. Swisher, G. V. Marinetti, and E.G. Eden. 1960. Studies of the
lipids of the erythrocyte. I. Quantitative analysis of the lipids of normal human red
blood cells. J. Lab. Clin. Med. 56: 281-289.
35. Mohrmann, I., M. Mohrmann, J. Biber, and H. Urer. 1986. Sodium-dependent
transport of Pi by an established intestinal epithelial cell line (CaCo-2). Am. J.
Physiol. 250: G323-G330.
36. Mitchell, D.B., K. S. Santone, and D. Acosta. 1980. Evaluation of cytotoxicity in
cultured cells by enzyme leakage. J. Tissue Cult. Methods 6: 113-116.
37. Donovan, J. M., and A. A. Jackson. 1993. Rapid determination by centrifugal
ultrafiltration of inter-mixed micellar/vesicular (non-lecithin-associated) bile salt
concentrations in model bile: influence of Donnan equilibrium effects. J. Lipid Res.
34: 1121-1129.
38. Eckhardt, E. R. M., B. J. M. van de Heijning, K. J. van Erpecum, W. Renooij, and
G. P. vanBerge-Henegouwen. 1998. Quantitation of cholesterol-carrying particles
in human gallbladder bile. J. Lipid Res. 39: 594-603.
39. Hori, T., K. Matsumoto, Y. Sakaitani, M. Sato, and M. Morotomi. 1998. Effect of
dietary deoxycholic acid and cholesterol on fecal steroid concentration and its
impact on the colonic crypt cell proliferation in azoxymethane-treated rats. Cancer
Lett. 124: 79-84.
40. Estep, T. N., W. I. Calhoun, Y. Barenholz, R. L. Biltonen, G. G. Shipley, and T. E.
Thompson. 1980. Evidence for metastability in stearoylsphingomyelin bilayers.
Biochemistry 19: 20-24.
41. Kuypers, F. A., B. Roelofsen, W. Berendsen, J. A. Op den Kamp, and L. L. van
Deenen. 1984. Shape changes in human erythrocytes induced by replacement of the
Chapter 6
176
native phosphatidylcholine with species containing various fatty acids. J. Cell Biol.
99: 2260-2267.
42. Schubert, R., and K.-H. Schmidt. 1988. Structural changes in vesicle membranes
and mixed micelles of various lipid compositions after binding of different bile
salts. Biochemistry 27: 8787-8794.
43. Mazer, N. A., G. B. Benedek, and M. C. Carey. 1980. Quasielastic light-scattering
studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-
lecithin solutions. Biochemistry 19: 601-615.
44. Yousef, I. M., and M. M. Fisher. 1976. In vitro effect of free bile acids on the bile
canalicular membrane phospholipids in the rat. Can. J. Biochem. 54: 1040-1046.
45. Gerloff, T., P. J. Meier, and B. Stieger. 1998. Taurocholate induces preferential
release of phosphatidylcholine from rat liver canalicular vesicles. Liver 18: 306-
312.
46. Billington, D., R. Coleman, and Y. A. Lusak. 1977. Topographical dissection of
sheep erythrocyte membrane phospholipids by taurocholate and glycocholate.
Biochim. Biophys. Acta  466: 526-530.
47. Thimister, P. W. L., W. P. M. Hopman, C. E. J. Sloots, G. Rosenbusch, A.
Tangerman, H. L. Willems, C. B. H. W. Lamers, and J. B. M. J. Jansen. 1994.
Effect of bile salt binding or protease inactivation on plasma cholecystokinin and
gallbladder responses to bombesin. Gastroenterology 107: 1627-1635.
48. Dillehay, D. L., S. K. Webb, E. M. Schmelz, and A. H. J. Merrill. 1994. Dietary
sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J.
Nutr. 124: 615-620.
49. Parodi, P. W. 1997. Cows' milk fat components as potential anticarcinogenic
agents. J. Nutr. 127: 1055-1060.
Addendum
HEPATIC BILE LIPID COMPOSITION IN PATIENTS WITH
OBSTRUCTIVE  JAUNDICE
Antonio Moschetta*, Piero Portincasa*, Karel J. van Erpecum,
O. Caputi-Iambrenghi, W. Renooij, Gerard P. vanBerge-henegouwen,
Giuseppe Palasciano.
preliminary data
* Authors who equally contributed to the work
 Addendum.
178
Introduction
In vitro experiments indicate that phospholipids with saturated acyl
chains such as sphingomyelin or dipalmitoyl phosphatidylcholine may
offer enhanced protection against detergent bile salts compared to
phospholipids that contain unsaturated acyl chains such as
phosphatidylcholine from egg yolk or phospholipids that are present in
human bile under normal conditions (1).
Although the outer leaflet of the hepatocyte canalicular membrane
contains both phosphatidylcholine and sphingomyelin as major
phospholipids (2), phosphatidylcholine (mainly unsaturated
(18:2>18:1>20:4) acyl chains at sn-2 position) is the exclusive
phospholipid in normal human bile (3). We hypothesized that under
cholestatic conditions considerable amounts of sphingomyelin may occur
in bile, with potential amelioration of cytotoxicity as a result. We
therefore examined hepatic bile lipid composition in patients with
obstructive jaundice due to bile duct stones.
Materials and Methods
Subjects
Bile was aspirated from the common bile duct during endoscopic
retrograde cholangio-pancreaticography (ERCP) in seven patients with
choledocholithiasis (male/female ratio 4/3, age 56±6 years, mean±SD).
Only antibiotics (quinolones) and anti-inflammatory drugs were
administered before ERCP. An increase in cholestatic indices (bilirubin,
gamma-GT, alkaline phosphatase) was observed in all patients (table 1).
The data reported in table 1 were obtained on the day of the ERCP. All
patients presented small birifrangent monohydrate cholesterol crystals as
observed at polarized light microscopy in bile immediately after
aspiration. During ERCP, a cholangiography catheter was inserted
proximally in the common bile duct after passing the stone and the first
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mL of bile was discarded. Thereafter, hepatic bile was collected during
2-3 min (~2 mL). All bile samples were immediately extracted according
to Bligh and Dyer (4). Extracts were stored at -20°C until further
analysis. The protocol was approved by the hospital’s ethical committee
and all patients had consented to participate in the study.
Table 1.
Liver biochemistry in 7 patients with choledocholithiasis.
Patient ALT
(U/L)
AST
(U/L)
γ-GT
(U/L)
Bilirubin tot
(µmol/L)
AP
(U/L)
A 45 61 110 20.6 283
B 50 78 109 22.4 351
C 43 59 210 27.0 296
D 60 75 159 37.6 259
E 51 82 181 39.3 314
F 55 61 131 33.2 330
G 49 59 124 33.7 381
mean±SE 50±2 68±4 146±15 31±3 316±16
Normal values < 35 < 35 < 45 < 17 < 120
ALT: alanine transaminase; AST: aspartate transaminase; γ-GT:
gamma-glutamyl transpeptidase; AP: alkaline phosphatase.
Materials
All bile salts were of the highest purity available and yielded single spots
upon thin-layer chromatography (butanol-acetic acid-water, 10:1:1
vol/vol/vol, application of 200 µg bile salt). Taurocholate (TC),
tauroursodeoxycholate (TUDC), glycocholate (GC),
taurochenodeoxycholate (TCDC), glycoursodeoxycholate (GUDC),
glycochenodeoxycholate (GCDC), taurodeoxycholate (TDC),
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glycodeoxycholate (GDC), taurolithocholate (TLC) and
glycolithocholate (GLC) were purchased from Sigma Chemical Co. (St.
Louis, MO, USA). Methylated fatty acids (16:0, 18:0, 18:1, 18:2, 20:0,
21:0, 22:0, 23:0, 24:0, 24:1, 25:0), used as standards for gas-liquid
chromatography, were purchased from Sigma. All other chemicals and
solvents were of ACS or reagent grade quality. The enzymatic
cholesterol assay kit was obtained from Boehringer (Mannheim,
Germany). 3α-Hydroxysteroid dehydrogenase for the enzymatic
measurement of bile salt concentrations (5) was purchased from Sigma.
The HPLC C18 column was purchased from Supelco (Supelcosil LC-18-
DB, Supelco, Bellefonte, USA) and C18 cartridges (Sep-pak®) for solid-
phase bile salt extraction from Waters (Milford, MA, USA).
Lipid analysis
Concentrations of cholesterol were determined enzymatically in extracts of bile
(6). Phospholipid concentrations were assayed by determining inorganic
phosphate according to Rouser (7). The phospholipids in the extracts were
separated by thin-layer chromatography (chloroform-methanol-acetic acid-
water 50:25:8:2, vol/vol/vol/vol), and quantified by determining the
phosphorus contents of separated phospholipid spots (7). In order to determine
the fatty acid profiles of phosphatidylcholine, 1 µmol phosphatidylcholine was
hydrolyzed in 1 mL nitrogen-flushed methanol-H2SO4 (95:5, by weight, 2 hrs,
70°C) (8). The methylated fatty acids were extracted three times with 1 mL
hexane; the pooled hexane phase was washed with 3 mL H2O, dried over
Na2SO4, concentrated under nitrogen, and separated and detected by gal-liquid
chromatography using a GC14-A gas-chromatograph (Shimadzu, Kyoto,
Japan), equipped with a bonded FSOT capillary column (length 30m, ∅ 0.32
mm).
Bile salt concentrations were determined with the 3α hydroxysteroid–
dehydrogenase method (5). The biliary cholesterol saturation index (CSI)
was calculated according to Carey’s critical tables (9).
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Bile salt species composition was determined by isocratic HPLC analysis
with phosphate-buffered 70% methanol, pH 5.25, as the eluant (10). An
external standard containing known quantities of each of the relevant
major conjugated bile salts was run prior to each analysis. Bile salts were
first purified from whole bile by solid-phase extraction as previously
described (11). Briefly, a C18 Sep-Pak® cartridge was rinsed with 10 mL
methanol and 10 mL water, whereupon 100 µL of bile, dissolved in 2 mL
water, was applied. Subsequently, the cartridge was rinsed with 10 mL
water, 3 mL 10 % acetone, and 10 mL water, and bile salts were eluted
with 3 mL methanol. After evaporation of methanol under a mild stream
of nitrogen at 45°C, the residue was dissolved in 1 mL HPLC buffer, 10
µL of which was injected for HPLC analysis. The cumulative bile salt
hydrophobicity index was calculated according to Heuman (12).
Statistical analysis
Values are expressed as mean ± SEM. Differences between groups were
tested with t-tests or ANOVA using NCSS software. Statistical
significance was defined as a two-tailed probability of less than 0.05.
RESULTS AND DISCUSSION
Lipid compositions of the hepatic biles are given in Table 2. Mol%
cholesterol and phospholipid appear low compared to hepatic biles of
normal subjects (13). As a result, cholesterol supersaturation is modest
(although all patients display supersaturated biles) and PL/(BS+PL)
ratios are low.
As expected, levels of the hydrophobic secondary bile salt deoxycholate
are low, with the result that cumulative bile salt hydrophobicity index is
lower than usual (0.25±0.02 vs 0.32±0.07 in normal subjects; Figure 1,
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Table 2). Ratio of taurine/glycine conijugated bile salts in biles was
1.08±0.09.
As shown in Figure 2, there are considerable amounts of sphingomyelin
(6.6±1.9 % of total phospholipids). The presence of significant amounts
of sphingomyelin in bile has been previously reported in an animal
model of experimental cholestasis (14). Acyl chain composition of
phosphatidylcholine appears to be similar to normal (mainly 18:2>18:1
and 20:4; Figure 3).
Table 2
Hepatic bile lipid compositions in 7 patients with choledocholithiasis
N Chol
mol %
PL
mol %
BS
Mol%
PL/(BS+PL)
Ratio
TLC
(g/dL)
CSI HI
A 3.4 11.4 85.2 0.121 1.80 1.1 0.21
B 3.5 12.1 84.4 0.125 1.70 1.1 0.19
C 3.1 9.4 87.5 0.097 1.65 1.2 0.21
D 3.8 10.1 86.1 0.105 2.04 1.3 0.16
E 7.9 25.4 76.7 0.271 1.79 1.4 0.29
F 6.5 16.1 77.4 0.172 1.64 1.7 0.30
G 6.8 22.9 70.3 0.246 1.80 1.3 0.29
mean±SE 5±1 15±2 81±2 0.2±0.02 1.7±0.05 1.3±0.07 0.25±0.02
TLC: total lipid concentration; CSI: cholesterol saturation index; HI:
cumulative bile salt hydrophobicity index.
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Figure 1. Bile salt composition of the hepatic biles of patients with
cholesterol choledocolitiasis. Biles are enriched only of the primary bile
salts tauro- and glycocholate, tauro- and glycochenodeoxycholate.
Bars indicate means, and vertical lines standard errors.
Figure 2. Phospholipid composition of the hepatic biles of patients with
cholesterol choledocolitiasis. Significant amounts of SM are present.
TC GC TCDC TDC GCDC GDC TL C
0
10
20
30
40
%
 
of
 
to
ta
l b
ile
 
sa
lts
L y s o PC SM PC PE
0
20
40
60
80
100
%
 
o
f t
o
ta
l p
ho
s
ph
ol
ip
id
s
 Addendum.
184
Figure 3. Phosphatidylcholine acyl chain composition in hepatic biles of
patients with cholesterol choledocholithiasis.
In conclusion, significant amounts of sphingomyelin may occur in
hepatic biles of patients with cholesterol choledocholithiasis. The
potential consequences with regard to protection against detergent bile
salts remain to be investigated.
References
1. Moschetta A, Van Berge-Henegouwen GP, Portincasa P, Palasciano G, Groen
AK, Van Erpecum KJ. Sphingomyelin exhibits greatly enhanced protection
compared with egg yolk phosphatidylcholine against detergent bile salts. J Lipid
Res 2000; 41:916-924.
2. Kremmer T, Wisher MH, Evans WH. The lipid composition of plasma
membrane subfractions originating from the three major functional domains of
the rat hepatocyte cell surface. Biochim Biophys Acta 1976; 455(3):655-664.
3. Hay DW, Cahalane MJ, Timofeyeva N, Carey MC. Molecular species of
lecithins in human gallbladder bile. J Lipid Res 1993; 34:759-768.
4. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification.
Can J Biochem Physiol 1959; 37:911-917.
5. Turley SD, Dietschy JM. Reevaluation of the 3a-hydroxysteroid dehydrogenase
assay for total bile acids in bile. J Lipid Res 1978; 19:924-928.
1 6 :0 1 8 :0 1 8 :1 1 8 :2 2 0 :4
0
10
20
30
40
50
%
 o
f t
o
ta
l
“Hepatic bile composition in obstructive jaundice”
185
6. Fromm H, Hamin P, Klein H, Kupke I. Use of a simple enzymatic assay for
cholesterol analysis in human bile. J Lipid Res 1980; 21:259-261.
7. Rouser G, Fleischer S, Yamamoto A. Two dimensional thin layer
chromatographic separation of polar lipids and determination of phospholipids
by phosphorus analysis of spots. Lipids 1970; 5(5):494-496.
8. Oldenborg V, Van Vugt F, Van Golde LM. Composition and metabolism of
phospholipids of Fasciola hepatics, the common liver fluke. Biochim Biophys
Acta 1975; 398(1):101-110.
9. Carey MC. Critical tables for calculating the cholesterol saturation of native
bile. J Lipid Res 1978; 19:945-965.
10. Rossi SS, Converse JL, Hofmann AF. High pressure liquid chromatographic
analysis of conjugated bile acids in human bile: simultaneous resolution of
sulfated and unsulfated litocholyl amidates and the common conjugated bile
acids. J Lipid Res 1987; 28:589-595.
11. Eckhardt ERM, van de Heijning BJM, Van Erpecum KJ, Renooij W, VanBerge-
Henegouwen GP. Quantitation of cholesterol-carrying particles in human
gallbladder bile. J Lipid Res 1998; 39:594-603.
12. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of
mixed bile salt solutions. J Lipid Res 1989; 30:719-730.
13. Eckhardt ER, Van Erpecum KJ, de Smet MB, Go PM, Berge-Henegouwen GP,
Renooij W. Lipid solubilization in human gallbladder versus hepatic biles. J
Hepatol 1999; 31(6):1020-1025.
14. Barnwell SG, Tuchweber B, Yousef IM. Biliary lipid secretion in the rat during
infusion of increasing doses of unconjugated bile acids. Biochim Biophys Acta
1987; 922(2):221-233.

chapter 7
HYDROPHILIC BILE SALTS ENHANCE DIFFERENTIAL
DISTRIBUTION OF SPHINGOMYELIN AND
PHOSPHATIDYLCHOLINE
BETWEEN MICELLAR AND VESICULAR PHASES:
POTENTIAL IMPLICATIONS FOR THEIR EFFECTS IN VIVO
Antonio Moschetta, Gerard P. vanBerge-Henegouwen, Piero Portincasa,
Willem Renooij, Albert K. Groen, Karel J. van Erpecum.
Journal of Hepatology 2001;34:492-499.
Chapter 7
188
Abstract
Background/Aims: The hepatocyte canalicular membrane outer leaflet
contains both phosphatidylcholine (PC) and sphingomyelin (SM).
Normally, PC is the exclusive phospholipid in bile. We examined effects
of bile salt hydrophobicity on cytotoxicity and on differential SM and PC
distribution between detergent-resistant aggregated vesicles (model for
detergent-resistant canalicular membrane) and mixed micelles or small
unilamellar vesicles (representing lipid phases in bile). Methods:
Aggregated vesicles were obtained by ultracentrifugation of cholesterol-
supersaturated model systems containing SM, PC and various bile salts,
micelles by ultrafiltration and unilamellar vesicles by dialysis of the
supernatant. Erythrocyte hemolysis and LDH release from CaCo-2 cells
upon incubation with various micelles were quantified. Results:
Preferential SM distribution and lipid solubilization in aggregated
vesicles increased in rank order taurodeoxycholate < taurocholate <
tauroursodeoxycholate < taurohyodeoxycholate, with reciprocal PC
enrichment in micelles and small unilamellar vesicles. Including small
amounts of PC within taurohyodeoxycholate micelles increased
cytotoxicity with more erythrocyte hemolysis and LDH release from
CaCo-2 cells upon incubation, but decreased cytotoxicity in case of
tauroursodeoxycholate micelles. Conclusions: Hydrophilic but not
hydrophobic bile salts preserve integrity of pathophysiologically relevant
phosphatidylcholine plus sphingomyelin-containing bilayers. Enhanced
biliary phospholipid secretion during taurohyodeoxycholate but not
during tauroursodeoxycholate therapy (Hepatology 1997;25:1306-14)
may relate to different interactions of these bile salts with phospholipids.
INTRODUCTION
Canalicular bile formation involves secretion of bile salts, phospholipids
and cholesterol. Mdr (multi drug resistance) 2 P-glycoprotein functions
as a “flippase” translocating phosphatidylcholine (PC) molecules from
the inner to the outer leaflet of the hepatocyte canalicular membrane (1)
and the bile salt export pump mediates bile salt transport over the
membrane (2). Since unilamellar vesicles have been visualized by
electron microscopy within the canalicular lumen (3), phospholipids and
cholesterol may be secreted into bile by a vesicular mechanism. In
addition, detergent canalicular bile salts could micellize considerable
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amounts of phospholipids and cholesterol from the outer leaflet of the
canalicular membrane (4,5).
Both sphingomyelin (SM) and phosphatidylcholine (PC) are the major
structural phospholipids in the outer leaflet of the hepatocyte canalicular
membrane (in an average ratio of 0.7)(6). In contrast, PC is the major (≈
95%) phospholipid species secreted into bile (7), possibly due to a high
lateral pressure in the membrane because of selective translocation of PC
molecules by mdr2 P-glycoprotein. The physical-chemical state of
canalicular membrane phospholipids could also contribute to preferential
biliary PC secretion: cholesterol has a higher affinity for SM than for PC
(8-11) and may be tightly bound in laterally segregated and detergent-
resistant SM domains in the membrane. Upon addition of bile salts to
isolated canalicular membranes, there is considerable release of PC but
not of SM from the membranes (12,13). These findings may relate to the
different molecular structure of PC and SM: whereas natural PC’s
contain acyl chains esterified to the sn-1 and sn-2 positions of the
glycerol backbone (mainly unsaturated acyl chains at the sn-2 position),
natural SM’s contain mainly saturated long acyl chains amide-linked to
the sphingosine backbone, with the potential for extensive hydrogen-
bonding between SM molecules (14).
In the rat model, infusion of hydrophobic bile salts causes cholestasis and
a considerable increase of SM contents in bile (15). Similarly, we found
in patients with benign recurrent intrahepatic cholestasis, considerable
amounts of SM (10-15% of total phospholipids) in bile during cholestatic
attacks, which was not the case in episodes without cholestasis
(unpublished observations). On the other hand, the hydrophilic bile salt
ursodeoxycholate may prevent or retard progressive liver damage in
patients with cholestatic liver diseases such as primary biliary cirrhosis.
A similar effect has been suggested for another hydrophilic bile salt,
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hyodeoxycholate (16). Various mechanisms have been postulated for
these beneficial effects, including reduction of damage of the hepatocyte
canalicular membrane by more hydrophobic bile salts (17). We therefore
examined in the present study effects of bile salt hydrophobicity on
differential distribution of phospholipids between aggregated vesicles
(that were considered because of their detergent-resistance as a model for
detergent-resistant canalicular membrane (9,18)) and mixed micelles or
small unilamellar vesicles (representing lipid phases in bile as visualized
by electron microscopy (3,9)) in cholesterol-supersaturated model
systems that contained various bile salts and both PC and SM. Although
tauroursodeoxycholate and taurohyodeoxycholate have similar
hydrophilicity as judged by their relative retention times at reverse phase
HPLC (19), their biological effects in vivo are quite different:
intraduodenal infusion of taurohyodeoxycholate but not
tauroursodeoxycholate strongly enhances biliary phospholipid secretion
(16,20). In order to examine potential mechanisms causing these
differences, we also compared detergent effects of these bile salts in
erythrocytes and in CaCo-2 cells.
MATERIAL AND METHODS
Materials
Taurodeoxycholate (TDC), taurocholate (TC), tauroursodeoxycholate
(TUDC) and taurohyodeoxycholate (THDC) were obtained from Sigma
Chemical Co. (St. Louis, MO, USA) and yielded a single spot upon thin-
layer chromatography (butanol-acetic acid-water, 10:1:1 vol/vol/vol,
application of 200 µg bile salt). Cholesterol (Sigma) was ≥ 98% pure by
reverse-phase HPLC (isopropanol - acetonitril 1:1, vol/vol, detection at
210 nm).  Phosphatidylcholine from egg yolk (EYPC; Sigma) and
sphingomyelin from egg yolk (EYSM; Avanti Polar-Lipids Inc.,
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Alabaster, AL, USA) all yielded a single spot upon thin-layer
chromatography (chloroform-methanol-water 65:25:4, vol/vol/vol,
application of  200 µg lipid). Acyl-chain composition of EYSM as
determined by gas-liquid chromatography (21) showed a preponderance
of 16:0 acyl chains. As shown by reverse-phase HPLC, EYPC contained
mainly 16:0 acyl chains at the sn-1 position and mainly unsaturated
(18:1>18:2>20:4) acyl chains at the sn-2 position, similar to PC in human
bile (22). All other chemicals and solvents were of ACS or reagent grade
quality.
Ultrafilters with a molecular weight cut-off of 10 kDa and 300 kDa were
purchased from Sartorius (Göttingen, Germany: Centrisart I), dialysis
membranes with a molecular weight cut-off of 300 kDa from Spectrum
Laboratories (Laguna Hills, CA, USA: SpectraPor). The enzymatic
cholesterol assay kit was obtained from Boehringer (Mannheim,
Germany). 3α-Hydroxysteroid dehydrogenase for the enzymatic
measurement of bile salt concentrations (23) and a colorimetric chloride-
kit were purchased from Sigma. Dulbecco’s modified Eagle’s minimum
essential medium (DMEM) was obtained from Flow Laboratories (Irvine,
G.B.). The reverse-phase C18 HPLC column was from Supelco
(Supelcosil LC-18-DB, Supelco, Bellefonte, PA, USA).
Preparation of lipid solutions
Lipid mixtures were vortex-mixed and dried at 45°C under a mild stream
of nitrogen, and subsequently  lyophilized during 24 hrs, before being
dissolved in aqueous 0.15 M NaCl plus 3mM NaN3. Tubes were sealed
with Teflon-lined screw caps under a blanket of nitrogen and vortex-
mixed for 5 min. followed by incubation at 37°C in the dark. The final
mol percentages of cholesterol, phospholipids and bile salts did not differ
more than 1% from the intended mol percentages.
Chapter 7
192
Lipid analysis
Phospholipid concentrations in model systems were assayed by
determining inorganic phosphate (24). Cholesterol concentrations were
determined with an enzymatic assay (25), and bile salts with the 3α-
hydroxysteroid dehydrogenase method (23). In systems containing both
PC and SM, the phospholipids were extracted (26), separated by thin-
layer chromatography (chloroform-methanol-acetic acid-water 50:25:8:2,
vol/vol/vol/vol), and quantified by determination of phosphorus contents.
IMC measurement
Apart from mixed (i.e. phospholipid-bile salt) micelles, model bile
systems also contain non-phospholipid associated bile salts, either as
monomers or -above their critical micellar concentration- associated in
"simple" micelles. The monomeric plus simple micellar bile salt
concentration is referred to as “intermixed micellar/vesicular (non
phospholipid-associated) bile salt concentration”, usually abbreviated as
“IMC” (27). We determined IMC in various model systems, using the
rapid centrifugal ultrafiltration technique with correction for Gibbs-
Donnan effects (9,28,29).
Isolation of vesicular and micellar phases
After 2 weeks incubation at 37°C, various phases were isolated from
cholesterol-supersaturated model systems as described (9). In brief,
detergent-resistant aggregated vesicles were precipitated by
ultracentrifugation during 30 min. at 50000 g and at 37°C in a TLS 55
rotor (Beckman, Palo Alto, CA, USA) (18). Micelles and small
unilamellar vesicles were isolated from the supernatant by ultrafiltration
with a highly selective 300 kDa ultrafilter resp. by dialysis (500 µL
sample, 16 hours, 37°C) in a SpectraPor dialysis device with a
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molecular weight cut-off of 300 kDa, against three times 20 volumes of
aqueous 0.15 M NaCl plus 3 mM NaN3 containing the relevant bile salt
at concentrations identical to the IMC of the various original model
systems in order to avoid artifactual shifts of lipids between vesicles and
micelles (9,28). The ultrafilters and dialysis membranes were completely
impermeable to small unilamellar or aggregated vesicles but completely
permeable to simple and mixed micelles (tested with a wide range of
micellar compositions (9), including TDC-, TC-, TUDC- or THDC-
containing mixed micelles at 37°C, at total lipid concentration of 2.4
g/dL and at PL/(BS+PL) ratios of 0.55, 0.5, 0.4 and 0.3, either without or
with small amounts (0.25 mol%) of cholesterol; with both SM and PC
(SM/PC ratio 1:1) as phospholipid). Recovery of cholesterol and
phospholipids in separated micellar, unilamellar and aggregated vesicular
phases was 95-100 % of lipids in the original whole model system.
Preparation of small unilamellar vesicles
Small unilamellar vesicles were prepared by sonication, stored above
40°C (i.e. above the main transition temperatures of the phospholipids),
and used within 12 hrs (28). Small unilamellar vesicles contained 8.4
mM EYPC, 8.4 mM EYSM and 6.9 mM cholesterol (cholesterol /
phospholipid ratio 0.4).
Resistance of erythrocytes against various bile salt-phospholipid
mixed micelles
Bile salt induced hemolysis was determined as described previously (28).
Briefly, 0.2 mL of erythrocytes were added to 0.8 mL of TDC, TC,
TUDC or THDC (bile salt conc. 2.5 to 180 mM), and incubated during
15 min. at 37°C. Thereafter, 7 mL buffer was added, in order to decrease
hemolysis to negligible levels (30). After centrifugation for 1 min. at
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10000 g, extent of lysis was assayed in the supernatant (absorbance at
540 nm) and compared with values after 15 min. incubation in distilled
water, the latter inducing 100% hemolysis (31). Erythrocytes (0.2mL)
were also added to 0.8mL TDC, TC, TUDC or THDC mixed micelles
(180 mM) that contained increasing amounts of PC (PC/(BS+PC) ratios
from 0 to 0.5). Experiments with THDC were also performed at a bile
salt concentration of 50 mM.
Resistance of CaCo-2 cells against various bile salt-phospholipid
mixed micelles
CaCo-2 cells were cultured as previously described (32) with minor
modification (28). After 10 days, postconfluent cultures were washed
with phosphate-buffered saline (pH 7.4) and cells were incubated with
micelles containing TDC, TC, TUDC or THDC (30 mM) plus various
amounts of PC (PC / (PC+BS) ratios from 0 to 0.4, pH 7.4). After 30
min. incubation at 37°C, the medium was collected and cells were treated
with 0.4% Triton X-100. Lactate dehydrogenase (LDH) activity -as a
sensitive parameter of cell damage- was measured according to Mitchell
et al. (33) both in medium and in Triton X-100 treated cells. Enzyme
activity in each single experiment was normalized as percentage of the
total LDH activity (medium + Triton X-100 treated cells).
Quasielastic light scattering (QLS) spectroscopy
QLS measurements were performed on a Malvern 4700c QLS
spectrometer (Malvern Ltd., Malvern, UK) equipped with an argon laser
(Uniphase Corp., San Jose, CA, USA) at a wavelength of 488 nm and at
an angle of 90°. All samples were maintained at a constant temperature
of 37°C in a water bath, for at least 15 min. prior to measurements. In
optically clear micellar solutions, the power of the laser was tuned to 50
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mW. Data are given as hydrodynamic radius (Rh) and are means of at
least 3 measurements.
Statistical analysis
Values are expressed as means ± SEM. Differences between groups were
tested for statistical significance by analysis of variance (ANOVA).
When ANOVA detected a significant difference, results were further
compared for contrasts using Fisher’s least significant difference test as
post-hoc test. Statistical significance was defined as a two-tailed
probability of less than 0.05.
RESULTS
Effect of hydrophobic and hydrophilic bile salts on distribution of
cholesterol and phospholipid between micellar and vesicular phases
Cholesterol supersaturated model systems containing both PC and SM,
and TDC, TC, TUDC or THDC and plotting in the right two-phase zone
of the equilibrium ternary phase diagram (inset Fig. 1 (34,35)) were all
highly turbid and microscopic examination revealed large amounts of
aggregated vesicles. Solid cholesterol crystals, however, were not
observed. IMC values were 0.8±0.1 mM, 3.7±0.1 mM, 5.3±0.1 mM and
4.9±0.1 mM in TDC-, TC-, TUDC- and THDC-containing systems, resp.
(P<0.05, TDC, TC vs TUDC, THDC). As shown in Fig. 1A, cholesterol
mainly distributed into the detergent-resistant aggregated vesicles. At
increasing bile salt hydrophilicity, distribution of the sterol into
aggregated vesicles increased, whereas distribution into small unilamellar
vesicles and in mixed micelles decreased. In contrast, phospholipids
distributed to a large extent into the micellar phase, particularly in case of
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more hydrophobic bile salts (Fig. 1B). At increasing bile salt
hydrophilicity, phospholipid solubilization in micelles decreased, and
aggregated vesicles became the main phospholipid carriers. In contrast to
cholesterol, phospholipid solubilization in small unilamellar vesicles
increased at increasing bile salt hydrophilicity (Fig. 1B).
Cholesterol/phospholipid ratios in micelles and small unilamellar vesicles
decreased at increasing bile salt hydrophilicity (Table 1).
Figure 1: Solubilization of cholesterol (A) and phospholipids (B) in
aggregated vesicles (solid bars), small unilamellar vesicles (hatched bars) and
mixed micelles (open bars) in model systems containing 6.9 mM cholesterol,
8.4 mM PC, 8.4 mM SM, and 16.8 mM TDC, TC, TUDC or THDC after 2
weeks incubation at 37°C (total lipid concentration = 2.4 g/dL, PL/(BS+PL)
ratio = 0.5, 17 mol% cholesterol; n=4 for each bile salt). At increasing bile
salt hydrophilicity, solubilization of cholesterol and (more pronounced)
phospholipids in aggregated vesicles increases significantly, with reciprocal
decreases of solubilization in micelles. Whereas solubilization of cholesterol in
small unilamellar vesicles decreases significantly at increasing bile salt
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hydrophilicity, solubilization of phosholipids in small unilamellar vesicles
increases significantly under these circumstances.
Inset: equilibrium bile salt-phospholipid-cholesterol ternary phase diagram.
1φ = 1-phase (micelles-containing) zone; 2φ = 2-phase (left: micelles+solid
crystals; right: micelles+vesicles) zones; 3φ = 3-phase
(micelles+vesicles+solid crystals-containing) zone. Dot indicates model bile
plotting in right two-phase zone. Continuous line: phase diagram for EYPC
and hydrophobic bile salts. Interrupted line: decreased one-phase micellar
zone and extension of right two-phase zone in case of more hydrophilic bile
salts or sphingomyelin as phospholipid (19,32).
Table 1. Cholesterol / Phospholipid ratios of various phases in
cholesterol supersaturated model biles
Cholesterol/Phospholipid ratio
AGG SUV MIC
TDC 0.94 ± 0.09 0.65 ± 0.05 0.05 ± 0.02
TC 1.05 ± 0.10 0.45 ± 0.05 0.04 ± 0.004
TUDC 0.98 ± 0.12 0.29 ± 0.02 0.03 ± 0.009
THDC 0.93 ± 0.09 0.35 ± 0.05 0.03 ± 0.01
AGG = aggregated vesicles. SUV = small unilamellar vesicles:
Significant difference in cholesterol/phospholipid ratios for all bile salts.
MIC = micelles: Significant difference in cholesterol/phospholipid ratios
for TDC vs TUDC or THDC.
Effect of hydrophobic and hydrophilic bile salts on distribution of
sphingomyelin and phosphatidylcholine between vesicles and
micelles
Fig. 2 shows the distribution of SM and PC into micelles, small
unilamellar and aggregated vesicles. Micellar enrichment with PC and
enrichment of aggregated vesicles with SM was evident in all systems,
but was most pronounced in the case of hydrophilic bile salts. Small
unilamellar vesicles also tended to be depleted in SM. We also added
TDC, TC, TUDC or THDC to sonicated PC-, SM- and cholesterol-
containing vesicles, and determined SM/PC ratios in micelles (obtained
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by ultrafiltration) at 15 min., 1 hr and 12 hrs. There was a progressive
depletion of SM in micelles during the experiment, which was most
pronounced in case of hydrophilic bile salts (Fig. 3).
Figure 2: Distribution of SM and PC between aggregated vesicles, small
unilamellar vesicles and micelles. Lipid compositions and duration of
incubation of the systems were the same as in Fig. 1 (n=4 for each bile
salt). SM preferentially distributes into aggregated vesicles with
reciprocal SM depletion in micelles and small unilamellar vesicles.
Asymmetric phospholipid distribution is most pronounced in case of
more hydrophilic bile salts. Reciprocal results were obtained for PC
solubilization. Interrupted line indicates SM / PC ratio in whole system.
Left Y axis applies to micelles and small unilamellar vesicles, right Y axis
to aggregated vesicles. MIC = micelles; SUV = small unilamellar
vesicles; AGG = aggregated vesicles.
Effect of hydrophobic and hydrophilic bile salts on distribution of
sphingomyelin and phosphatidylcholine between vesicles and
micelles
Fig. 2 shows the distribution of SM and PC into micelles, small
unilamellar and aggregated vesicles. Micellar enrichment with PC and
enrichment of aggregated vesicles with SM was evident in all systems,
but was most pronounced in the case of hydrophilic bile salts. Small
unilamellar vesicles also tended to be depleted in SM. We also added
TDC, TC, TUDC or THDC to sonicated PC-, SM- and cholesterol-
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containing vesicles, and determined SM/PC ratios in micelles (obtained
by ultrafiltration) at 15 min., 1 hr and 12 hrs. There was a progressive
depletion of SM in micelles during the experiment, which was most
pronounced in case of hydrophilic bile salts (Fig. 3).
Figure 3: SM and PC distribution into the micellar phase, as determined
by ultrafiltration at various time points after addition of TDC, TC, TUDC
or THDC (final bile salt conc. 16.8 mM) to sonicated small unilamellar
vesicles containing cholesterol (final conc. 6.9 mM) and both PC and SM
(SM/PC ratio 1:1; final phospholipid conc. 16.8 mM). Temperature was
maintained at 37°C throughout the experiment (n=4 for each bile salt).
SM solubilization in micelles decreases during the experiment. Decreases
occur at an earlier stage and are most pronounced in case of hydrophilic
bile salts. Differences between each time point and between all bile salts
are significant. Interrupted line indicates SM / PC ratio in whole system.
() TDC; () TC; (    ) TUDC; () THDC.
Effect of hydrophobic and hydrophilic bile salts on distribution of
sphingomyelin and phosphatidylcholine between vesicles and
micelles
Fig. 2 shows the distribution of SM and PC into micelles, small
unilamellar and aggregated vesicles. Micellar enrichment with PC and
enrichment of aggregated vesicles with SM was evident in all systems,
but was most pronounced in the case of hydrophilic bile salts. Small
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unilamellar vesicles also tended to be depleted in SM. We also added
TDC, TC, TUDC or THDC to sonicated PC-, SM- and cholesterol-
containing vesicles, and determined SM/PC ratios in micelles (obtained
by ultrafiltration) at 15 min., 1 hr and 12 hrs. There was a progressive
depletion of SM in micelles during the experiment, which was most
pronounced in case of hydrophilic bile salts (Fig. 3).
Figure 4: Effect of bile salt hydrophobicity on lysis of human
erythrocytes. Red blood cells were incubated for 15 min. at 37°C with
distilled water (100% lysis) or with  increasing concentrations of various
bile salts (see “Materials and Methods” (n=4 for each bile salt)).
Whereas low concentrations of TDC or slightly higher concentrations of
TC result in 100% hemolysis, this is not the case for TUDC and THDC
even after incubation with extremely high concentrations.
() TDC; () TC; (   ) TUDC; () THDC.
Hemolysis induced by hydrophobic and hydrophilic bile salts and
protective effects of phosphatidylcholine
Although low concentrations (≥ 10 mM) of TDC and slightly higher
concentrations (≥ 50 mM) of TC induced 100 % hemolysis, incubation
with TUDC or THDC, up to 180 mM, induced only moderate hemolysis
(Fig. 4). As displayed in Fig. 5, incorporation of PC at PC/(BS+PC)
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ratios of ≥ 0.3 in TUDC micelles prevented cytolysis completely,
whereas the same protective effects occurred for TC-PC and TDC-PC
micelles at PC / (BS+PC) ratios of ≥ 0.4 resp. ≥ 0.5. In contrast,
incorporation of PC in THDC micelles did not prevent, but rather
increased hemolysis to maximal values (Fig. 5). At 50 mM bile salt
concentration, there was increased hemolysis upon incubation with
THDC-PC micelles at PC/(BS+PC) ratios of 0.1 and 0.2 with a reduction
at higher ratios (Fig. 5).
Figure 5: Protective effect of PC against lysis of human erythrocytes
induced by hydrophobic or hydrophilic bile salts. Red blood cells were
incubated for 15 min. at 37°C with micelles containing various bile salts
(180 mM) and progressive amounts of PC (n=5 for each bile salt). For
all bile salts except THDC, hemolysis is progressively inhibited at
increasing PC contents. In contrast, in case of THDC, hemolysis
increases when PC is included in these micelles. The increased detergent
effects of THDC mixed micelles compared to simple micelles are even
more evident at 50 mM bile salt concentration.
() TDC; () TC; (   ) TUDC; () THDC (all 180 mM bile salt conc);
(	
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LDH release by CaCo-2 cells induced by hydrophobic and
hydrophilic bile salts and protective effects of phosphatidylcholine
As shown in Fig. 6, LDH release upon incubation of CaCo-2 cells
with TUDC micelles was always neglegible regardless the presence of
PC. Incorporation of increasing amounts of PC in TDC- and TC-micelles
progressively reduced LDH release: virtually complete protection
occurred at PC/(BS+PC) ratios of 0.4 and 0.3 for TDC-PC resp. TC-PC
micelles. In contrast, incorporation of PC in THDC micelles at a
PC/(BS+PC) ratio of 0.1 increased rather than decreased LDH release. At
higher PC/(BS+PC) ratios, LDH decreased again, with complete
protection at ratios of ≥ 0.3.
Figure 6: Effect of PC on LDH release by CaCo-2 cells induced by
various bile salts. CaCo-2 cells were incubated for 30 min. at 37°C with
micelles containing various bile salts (30 mM) and progressive amounts
of PC (n=4 for each bile salt). LDH release by TUDC micelles is always
neglegible regardless the presence of PC. For TC and TDC, LDH release
is progressively inhibited at increasing PC contents. Virtually complete
prevention of LDH release occurs at PC/(BS+PC) ratios of 0.3 and 0.4
for TC and TDC respectively. The pattern is different in case of THDC:
LDH release increases when PC is included in micelles at PC/(BS+PC)
ratios of 0.1, with a reduction at higher ratios (complete prevention of
LDH release at PC/(BS+PC) ratio ≥ 0.3).
() TDC; () TC; (   ) TUDC; () THDC.
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Effects of phosphatidylcholine on micellar sizes
As shown in Fig. 7, TC and TUDC micellar sizes as measured by
quasi-elastic light scattering spectroscopy increased progressively at
increasing PC content. In case of THDC,  micellar sizes were relatively
high in absence of PC. There was a decrease in micellar sizes at
PC/(BS+PC) ratio of 0.1, with an increase at higher ratios. For TDC-
containing micelles, sizes at PC/(BS+PC) ratios of 0 and 0.1 did not
differ, but sizes increased at higher PC contents.
Figure 7: Micellar sizes, expressed as hydrodynamic radius (Rh), as
measured by quasielastic light scattering spectroscopy, in solutions
containing various bile salts (conc. 30 mM) and increasing amounts of
PC (n=4 for each bile salt). Whereas in case of TC or TUDC solutions,
micellar sizes increase progressively at increasing PC contents, in case
of THDC there is a decrease of micellar size at PC/(BS+PC ratio 0.1,
with increased sizes at higher ratios. In case of TDC micelles, sizes at
PC/(BS+PC) ratios  0 and 0.1 do not differ, but sizes increase at higher
ratios.
() TDC; () TC; (   ) TUDC; () THDC.
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DISCUSSION
The main finding of the present in vitro study was that bile salt
hydrophobicity had a strong influence on differential PC vs SM
distribution: in cholesterol-supersaturated systems that contained both PC
and SM, preferential SM distribution into detergent-resistant aggregated
vesicles and preferential PC distribution into small unilamellar vesicles
and micelles occurred in the rank order TDC < TC < TUDC < THDC.
Similarly, in a time-course study, after addition of various bile salts to
sonicated vesicles that contained PC, SM and cholesterol, enrichment of
PC in micelles occurred earlier and to a larger extent in case of
hydrophilic bile salts.
The great majority of cholesterol (84-96% of total) distributed into the
aggregated vesicles, whereas micelles were a prominent (29-62% of
total) phospholipid carrier. These findings are consistent with the much
greater potential of micelles to solubilize phospholipids than cholesterol
(36,37) The increased solubilization of lipids in aggregated vesicles and
decreased solubilization in micelles in case of hydrophilic bile salts (Fig.
1) is not unexpected, given the strong reduction of the one-phase micellar
zone and the marked left-ward expansion of the right two-phase (micelles
+ vesicles-containing) zone in the EYPC-cholesterol-bile salt equilibrium
ternary phase diagram in case of hydrophilic compared to hydrophobic
bile salts (see inset Fig. 1 (35)). In fact, this left-ward expansion of the
right two-phase zone may relate to decreased cholesterol/phospholipid
ratios and increased stability of small unilamellar vesicles at increasing
bile salt hydrophilicity as found in the present study (Table 1)(38).
Although these data indicate that hydrophilic but not hydrophobic bile
salts preserve integrity of pathophysiologically relevant PC+SM-
containing bilayers, there were no significant differences between TUDC
and THDC. In contrast to TUDC, THDC treatment induces a marked
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increase in biliary phospholipid secretion in vivo (16,20). We therefore
proceded to the erythrocyte and CaCo-2 cell models in order to quantify
detergent effects of various bile salts as well as protective effects of
including PC within these micelles. In the erythrocyte model, TDC
caused 100%  hemolysis at low concentrations, whereas the same
occurred at slightly higher concentrations for TC. In contrast, both
TUDC and THDC caused only moderate hemolysis, even at very high
concentrations. Nevertheless, including increasing amounts of PC within
the micelles progressively decreased hemolysis in case of TUDC but
increased hemolysis in case of THDC. Similar results were obtained in
the CaCo-2 cell model. We have previously shown in the erythrocyte or
CaCo-2 cell models that protective effects of including PC within bile
salt micelles occur at the level of these micelles rather than by transfer of
PC molecules from these micelles into the cell membrane (28). Our
present findings suggest different bile salt-phospholipid interactions and
micellar structures for TUDC and THDC. In case of THDC (but not
TUDC), incorporation of PC may promote micelle formation with
decreased particle sizes as a result of packing constraints. This
suggestion is supported by the different patterns of micellar size
variations for THDC and TUDC at progressive micellar PC contents
(Fig. 7). Although these differences may be relevant for the biological
effects of TUDC vs THDC in vivo, the exact physical-chemical
explanation of our findings needs further research. One should also
realize, that differential effects of TUDC vs THDC on intracellular PC
transport (possibly mediated by PC transfer protein (39)) or on mdr2 P-
glycoprotein could be involved in their different effects on biliary PC
secretion. In addition, results of our model bile studies (Figs 1 and 2)
were obtained after two-weeks incubation, with the systems probably
being near thermodynamic equilibrium.
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In summary, the present study indicates that hydrophilic but not
hydrophobic bile salts preserve integrity of pathophysiologically relevant
phosphatidylcholine- plus sphingomyelin-containing bilayers, with
enhanced differential distribution of PC vs SM between micellar and
vesicular phases. Different bile salt-phospholipid interactions may
account for the different in vivo effects of the hydrophilic bile salts
tauroursodeoxycholate and taurohyodeoxycholate.
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 Summary
High fecal levels of hydrophobic bile salt deoxycholate are associated
with increased risk of colonic adenomas and cancer. Since phospholipids
protect against detergent effects and cytotoxicity of bile salt micelles,
and ~30% of dietary sphingomyelin reaches the colon, we examined
whether sphingomyelin influences apoptosis and hyperproliferation
induced by deoxycholate in vitro. Methods: In CaCo-2 cells, apoptosis
with concomitant caspase-3 activity was quantitated after 2, 4 and 16 hrs
incubation with 50-500 µM deoxycholate, with or without
sphingomyelin. Hyperproliferation (by bromodeoxyuridine assay) and
phosphorylation of cellular proteins were evaluated after 16 hrs
incubation. In erythrocytes, phosphatidylserine exposure upon incubation
with deoxycholate -with or without sphingomyelin- was determined by
quantitating its binding to annexin V. Results: at 2 hrs and 4 hrs
incubation, deoxycholate induced dose-dependent apoptosis, with
concomitant caspase-3 activation. At 16 hrs, apoptosis had decreased
markedly, but there was dose-dependent hyperproliferation (with
changed phosphorylation status of cellular proteins) at this time-point.
Deoxycholate also induced in the erythrocyte model (without
intracellular signaling and nucleus) phosphatidylserine exposure on the
membrane outer leaflet. Sphingomyelin dose-dependently reduced
hyperproliferation, apoptosis and phosphatidylserine exposure at all time
points. Conclusions: sphingomyelin reduced hyperproliferation and
apoptosis by deoxycholate possibly by decreasing detergent activity of
the bile salt in the incubation medium. These findings may be relevant
for colonic cancer protection by dietary modification.
Introduction
In Western populations on high fat diet, there is a clear association
between fecal bile salt excretion and risk of colon cancer (1;2). In
particular, the secondary and hydrophobic bile salt deoxycholate may act
as tumor promotor by inducing hyperproliferation (3-5). Deoxycholate
has also been shown to increase the numbers of tumors induced by
complete carcinogens (6;7). On the other hand, deoxycholate may also
induce apoptosis in some adenoma and carcinoma cell lines (8-11).
Although phospholipids with unsaturated acyl chains at the sn-2 position
such as egg yolk phosphatidylcholine or phosphatidylcholine in bile
decrease detergent effects and cytotoxicity of bile salt micelles (12),
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phosphatidylcholines with disaturated acyl chains such as dipalmitoyl
phosphatidylcholine or sphingomyelins are considerably more effective
in this respect (13). The human diet contains considerable amounts of
phosphatidylcholines and sphingomyelins. Recent data indicate that
disaturated phosphatidylcholines such as dipalmitoyl
phosphatidylcholine are more resistant to hydrolysis by phospholipase A2
than phosphatidylcholines with unsaturated acyl chains (14). Similarly,
although alkaline sphingomyelinase in bile (15) and in the small intestine
(16) may hydrolyze sphingomyelin, considerable amounts (~30% of
ingested quantities) of the sphingolipid appear to reach the colon (17-19).
Dietary supplementation with sphingomyelin has been shown to suppress
experimental colon cancer in mice (20). We therefore examined potential
effects of sphingomyelin on hyperproliferation or apoptosis induced by
deoxycholate in the CaCo-2 cell model.
MATERIALS AND METHODS
Materials
Deoxycholate (DC) was obtained from Sigma Chemical Co. (St. Louis, MO,
USA) and yielded a single spot upon thin-layer chromatography (butanol-
acetic acid-water, 10:1:1 vol/vol/vol, application of 200 µg bile salt).
Sphingomyelin from egg yolk (EYSM; Avanti Polar-Lipids Inc., Alabaster,
AL, USA) yielded a single spot upon thin-layer chromatography (chloroform-
methanol-water 65:25:4, vol/vol/vol, application of  200 µg lipid). Acyl chain
compositions as determined by gas-liquid chromatography (21) were virtually
identical to previously published data (22) and showed a preponderance of 16:0
acyl chains for EYSM, similar to sphingomyelin in human bile (23).
Dulbecco’s modified Eagle’s minimum essential medium (DMEM) was
obtained from Flow Laboratories (Irvine, G.B.). All other chemicals and
solvents were of ACS or reagent grade quality.
3α-Hydroxysteroid dehydrogenase, the Bradford reagent and the caspase-3
assay were purchased from Sigma. The cell proliferation elisa BrdU kit and the
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cell death detection elisa kit were purchased from Roche Molecular
Biochemicals (Mannheim, Germany). The Annexin V-fluorescein
isothiocyanate (FITC) apoptosis detection kit was obtained from BD
PharMingen (San Diego, USA).
Preparation of lipid solutions
Lipid mixtures containing variable proportions of deoxycholate (from stock
solutions in methanol) and/or sphingomyelin (from stock solutions in
chloroform) were vortex-mixed and dried at 45°C under a mild stream of
nitrogen, before being dissolved in DMEM supplemented with 20% fetal calf
serum (Gibco, New England, N.Y., USA). Solutions were prepared freshly for
all experiments. Bile salt concentrations were assayed by the 3α-
hydroxysteroid dehydrogenase method (24) and sphingomyelin concentrations
by determining inorganic phosphate according to Rouser (25).
Cell culture
CaCo-2 cells were grown in T-75 plastic flasks in DMEM supplemented with
20% fetal calf serum (Gibco, New England, N.Y., USA), 50 U/mL penicillin
and 50 U/mL streptomycin (Irvine, GB). Before confluency, the cells were split
(split ratio 1:8) as follows: CaCo-2 cells were rinsed twice with Hank’s
balanced salt solution (Gibco, New England, N.Y., USA) and incubated during
5 min. at 37°C with 1 mL of dissociation solution (Sigma, St. Louis MO,
USA), after DMEM medium supplemented with 20% fetal calf serum was
added to the cell suspension. Monolayers were grown in microwell plates in
DMEM, which was replaced daily with fresh medium. After 10 days, the
postconfluent cultures were washed with phosphate-buffered saline (pH 7.4)
and the cells were incubated with DC at various concentrations (from 50 to 500
µM) and at various incubation times (2hrs, 4hrs and 16 hrs). Experiments were
also conducted with DC 400 µM and 500 µM plus SM at SM/(DC+SM) molar
ratios ranging from 0 to 0.3 as well as with SM alone in concentrations from 50
to 200 µM.
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Apoptosis was measured based on a photometric enzyme immunoassay
for the qualitative and quantitative determination of cytoplasmic DNA
fragments (26).
Caspase-3 activity was assayed by the spectrophotometric detection (OD
405 nm) of the chromophore p-nitroaniline after hydrolysis of the
peptide substrate acetyl-Asp-Glu-Val-Asp (Ac-DEVD-pNA) (27).
Proliferation was assayed  by determining incorporation of the
pyrimidine analogue bromodeoxyuridine (BrdU) during DNA synthesis
(3). After incubation with the bile salt solution, BrdU was added to the
cells, followed by reincubation during 4 hrs.
Phosphorylation status of proteins in cell lysates was determined with a
Western blot (Mini Protean Biorad) using a specific antiphosphotyrosine
antibody, after 16 hrs incubation.
Annexin V-phosphatidylserine binding in erythrocytes.
Phosphatidylserine (PS) normally localizes to the inner leaflet of cell
membrane but becomes exposed to the cell surface after pro-apoptotic
stimuli (28). Erythrocytes cannot undergo apoptosis because they lack a
nucleus, but PS-exposure signals the removal of aged red cells from the
circulation (29;30). Annexin V belongs to a family of phospholipid
binding proteins and exhibits a high calcium-dependent affinity for
membranes containing PS in their outer leaflets (31). First, we isolated
and washed red blood cells obtained freshly from a single volunteer; then
we incubated these cells for 30 min. at 37°C with DCA and/or SM.
Finally, we measured cell-associated fluorescence in a Becton Dickinson
FACScan, according with Kuypers et al. (32), after addition of FITC-
labeled annexin V in the presence of calcium. During each incubation,
hemolysis was also determined by measuring release of hemoglobin in
supernatant (13).
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Figure 1. Apoptosis and caspase-3 activity in CaCo-2 cells after 4 hrs
incubation with various deoxycholate concentrations without or with SM.
There is a dose-dependent increase in DC-induced apoptosis (A) and caspase-
3 activation (B) as well as a dose-dependent inhibition of 500 µM DC-induced
apoptosis (C) and caspase-3 activation (D) in presence of SM.
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RESULTS
After 2 hrs (not shown) and 4 hrs (Fig 1A) incubation with various DC
concentrations, there was a dose-dependent induction of apoptosis. With
500µM DC, there were ~35% apoptotic cells after two hrs, and ~45%
apoptotic cells after 4 hrs. After 16 hrs incubation, apoptosis apparently
decreased strongly, with only ~ 10% apoptotic cells at 500 µM DC.
Figure 2. (A) DC induces dose-dependent hyperproliferation as
measured by BrdU uptake after 16 hrs incubation and (B) there is a
dose-dependent inhibition by SM of 500µM DC-induced
hyperproliferation.
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Nevertheless, dose dependency could still be observed at this time point.
As shown in Figure 1B, after 4 hrs incubation, apoptosis was associated
with dose-dependent caspase-3 activation. Addition of SM to the
incubated bile salts dose-dependently inhibited apoptosis (Fig 1C;
complete protection at SM/(DC+SM) molar ratio = 0.3 for 4 hrs
incubation with 500 µM DC) and caspase-3 activation (Fig 1D).
Incubation with SM alone (50, 100, 150, 200 µM) did not induce any
apoptosis or caspase-3 activity.
Proliferation could not be studied in the earliest stages of incubation
because of the time required for BrdU to be incorporated in the DNA.
Nevertheless, after 16 hrs incubation, DC induced dose-dependent
hyperproliferation (Fig 2A), with dose-dependent protection if SM is
also included in the incubation (Fig 2B: complete protection at
SM/(DC+SM) molar ratio = 0.2 for 500 µM DC). Incubation with SM
alone (50, 100, 150, 200 µM) did not induce any hyperproliferation.
These findings were confirmed by changes at inverted light microscopy
(Fig 3 A-C).
Western blot with the aid of a specific antiphosphotyrosine antibody
revealed a marked change in phosphorylation status of cellular proteins.
After 16 hrs incubation with 300-500 µM DC, phosphorylation of
proteins < 40kDa virtually disappeared. This change was prevented by
including SM in the incubation mixture. SM alone had no effects on
phosphorylation status as compared with control incubation (Fig 4). It
should be noted that Ponceau S. staining of the blot in Fig 4 did not
reveal any differences between various lines. In particular, protein bands
< 40 kDa were identical, indicating that only phosphorilation status of
these proteins was affected by the incubation with DC.
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Figure 3. Morphological changes of CaCo-2 cells examined at inverted
light microscopy after 16 hrs incubation with (A) control, (B) DC
500µM, (C) DC 500 µM plus SM at SM/(DC+SM) ratio = 0.3.
We also examined effects of DC incubation -with or without SM- on PS-
exposure to the cell surface of the erythrocyte membrane. As shown in
Figs. 5A and B, during incubation with 600 µM DC there is significant
PS exposure (~ 18% of erythrocytes), without significant hemolysis. Sm
dose-dependently inhibited PS exposure, with complete protection at
SM/(DC+SM) molar ratio of 0.2 (Fig 5C). It is important to note that in
the latter experiment, hemolysis was neglegible (< 1%) with all
SM/(DC+SM) ratios tested (i.e. 0, 0.05, 0.1, 0.15, 0.2).
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Figure 4
DISCUSSION
Formation of colonic adenomas and cancer may occur because of a
disturbed balance between (hyper)proliferation and apoptosis. High fecal
levels of the secondary and hydrophobic bile salt deoxycholate (DC) are
associated with increased colonic adenomas and cancer risks (1;2).
Previous studies on deoxycholate have reported either apoptosis (8-11)
or hyperproliferation (3-5). Different results may be explained by
different methodology used in these reports. In the present study, we
found evidence of dose-dependent apoptosis in the earliest stages (2 and
4 hrs) of incubation with DC. At later stages (16 hrs), apoptosis as well
as caspase-3 activity were dramatically reduced. Also, DC-induced
apoptosis required caspase-3 activation, as reported before (33;34).
14.3 kDa
1     2     3     4     5       6      7
97 kDa
66 kDa
46 kDa
33 kDa
Phosphorilation status of cellular proteins detected by Western blot with the
aid of a specific antiphosphotyrosine antibody after 16 hrs incubation
1. control; 2. DC 300µM; 3. DC 400µM; 4. DC 500µM;
5. DC 500µM+SM at SM/DC+SM=0.3; 6. SM 100µM; 7. SM 200µM
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Figure 5
Figure 5. (A) Progressive hemolysis after 30 min. incubation with
increasing concentrations of DC. (B) Progressive increase in % of cells
with PS-exposure at increasing DC concentrations. (C) Dose-dependent
inhibition by SM of DC-induced PS-exposure on erythrocyte surfaces.
(DC conc. 600 µM with or without SM: no significant hemolysis detected
at this concentration).
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Proliferation could not be evaluated in the earliest stages of incubation,
because of the time required for BrdU incorporation in DNA.
Nevertheless, after 16 hrs incubation, DC induced dose-dependent
hyperproliferation. Western blotting with the aid of a specific
antiphosphotyrosine antibody revealed marked changes of the
phosphorylation status of cellular proteins at this time point. The
significance of decreased phosphorylation of proteins < 40 kDa is
currently being investigated.
The second major finding of this study was that sphingomyelin dose-
dependently inhibited apoptosis as well as hyperproliferation. Upon
hydrolysis of sphingomyelin (SM) by neutral or alkaline
sphingomyelinase (35;36), resulting ceramide is currently believed to be
an important pro-apoptotic molecule within the intracellular signalling
pathway, and sphingomyelinase requires bile salts to express its proper
enzymatic activity (37). Nevertheless, it is unlikely that in the present
work, the mechanism of the SM effects was by influencing intracellular
signalling, since apoptosis was inhibited rather than promoted by SM.
Also, we found that SM dose-dependently inhibited DC-induced
exposure of phosphatidylserine on the outer leaflet (a marker of early
“apoptosis”) of the erythrocyte cell membrane; in this case the
intracellular signalling pathway and nucleus are absent. An alternative
explanation would be a local effect of SM on DC detergent activity in the
incubation medium. In a previous study, we found evidence for such a
local protective effect if SM was incorporated in bile salt micelles (13).
The proposed mechanism was a decrease of intermixed micellar-
vesicular bile salt concentration (i.e. non-phospholipid associated bile
salts: monomers + simple micelles, thought to be responsible for
detergent effects and cytotoxicity (38)), due to incorporation of the
sphingolipid in the micelles. In the present study, the bile salt
concentrations were much lower, far below the critical micellar
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concentration. Nevertheless, one may speculate that SM inhibits activity
of bile salt trimers or dimers in the solution.
In summary, we found that in the CaCo-2 cell model,
pathophysiologically relevant concentrations of DC induce dose-
dependent apoptosis and caspase-3 activity in the early stages of
incubation, and hyperproliferation at later stages. Sphingomyelin dose-
dependently inhibits apoptosis as well as hyperproliferation, presumably
through a local effect on deoxycholate activity in the incubation medium.
These findings may have important implications for colon cancer
pathogenesis.
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Cholesterol is poorly soluble in an aqueous environment. In bile, the
sterol is solubilized in mixed micelles by bile salts and phospholipids. In
case of supersaturation, cholesterol is kept in vesicles (spherical bilayers)
with phospholipid or phase-separated as crystals.
Accurate isolation of micellar and vesicular lipid carriers in model
systems is important for the study of the cholesterol crystallization and
gallstone formation. Gel filtration using an eluant containing bile salts in
concentrations and compositions identical to the IMC (intermixed
micellar-vesicular –i.e. non-phospholipid associated- bile salt
concentration) of the original system is the method of choice when
human biles are analyzed, since they contain most unilamellar vesicles.
Separation and isolation of vesicles and mixed micelles then occurs
without artifactual perturbation of the lipid distribution
pseudoequilibrium. In contrast, supersaturated model biles with often
large amounts of aggregated vesicles cannot generally be analyzed
properly by this procedure, since aggregated vesicles are too large to
enter the gel properly and may be lost during the procedure. A new
method for separating lipid carriers in model biles has been proposed in
chapter 2. First, vesicular aggregates and -if present- cholesterol crystals
are precipitated by ultracentrifugation. Cholesterol crystals can be
quantitated after dissolution of vesicular aggregates by adding excess
deoxcholate to the pellet. Second, mixed micelles are isolated by
ultrafiltration through a highly selective filter. Last, unilamellar vesicles
are obtained by dialysis against a solution containing bile salts at
intermixed micellar-vesicular concentrations. With this method, we
investigated the effects of various bile salts and various phospholipid
classes on lipid solubilization in micellar or vesicular phases as well as
on cholesterol crystallization (chapter 3). The rationale was that the
hydrophilic bile salt ursodeoxycholate is frequently used in clinical
practice to dissolve cholesterol gallstones, and that dietary modulation of
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biliary phospholipid composition from phosphatidylcholine with
unsaturated acyl chains (the exclusive phospholipid in bile) toward
phospholipids with mainly saturated acyl chains has been suggested to
prevent gallstone formation. We found enhanced lipid distribution into
vesicular phases, and reciprocal decreases of micellar lipid solubilization
in case of more hydrophilic bile salts such as ursodeoxycholate or in case
of more saturated phospholipids. Whereas disaturated
phosphatidylcholines or sphingomyelins increased crystallization
compared to phosphatidylcholines with unsaturated acyl chains in all
crystal-containing zones, the hydrophilic bile salt tauroursodeoxycholate
inhibited crystallization by formation of vesicular phases. Treatment with
ursodeoxycholate appears preferable to disaturated phospholipids for the
prevention of cholesterol crystallization and gallstones.
Apart from cholesterol crystallization, this thesis also focused on
the process of nascent bile formation. It is uncertain why
phosphatidylcholine is the predominant phospholipid in bile, although
both sphingomyelin and phosphatidylcholine are the major structural
phospholipids in the outer leaflet of the hepatocyte canalicular
membrane. In chapter 4, we have determined the distribution of
phosphatidylcholine from egg yolk (similar acyl chain composition as
phosphatidylcholine in bile) and sphingomyelin into micelles and small
unilamellar vesicles (model for canalicular bile) or detergent-resistant
aggregated vesicles (model for canalicular membrane). We found at
increasing cholesterol contents of the system, preferential distribution of
lipids and progressive enrichment of vesicular aggregates with
sphingomyelin containing long saturated acyl chains. In contrast, there
was preferential distribution of phosphatidylcholine into mixed micelles
and small unilamellar vesicles under these circumstances. Different
physical-chemical characteristics of the two phospholipids may relate to
their different distribution in vivo. It this respect, one should realize that
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cholesterol has a high affinity for sphingomyelin and is thought to be
preferentially located together with this phospholipid in detergent-
resistant domains in the bilayer. In chapter 5, we have studied by means
of spectrophotometry and by sequential state-of-the-art cryo-
transmission electron microscopy, effects of including sphingomyelin
within egg yolk phosphatylcholine-containing vesicles (with and without
cholesterol) on vesicle → micelle phase transitions that were induced by
addition of bile salts. Incorporation of sphingomyelin destabilized egg
yolk phosphatidylcholine vesicles and enhanced vesicle → micelle phase
transitions, with formation of intermediate open, multilamellar and fused
vesicular structures. When cholesterol was also included in the bilayer,
sphingomyelin-egg yolk phosphatidylcholine vesicles appeared highly
resistant against bile salt-induced micellar solubilization. Instead,
intermediate disk-like micelles, and thereafter, multilamellar and large
aggregated vesicles were formed. These findings point to a key role of
cholesterol in formation of pathophysiologically relevant
phosphatidylcholine plus sphingomyelin-containing bilayers and in
modulating interactions between vesicles and detergent bile salts. These
data may have implications for canalicular bile formation and intestinal
lipid solubilization.
Bile salts may present as “good” or “bad” guys. The good aspect is their
effect in intestinal lipid absorption, bile formation and cholesterol
solubilization. The “bad” aspect is the potential cytotoxicity induced by
the detergent bile salts. At the concentrations occurring in hepatic and
gallbladder biles, bile salts could theoretically damage the apical
membrane of the hepatocytes and of the cells lining the biliary tract. The
absence of such a damaging effect in vivo suggests the existence of
cytoprotective mechanisms. In in vitro studies, inclusion of egg yolk
phosphatidylcholine within bile salt micelles protects against bile salt-
induced cytotoxicity. In line with these findings, mice with homozygous
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disruption of the mdr2 gene (complete absence of phosphatidylcholine in
bile) exhibit severe hepatocyte damage in vivo. In chapter 6 we have
compared protective effects of incorporating phosphatidylcholine from
egg yolk (similar to phosphatidylcholine in human bile) and
sphingomyelin within bile salt micelles. Sphingomyelin offered greatly
enhanced protection against bile salt-induced cytotoxicity compared to
egg yolk phosphatidylcholine, which may relate to lower intermixed
micellar-vesicular (i.e. non-phospholipid associated) bile salt
concentrations in case of sphingomyelin. Interestingly, we found that
considerable amounts of sphingomyelin may occur in bile of patients
with obstructive jaundice, with potential amelioration of cytotoxicity as a
result (addendum to chapter 6).
Hydrophobic bile salts are known to exert more cytotoxic effects than
hydrophilic bile salts. In fact, hydrophilic bile salts such as
ursodeoxycholate or hyodeoxycholate may protect against toxicity by
hydrophobic bile salts. In chapter 7 we have examined the effects of bile
salt hydrophobicity on lipid distribution between micelles and small
unilamellar vesicles (model for canalicular bile) and detergent-resistant
aggregated vesicles (model for canalicular membrane). Hydrophilic but
not hydrophobic bile salts preserved integrity of pathophysiologically
relevant phosphatidylcholine- plus sphingomyelin-containing bilayers,
with enhanced differential distribution of phosphatidylcholine vs
sphingomyelin between micellar and vesicular phases. Despite their
similar hydrophilicity, the bile salts ursodeoxycholate and
hyodeoxycholate exert quite different biological effects in vivo:
intraduodenal infusion of taurohyodeoxycholate but not
tauroursodeoxycholate strongly enhances biliary phospholipid secretion.
We found in the erythrocyte and CaCo-2 cell models evidence for
different interactions of tauroursodeoxycholate and hyodeoxycholate
Summary
232
with micellar phospholipids, possibly related to their different in vivo
effects.
Epidemiological and experimental studies have indicated a consistent
correlation between increased risk of colon cancer and elevated levels of
fecal bile salts in Western populations that consume high-fat diets.
Deoxycholate may act as a tumor promoter, inducing hyperproliferation
and increasing the number of tumors elicited by complete carcinogens.
Also, deoxycholate is able to induce apoptosis in some adenoma and
carcinoma cell lines. High-fat diet promotes bile salt accumulation in
feces, where enteric bacteria metabolize them to secondary bile salts,
principally deoxycholate and lithocholate. Dietary supplementation with
sphingomyelin suppresses experimental colon cancer in mice, and
appreciable amounts of dietary sphingomyelin appear to reach to the
colon. In chapter 8, we have examined in CaCo-2 cells potential effects
of sphingomyelin on hyperproliferation or apoptosis induced by
deoxycholate. Pathophysiologically relevant concentrations of this bile
salt induced dose-dependent apoptosis and caspase-3 activity in the early
stages of incubation, but hyperproliferation at later stages.
Sphingomyelin dose-dependently inhibited apoptosis as well as
hyperproliferation, presumably through a local effect on deoxycholate
activity in the incubation medium. These findings may have important
implications for colon cancer prevention.
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Samenvatting en discussie
Cholesterol is slecht oplosbaar in water. In de gal wordt cholesterol
daarom in oplossing gehouden door vorming van gemengde micellen
samen met galzouten en fosfolipid. In geval van oververzadiging (i.e.
overschrijding van de micellaire oplosbaarheid van cholesterol) vormt
cholesterol samen met fosfolipid zogenaamde vesicles (“vetbolletjes”) of
slaat het neer als cholesterolkristal (het begin van galsteenvorming). Een
betrouwbare scheiding van micellen en vesicles is belangrijk bij de
bestudering van cholesterolkristallisatie en galsteenvorming. Voor
humane gal is gelfiltratie de beste scheidingsmethode. Er moet dan wel
als eluens een buffer gebruikt worden die galzouten bevat in een
concentratie en samenstelling identiek aan de zogenaamde “intermixed
micellaire-vesiculaire (niet met fosfolipiden geassocieerde) concentratie”
(IMC: i.e. galzout monomeren en “simpele” galzoutmicellen) in de
oorspronkelijke gal. Dit is nodig om de lipiddistributie tussen de
micellen en vesicles niet te verstoren. Modelgal bevat echter meestal veel
geaggregeerde vesicles. Door hun grootte kunnen die vaak niet het
gelfiltratiemateriaal passeren. In hoofdstuk 2 wordt een niewe
scheidingsmethode voor modelgal beschreven. Allereerst worden
geaggregeerde vesicles en –indien aanwezig- cholesterolkristallen met
behulp van ultracentrifugatie neergeslagen. De hoeveelheid
cholesterolkristallen kan vervolgens bepaald worden, nadat eerst de
geaggregeerde vesicles opgelost zijn door toevoeging van exces
deoxycholaat aan de pellet. Hierna worden de gemengde micellen
geïsoleerd met behulp van ultrafiltratie door een selectief filter. Ten
slotte worden de unilamellaire vesicles geïsoleerd met behulp van dialyse
tegen een buffer die galzouten bevat in een concentratie en een
samenstelling identiek aan de IMC. Met deze nieuwe methode
onderzochten wij de invloed van verschillende galzouten en fosfolipiden
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op de lipiddistributie tussen micellen en vesicles en op de
cholesterolkristallisatie (hoofdstuk 3). De reden om dit onderzoek uit te
voeren was, dat door behandeling met het hydrofiele galzout
ursodeoxycholaat cholesterolkristallisatie en het ontstaan van galstenen
voorkomen kan worden. Bovendien heeft modificatie van de biliaire
fosfolipidsamenstelling (fosfatidylcholine met meer verzadigde vetzuren)
door aanpassing van het dieet misschien een vergelijkbaar gunstig effect.
Wij vonden minder solubilisatie van lipid in micellen en een toegenomen
solubilisatie in vesicles en in geval van hydrofiele galzouten
(tauroursodeoxycholaat). Fosfolipiden met verzadigde vetzuurketens
hadden een zelfde effect op de verdeling van lipid tussen micellen en
vesicles. Fosfolipiden met verzadigde vetzuurketens bleken echter
cholesterolkristallisatie te bevorderen, terwijl kristallisatie juist geremd
werd door tauroursodeoxycholaat. Behandeling met ursodeoxycholaat
heeft dan ook de voorkeur boven dietaire modificatie van de biliaire
fosfolipidsamenstelling, als men cholesterolkristallisatie en het ontstaan
van galstenen wil tegengaan.
Behalve cholesterolkristallisatie werden ook enkele aspecten van
galvorming met behulp van modelsystemen bestudeerd.
Fosfatidylcholine is het belangrijkste fosfolipid in de gal. Behalve
fosfatidylcholine bevat de buitenlaag van de canaliculaire (i.e. aan de
galgangetjes grenzende) membraan van de levercel ook een aanzienlijke
hoeveelheid van het fosfolipid sfingomyeline. In hoofdstuk 4 hebben wij
daarom in modelsystemen de verdeling onderzocht van sfingomyeline en
fosfatidylcholine afkomstig van eidooier (met vnl onverzadigde
vetzuurketens, vergelijkbaar met fosfatidylcholine in gal) tussen
enerszijds micellen en unilamellaire vesicles (beide model voor lipiden
in gal) en anderszijds geaggregeerde vesicles (model voor canaliculaire
membraan). Bij een toenemend cholesterolgehalte in het modelsysteem
bleek er sprake van een preferentiële lipiddistributie en een toenemende
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verrijking met sfingomyeline in geaggregeerde vesicles. Gemengde
micellen en unilamellaire vesicles waren daarentegen verrijkt met
fosfatidylcholine. Het verschil tussen beide fosfolipiden berust op hun
verschillende fysisch-chemische eigenschappen. Cholesterol heeft een
sterke affiniteit voor sfingomyeline en bevindt zich waarschijnlijk samen
met dit fosfolipid in aparte membraandomeinen die resistent zijn tegen
detergentia zoals galzouten. In hoofdstuk 5 hebben wij met behulp van
spectrofotometrie en sequentiële cryo-transmissie electronenmicroscopie
de vesicle	


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van galzouten aan fosfatidylcholine+sfingomyeline bevattende vesicles
(met of zonder cholesterol in de vesiculaire membraan). Incorporatie van
sfingomyeline in fosfatidylcholine-bevattende vesicles maakte de vesicle
membraan gevoeliger voor detergerende galzouten en versnelde het
optreden van vesicle	

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open, multilamellaire en gefuseerde vesiculaire structuren. Als echter
ook cholesterol in de vesiculaire membraan was geïncorporeerd, bleken
fosfatidylcholine+sfingomyeline bevattende vesicles juist erg resistent
tegen micellaire solubilisatie door galzouten. Met behulp van electronen
microscopie werden in dit geval intermediaire schijfvormige micellen en
vervolgens grote multilamellaire en geaggregeerde vesiculaire structuren
gevisualiseerd. Deze gegevens wijzen op het belang van cholesterol bij
de vorming van fysiologisch relevante membranen en bij de interacties
tussen vesicles en detergerende galzouten. Onze bevindingen kunnen
potentiële implicaties hebben voor het proces van galvorming en
intestinale lipidsolubilisatie.
Galzouten hebben behalve gunstige ook potentieel ongunstige
eigenschappen. Enerszijds bevorderen zij de intestinale lipidabsorptie,
galvorming en cholesterolsolubilisatie. Anderszijds zouden zij door hun
detergerend effect ook tot beschadiging van lever-, galweg/galblaas- en
darmcellen kunnen leiden. Aangezien deze beschadiging in vivo
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normaliter niet optreedt, bestaan er blijkbaar ook beschermende
mechanismen. Zo bleek in in vitro studies het fosfolipid fosfatidylcholine
te beschermen tegen galzouttoxiciteit. In overeenstemming met deze
gegevens treedt bij mdr2 “knockout” muizen (geen fosfatidylcholine in
gal) een ernstige leverbeschadiging op. In hoofdstuk 6 hebben wij de
beschermende effecten van fosfatidylcholine afkomstig van eidooier
(vergelijkbare vetzuursamenstelling als fosfatidylcholine in gal) en van
sfingomyeline tegen galzouttoxiciteit vergeleken. Sfingomyeline bleek
een veel betere bescherming te bieden, mogelijk doordat het de
“intermixed micellaire-vesiculaire galzoutconcentratie” (IMC) sterk
verlaagt. De galzouten in de IMC worden namelijk verantwoordelijk
gehouden voor het optreden van cytotoxiciteit. In dit opzicht was het dan
ook een interessante bevinding, dat bij patiënten met cholestase
aanzienlijke hoeveelheden sfingomyeline in de gal bleken voor te komen,
waardoor verdere levercelbeschadiging misschien voorkomen zou
kunnen worden (addendum hoofdstuk 6).
Hydrofobe galzouten zijn over het algemeen meer cytotoxisch dan
hydrofiele galzouten. Ursodeoxycholaat en hyodeoxycholaat –beide
hydrofiele galzouten- beschermen zelfs tegen toxiciteit door meer
hydrofobe galzouten. In hoofdstuk 7 hebben wij het effect van
galzouthydrofobiciteit op de verdeling van lipiden tussen micellen
(model voor gal) en geaggregeerde vesicles (model voor canaliculaire
membraan van de levercel) onderzocht. In tegenstelling tot hydrofobe
galzouten veroorzaakten hydrofiele galzouten geen beschadiging van
pathofysiologisch relevante fosfatidylcholine+sfingomyeline+cholesterol
bevattende membranen. Ook was er een preferentiële distributie van
fosfatidylcholine in micellen en van sfingomyeline in vesicles in het
geval van hydrofiele galzouten. Hoewel ursodeoxycholaat en
hyodeoxycholaat nauwelijks verschillen in mate van hydrofiliciteit, zijn
hun effecten in vivo heel verschillend. Terwijl na intraduodenale infusie
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van taurohyodeoxycholaat een sterke toename van de biliaire
fosfolipidsecretie optreedt, is dat niet het geval bij infusie van
tauroursodeoxycholaat. Wij vonden in erythrocyten en CaCo2 cellen
aanwijzingen voor een verschillende interactie van deze galzouten met
micellaire fosfolipiden, wat misschien hun verschillend effect in vivo zou
kunnen verklaren.
Op grond van epidemiologische en experimentele studies lijkt er
in de westerse wereld (vetrijk dieet) een correlatie te zijn tussen het risico
op dikke darm kanker een de hoeveelheid galzouten in de ontlasting. Met
name het hydrofobe galzout deoxycholaat zou als een tumor promotor
kunnen fungeren, waardoor hyperproliferatie van dikke darm cellen zou
kunnen optreden, met verhoogd risico op tumorinductie. Aan de andere
kant kan deoxycholaat ook apoptose (“geprogrammeerde celdood”)
induceren in sommige kankercellijnen. Door een vetrijk dieet neemt de
hoeveelheid galzouten in de faeces toe. Bacteriën in de dikke darm zetten
die dan om in secundaire galzouten (voornamelijk deoxycholaat en
lithocholaat). In muizen blijkt sfingomyeline in het dieet bovendien
dikke darm kanker te kunnen tegengaan. Uit eerder onderzoek is
gebleken, dat er aanzienlijke hoeveelheden dietair sfingomyeline in de
dikke darm terecht komen. In hoofdstuk 8 hebben wij daarom in CaCo2
cellen de invloed van sfingomyeline op de door deoxycholaat
geïnduceerde apoptose en hyperproliferatie onderzocht. Deoxycholaat in
pathofysiologisch relevante concentraties bleek in de eerste uren na
toevoeging apoptose en daarbij behorende activatie van caspase-3 te
induceren, maar in latere stadia tot hyperproliferatie te leiden.
Sfingomyeline ging zowel apoptose als hyperproliferatie tegen,
waarschijnlijk door een locaal effect op het deoxycholaat in het
incubatiemedium. Deze bevindingen zijn mogelijk relevant voor de
preventie van dikke darm kanker.
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Sommario e discussione
Il colesterolo è una molecola insolubile in acqua. Nella bile, il
colesterolo è solubilizzato nelle micelle miste insieme ai sali biliari ed ai
fosfolipidi. Nel caso di sovrasaturazione biliare, il colesterolo è
contenuto all’interno di vescicole di fosfolipidi (bilayer sferici) o
precipita in forma di cristalli visibili alla microscopia ottica.
Una separazione accurata dei carrier lipidici micellari e vescicolari è
importante per lo studio della cristallizzazione del colesterolo e della
formazione dei calcoli (colelitiasi colesterinica). Nell’analizzare la bile
umana (che contiene molte vescicole piccole unilamellari), il metodo di
scelta nella separazione delle micelle e vesicole è la filtrazione attraverso
gel con l’utilizzo come eluenti di sali biliari in concentrazione e
composizione identiche all’IMC (concentrazione di sali biliari inter
micelle miste e vescicole, cioè quei sali biliari non associati ai
fosfolipidi). In questo modo la separazione e l’isolamento delle vescicole
e delle micelle avviene senza artefatti. Al contrario, modelli di bile
sovrasaturi in colesterolo, che presentano pertanto una elevata quantità di
aggregati di vescicole, non possono essere analizzati con questo metodo,
poiché gli aggregati vescicolari sono troppo grandi per entrare nel gel in
maniera corretta e potrebbero essere persi durante la procedura. Un
nuovo metodo per separare i carrier lipidici nei modelli di bile è stato
proposto nel capitolo 2. In primo luogo, gli aggergati di vescicole ed i
cristalli di colesterolo  -se presenti- sono precipitati con
ultracentrifugazione. I cristalli di colesterolo possono essere quantificati
dopo la dissoluzione degli aggregati di vescicole con l’aggiunta di
desossicolato nel pellet. Secondo, le micelle miste sono isolate con una
ultrafiltrazione del sovranatante con filtri altamente selettivi. Infine, le
vescicole unilamellari sono ottenute attraverso dialisi contro una
soluzione contenente sali biliari alla concentrazione inter micelle miste-
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vescicole. Con questo metodo, nel successivo capitolo (capitolo 3), si è
voluto studiare accuratamente gli effetti di varie classi di sali biliari e
fosfolipidi sia sulla solubilizzazione del colesterolo nelle fasi micellare e
vescicolare che sulla cristallizzazione del colesterolo stesso. Il razionale
dello studio era che il sale biliare idrofilico ursodesossicolato è
frequentemente usato nella pratica clinica per dissolvere i calcoli di
colesterolo e che modulazioni dietetiche della composizione dei
fosfolipidi biliari (dalla fosfatidilcolina con catene di acidi grassi insaturi
-unico fosfolipide presente nella bile umana- a fosfolipidi principalmente
con catene di acidi grassi saturi) potrebbero agire nella prevenzione della
colelitiasi colesterinica. In questo studio abbiamo riscontrato una elevata
distribuzione di lipidi nelle vescicole ed una reciproca diminuizione della
solubilizzazione di lipidi nelle micelle miste nel caso di sali biliari più
idrofilici come l’ursodesossicolato o di fosfolipidi più saturi. Mentre la
sfingomielina (fosfolipide contenente catene di acidi grassi saturi)
aumenta la cristallizzazione del colesterolo rispetto alla fosfatidilcolina
in tutti modelli di bile con cristalli, l’idrofilico ursodesossicolato inibisce
la cristallizzazione attraverso la formazione delle vescicole. Un
trattamento con ursodesossicolato sembra, dunque, preferibile a
modificazione dietetiche con fosfolipidi con catene  di acidi grassi saturi
nella prevenzione della cristallizzazione e della colelitiasi colesterinica.
In questa tesi, oltre alla cristallizzazione del colesterolo, è stato anche
investigato il processo alla base della formazione della bile. Il razionale
del capitolo 4 nasce dalla considerazione che non si conosce il motivo
per cui la fosfaticolina è il fosfolipide predominante nella bile,
nonostante sia la sfingomielina che la fosfatidilcolina sono i maggiori
fosfolipidi strutturali nel foglietto esterno della membrana canalicolare
epatocitaria. È stata pertanto studiata la distribuzione della
fosfatidilcolina isolata dal tuorlo d’uovo (con una composizione di acidi
grassi simile alla fosfatilcolina nella bile) e la sfingomielina tra micelle e
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piccole vescicole unilamellari (modello per la bile canalicolare) e gli
aggregati di vesicole resistenti all’attività detergente (modello per la
membrana canalicolare epatocitaria). All’aumento della concentrazione
di colesterolo nel sistema, si evidenziava sia una distribuzione
progressiva dei lipidi che un progressivo aumento di sfingomielina negli
aggregati vesicolari. Viceversa, alle stesse condizioni, la fosfatidicolina
era preferenzialmente solubilizzata nelle micelle e nelle vescicole
unilamellari. Questa diversa distribuzione dei due fosfolipidi tra i vari
carrier può essere dettata dalle loro diverse caratteristiche fisico-
chimiche. A tal riguardo, si deve sottolineare che il colesterolo ha una
elevata affinità per la sfingomielina ed è preferenzialmente distribuito
con essa all’interno di dominii di membrana resistenti all’attività
detergente. Nel capitolo 5, è descritto uno studio sull’effetto
dell’inclusione di sfingomielina in vescicole di fosfatidicolina dal tuorlo
d’uovo con e senza colesterolo sulla transizione dalla fase vescicolare a
quella micellare indotta dall’aggiunta di sali biliari. Lo studio è stato
effettuato con spettrofotometria e microscopia elettronica sequenziale
con controllo della temperatura e dell’umidità. L’incorporazione della
sfingomielina destabilizzava le vescicole di fosfatidilcolina ed
aumentava la transizione vescicole → micelle, con la formazione di
strutture intermedie quali vescicole aperte, multilamellari e fuse. In
presenza di colesterolo, le vescicole contenenti anche sfingomielina
risultavano altamente resistenti alla solubilizzazione micellare indotta dai
sali biliari. In questo caso, strutture intermedie quali micelle a forma di
disco erano visualizzate e successivamente, grandi aggregati di vescicole
e vescicole multilamellari. Questi dati sottolineano il ruolo di punta del
colesterolo nella formazione dei bilayer contenenti fosfatidicolina e
sfingomielina e nella interazione tra vescicole e sali biliari, con
potenziali implicazioni sia nel processo di  formazione della bile
canalicolare che nella solubilizzazione dei lipidi nel lume intestinale.
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Per usare una semplificazione, i sali biliari possono essere considerati sia
“buoni” che “cattivi”. L’aspetto positivo è il loro effetto
sull’assorbimento intestinale di lipidi, sulla formazione della bile e sulla
solubilizzazione del colesterolo. L’aspetto “cattivo” è la loro potenziale
citotossicità. Alle concentrazioni riscontrate nella bile epatica e
colecistica, i sali biliari potrebbero teoreticamente danneggiare la
membrana apicale degli epatociti e delle cellule che tappezzano le vie
biliari. L’assenza di questo effetto dannoso in vivo suggerisce l’esistenza
di meccanismi di citoprotezione. Studi in vitro hanno dimostrato che
l’inclusione di fosfatidilcolina dal tuorlo d’uovo all’interno delle micelle
di sali biliari protegge dalla tossicità indotta dai sali biliari stessi. In linea
con questi dati, mice con una mutazione omozigote del gene mdr2
(assenza completa di fosfatidilcolina nella bile) presentano un danno
severo degli epatociti in vivo. Nel capitolo 6 l’effetto protettivo sulla
tossicità indotta dai sali biliari da parte della fosfatidilcolina dal tuorlo
d’uovo è stato paragonato a quello della sfingomielina. La sfingomielina
offriva una protezione significativamente maggiore rispetto alla
fosfatidicolina sull’effetto detergente dei sali biliari, probabilmente per i
più bassi valori della concentrazione inter micellare-vescicolare dei sali
biliari nel caso della sfingomielina. È interessante notare che una
significativa concentrazione di sfingomielina si può riscontrare nella bile
dei pazienti con colestasi da ostruzione della vie biliari, con un
potenziale miglioramento della tossicità (addendum capitolo 6).
I sali biliari idrofobici hanno un effetto citotossico superiore a quello dei
sali biliari idrofilici. Infatti, sali biliari idrofilici come l’urodesossicolato
o l’iodeosossicolato possono proteggere dalla tossicità indotta da sali
biliari più idrofobici. Nel capitolo 7, è stato studiato l’effetto
dell’idrofobicità dei sali biliari sulla distribuzione dei lipidi tra le micelle
e le vescicole unilamellari (modello per la bile canalicolare) e gli
aggregati di vescicole resistenti all’attività detergente (modello per la
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membrana canalicolare epatocitaria). I sali biliari idrofilici sono in grado
di preservare l’integrità dei bilayer contenenti sfingomielina e
fosfatidicolina, con un aumento della distribuzione della fosfatidicolina
vs sfingomielina tra le fasi micellari e vescicolari. Nonostante la simile
idrofilicità, i sali biliari ursodesossicolato e iodesossicolato hanno effetti
in vivo molto diversi: l’infusione intraduodenale di tauroiodesossicolato,
al contrario del tauroursodeossicolato, aumenta significativamente la
secrezione dei fosfolipidi nella bile. In questo studio su vari modelli
cellualari (eritrociti e cellule in coltura di carcinoma di colon), sono state
riscontrate evidenze per interazioni fisico-chimiche differenti tra
tauroursodesossicolato e tauroiodesossicolato con i fosfolipidi all’interno
delle micelle.
Studi epidemiologici e sperimentali hanno indicato una correlazione
consistente tra un aumentato rischio di carcinoma del colon ed elevati
livelli di sali biliari nelle feci tra la popolazione del mondo occidentale
che consuma una dieta ricca in grassi. Il desossicolato può agire sia come
promotore di tumori (inducendo iperproliferazione cellulare) che
aumentando il numero di tumori indotti da agenti carcinogeni. Inoltre, è
stato precedentemente dimostrato che il desossicolato è in grado di
indurre l’apoptosi in alcune linee cellulari di adenoma ed
adenocarcinoma. Una dieta ricca in grassi induce l’accumulo dei sali
biliari nelle feci, dove vengono metabolizzati dalla flora batterica
intestinale in sali biliari secondari, principalmente desossicolato e
litocolato. L’aumentato introito di sfingomielina con la dieta sopprime la
formazione di carcinoma di colon indotto in maniera sperimentale e una
quantità apprezzabile di sfingomielina ingerita giunge al colon. Nel
capitolo 8, sono stati studiati gli effetti della sfingomielina sull’apoptosi
e l’iperproliferazione cellulare indotta dai sali biliari. Concentrazioni
patofisiologicamente rilevanti di desossicolato inducevano apoptosi ed
attivazione della caspasi-3 in maniera dose dipendente negli stadi iniziali
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dell’incubazione, con iperproliferazione cellulare successivamente. La
sfingomielina era in grado di inibire in maniera dose-dependente sia
l’apoptosi che l’iperproliferazione, presumibilmente attraverso un effetto
diretto sull’attività del desossicolato in soluzione. Questi dati potrebbero
avere implicazioni importanti nella prevenzione del carcinoma del colon.
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